0001171843-12-003077.txt : 20120810 0001171843-12-003077.hdr.sgml : 20120810 20120810121709 ACCESSION NUMBER: 0001171843-12-003077 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20120630 FILED AS OF DATE: 20120810 DATE AS OF CHANGE: 20120810 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSCAT INC CENTRAL INDEX KEY: 0000099302 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 160874418 STATE OF INCORPORATION: OH FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-03905 FILM NUMBER: 121023553 BUSINESS ADDRESS: STREET 1: 35 VANTAGE POINT DRIVE CITY: ROCHESTER STATE: NY ZIP: 14624 BUSINESS PHONE: 5853527777 MAIL ADDRESS: STREET 1: 35 VANTAGE POINT DRIVE CITY: ROCHESTER STATE: NY ZIP: 14624 FORMER COMPANY: FORMER CONFORMED NAME: TRANSMATION INC DATE OF NAME CHANGE: 19920703 10-Q 1 f10q_081012.htm FORM 10-Q f10q_081012.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q

[x]   Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended:  June 30, 2012

or

[  ]   Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from _______________ to _______________

Commission File Number:  000-03905

TRANSCAT, INC.
(Exact name of registrant as specified in its charter)

Ohio
 
16-0874418
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)

35 Vantage Point Drive, Rochester, New York 14624
(Address of principal executive offices) (Zip Code)

(585) 352-7777
(Registrant’s telephone number, including area code)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes [x]     No [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [x]     No [  ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [  ]
Accelerated filer [  ]
Non-accelerated filer [  ] (Do not check if a smaller reporting company)
Smaller reporting company [x]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes [  ]   No [x]

The number of shares of common stock, par value $0.50 per share, of the registrant outstanding as of August 6, 2012 was 7,409,652.
 
 
 

 
 

 
       
Page(s)
PART I.
 
FINANCIAL INFORMATION
   
         
     
         
     
         
     
         
     
         
     
         
     
         
     
         
   
         
   
         
   
         
PART II.
 
OTHER INFORMATION
   
         
   
         
 
     
 


 
 

 
PART I.  FINANCIAL INFORMATION

ITEM 1.  CONSOLIDATED FINANCIAL STATEMENTS


TRANSCAT, INC.
(In Thousands, Except Per Share Amounts)

   
(Unaudited)
 
   
First Quarter Ended
 
   
June 30,
2012
   
June 25,
2011
 
             
Product Sales
  $ 16,365     $ 17,182  
Service Revenue
    8,732       8,423  
Net Revenue
    25,097       25,605  
                 
Cost of Products Sold
    12,155       12,914  
Cost of Services Sold
    6,735       6,393  
Total Cost of Products and Services Sold
    18,890       19,307  
                 
Gross Profit
    6,207       6,298  
                 
Selling, Marketing and Warehouse Expenses
    3,441       3,626  
Administrative Expenses
    2,172       2,102  
Total Operating Expenses
    5,613       5,728  
                 
Operating Income
    594       570  
                 
Interest and Other Expense, net
    47       45  
                 
Income Before Income Taxes
    547       525  
Provision for Income Taxes
    186       200  
                 
Net Income
  $ 361     $ 325  
                 
Basic Earnings Per Share
  $ 0.05     $ 0.04  
Average Shares Outstanding
    7,375       7,277  
                 
Diluted Earnings Per Share
  $ 0.05     $ 0.04  
Average Shares Outstanding
    7,681       7,608  

See accompanying notes to consolidated financial statements.
 
1

 
TRANSCAT, INC.
(In Thousands)

   
(Unaudited)
 
   
First Quarter Ended
 
   
June 30,
2012
   
June 25,
2011
 
             
Net Income
  $ 361     $ 325  
                 
Other Comprehensive (Loss) Income:
               
Currency Translation Adjustment
    (5 )     (2 )
Unrecognized Prior Service Cost, net of tax
    (82 )     3  
Unrealized Loss on Other Assets, net of tax
    (4 )     -  
      (91 )     1  
                 
Comprehensive Income
  $ 270     $ 326  
                 
See accompanying notes to consolidated financial statements.


 
2

 
TRANSCAT, INC.
CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Share and Per Share Amounts)

   
(Unaudited)
       
   
June 30,
2012
   
March 31,
2012
 
           
Current Assets:
           
Cash
  $ 44     $ 32  
Accounts Receivable, less allowance for doubtful accounts of $97 and $99 as of June 30, 2012 and March 31, 2012, respectively
    11,905       13,800  
Other Receivables
    1,041       845  
Inventory, net
    7,224       6,396  
Prepaid Expenses and Other Current Assets
    1,067       1,064  
Deferred Tax Asset
    857       1,041  
Total Current Assets
    22,138       23,178  
Property and Equipment, net
    5,426       5,306  
Goodwill
    13,384       13,390  
Intangible Assets, net
    2,265       2,449  
Deferred Tax Asset
    315       -  
Other Assets
    849       654  
Total Assets
  $ 44,377     $ 44,977  
                 
LIABILITIES AND SHAREHOLDERS' EQUITY
               
Current Liabilities:
               
Accounts Payable
  $ 6,248     $ 7,516  
Accrued Compensation and Other Liabilities
    2,873       5,171  
Income Taxes Payable
    219       366  
Total Current Liabilities
    9,340       13,053  
Long-Term Debt
    5,852       3,365  
Deferred Tax Liability
    -       139  
Other Liabilities
    1,382       1,042  
Total Liabilities
    16,574       17,599  
                 
Shareholders' Equity:
               
Common Stock, par value $0.50 per share, 30,000,000 shares authorized; 7,905,461 and 7,840,994 shares issued as of June 30, 2012 and March 31, 2012, respectively; 7,406,679 and 7,341,007 shares outstanding as of June 30, 2012 and March 31, 2012, respectively
    3,953       3,920  
Capital in Excess of Par Value
    10,932       10,810  
Accumulated Other Comprehensive Income
    357       448  
Retained Earnings
    14,755       14,394  
Less:  Treasury Stock, at cost, 498,782 shares
    (2,194 )     (2,194 )
Total Shareholders' Equity
    27,803       27,378  
Total Liabilities and Shareholders' Equity
  $ 44,377     $ 44,977  

See accompanying notes to consolidated financial statements.
 
3

 
 
   
(Unaudited)
First Quarter Ended
 
   
June 30,
 2012
   
June 25,
 2011
 
Cash Flows from Operating Activities:
           
Net Income
  $ 361     $ 325  
Adjustments to Reconcile Net Income to Net Cash
               
Used in Operating Activities:
               
Deferred Income Taxes
    (218 )     (8 )
Depreciation and Amortization
    600       670  
Provision for Accounts Receivable and Inventory Reserves
    70       66  
Stock-Based Compensation Expense
    75       258  
Changes in Assets and Liabilities:
               
Accounts Receivable and Other Receivables
    1,662       (297 )
Inventory
    (808 )     (1,028 )
Prepaid Expenses and Other Assets
    (346 )     (163 )
Accounts Payable
    (1,254 )     213  
Accrued Compensation and Other Liabilities
    (2,089 )     (543 )
Income Taxes Payable
    (147 )     (58 )
Net Cash Used in Operating Activities
    (2,094 )     (565 )
                 
Cash Flows from Investing Activities:
               
Purchases of Property and Equipment
    (453 )     (610 )
Business Acquisition
    -       (125 )
Net Cash Used in Investing Activities
    (453 )     (735 )
                 
Cash Flows from Financing Activities:
               
Revolving Line of Credit, net
    2,487       1,296  
Payments on Other Debt Obligations
    -       (6 )
Payments of Contingent Consideration
    (14 )     (58 )
Issuance of Common Stock
    80       70  
Excess Tax Benefits Related to Stock-Based Compensation
    -       6  
Net Cash Provided by Financing Activities
    2,553       1,308  
                 
Effect of Exchange Rate Changes on Cash
    6       2  
                 
Net Increase in Cash
    12       10  
Cash at Beginning of Period
    32       32  
Cash at End of Period
  $ 44     $ 42  
                 
                 
Supplemental Disclosure of Cash Flow Activity:
               
Cash paid during the period for:
               
Interest
  $ 22     $ 18  
Income Taxes, net
  $ 553     $ 262  
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
               
Contingent Consideration Related to Business Acquisition
  $ -     $ 100  
 
See accompanying notes to consolidated financial statements.
 
4

 
TRANSCAT, INC.
(Unaudited)

   
Common Stock
Issued
$0.50 Par Value
   
Capital
In
Excess
of Par
   
Accumulated
Other
Comprehensive
   
Retained
   
Treasury Stock
Outstanding
at Cost
       
   
Shares
   
Amount
   
Value
   
Income
   
Earnings
   
Shares
   
Amount
   
Total
 
                                                 
Balance as of March 31, 2012
    7,840     $ 3,920     $ 10,810     $ 448     $ 14,394       499     $ (2,194 )   $ 27,378  
Issuance of Common Stock
    13       7       73                                       80  
Stock-Based Compensation
    52       26       49                                       75  
Other Comprehensive Loss
                            (91 )                             (91 )
Net Income
                                    361                       361  
                                                                 
Balance as of June 30, 2012
    7,905     $ 3,953     $ 10,932     $ 357     $ 14,755       499     $ (2,194 )   $ 27,803  
                                                                 
 
 
See accompanying notes to consolidated financial statements.



 
 

 
 
5

 
TRANSCAT, INC.
(In Thousands, Except Per Share Amounts)
(Unaudited)

NOTE 1 – GENERAL

Description of Business:  Transcat, Inc. (“Transcat” or the “Company”) is a distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair, inspection and other compliance services primarily for pharmaceutical and FDA-regulated, industrial manufacturing, energy and utilities, chemical manufacturing and other industries.

Basis of Presentation: Transcat’s unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”).  Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements.  In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included.  The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year.  The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended March 31, 2012 (“fiscal year 2012”) contained in the Company’s 2012 Annual Report on Form 10-K filed with the SEC.

Fair Value of Financial Instruments:  Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy.  The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels.  Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions.  The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to variable interest rate pricing, and the carrying amounts for cash, accounts receivable and accounts payable approximate fair value due to their short-term nature.  Investment assets, which fund the Company’s non-qualified deferred compensation plan are included as a component of other assets (non-current) on the Consolidated Balance Sheets, consist of mutual funds and are valued based on quoted market prices in active markets.

Stock-Based Compensation:  The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock, based on the fair market value of the award as of the grant date.  The Company records compensation cost related to unvested stock awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period of each award.  Excess tax benefits from the exercise of stock awards are presented in the Consolidated Statements of Cash Flows as a financing activity.  Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards.  The Company did not capitalize any stock-based compensation costs as part of an asset.  The Company estimates forfeiture rates based on its historical experience.  During the first quarter of the fiscal year ending March 30, 2013 (“fiscal year 2013”) and fiscal year 2012, the Company recorded non-cash stock-based compensation cost of less than $0.1 million and $0.3 million, respectively, in the Consolidated Statements of Operations.

Foreign Currency Translation and Transactions:  The accounts of Transmation (Canada) Inc., a wholly-owned subsidiary, are maintained in the local currency and have been translated to U.S. dollars.  Accordingly, the amounts representing assets and liabilities, except for equity, have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period.  Gains and losses arising from translation of Transmation (Canada) Inc.’s balance sheets into U.S. dollars are recorded directly to the accumulated other comprehensive income component of shareholders’ equity.

Transcat records foreign currency gains and losses on Canadian business transactions.  The net foreign currency loss was less than $0.1 million in the first quarter of fiscal years 2013 and 2012.  The Company utilizes foreign exchange forward contracts to reduce the risk that its earnings would be adversely affected by changes in currency exchange rates.  The Company does not apply hedge accounting and therefore the change in the fair value of the contracts, which totaled less than $0.1 million during the first quarter of fiscal years 2013 and 2012, was recognized as a component of other expense in the Consolidated Statements of Operations.  The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged.  On June 30, 2012, the Company had a foreign exchange contract, which matured in July 2012, outstanding in the notional amount of $1.6 million. The Company does not use hedging arrangements for speculative purposes.

 
6

 
Earnings Per Share:  Basic earnings per share of common stock are computed based on the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share of common stock reflect the assumed conversion of stock options and unvested restricted stock awards using the treasury stock method in periods in which they have a dilutive effect.  In computing the per share effect of assumed conversion, funds which would have been received from the exercise of options and unvested restricted stock and the related tax benefits are considered to have been used to purchase shares of common stock at the average market prices during the period.  The resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding.

The average shares outstanding used to compute basic and diluted earnings per share are as follows:

   
First Quarter Ended
 
   
June 30,
2012
   
June 25,
2011
 
Average Shares Outstanding – Basic
    7,375       7,277  
Effect of Dilutive Common Stock Equivalents
    306       331  
Average Shares Outstanding – Diluted
    7,681       7,608  
Anti-dilutive Common Stock Equivalents
    428       475  

Subsequent Event:  On July 16, 2012, the Company acquired Anacor Compliance Services, Inc., a nationally-recognized provider of specialized analytical, calibration, compliance and validation services to the life sciences sector including biotechnology, medical device and pharmaceutical industries.  The acquisition is not considered material.

NOTE 2 – DEBT

Description:  Transcat, through its credit agreement (the “Credit Agreement”) which matures in January 2014, has a revolving credit facility in the amount of $15.0 million (the “Revolving Credit Facility”).  As of June 30, 2012, $15.0 million was available under the Credit Agreement, of which $5.9 million was outstanding and included in long-term debt on the Consolidated Balance Sheet.

Interest and Other Costs:  Interest on the Revolving Credit Facility accrues, at Transcat’s election, at either a base rate (the “Base Rate”), as defined in the Credit Agreement, or the London Interbank Offered Rate (“LIBOR”), in each case, plus a margin.  Commitment fees accrue based on the average daily amount of unused credit available on the Revolving Credit Facility.  Interest and commitment fees are adjusted on a quarterly basis based upon the Company’s calculated leverage ratio, as defined in the Credit Agreement.  The Base Rate and the LIBOR as of June 30, 2012 were 3.3% and 0.2%, respectively.  The Company’s interest rate for the first quarter of fiscal year 2013 ranged from 1.1% to 2.8%.

Covenants:  The Credit Agreement has certain covenants with which the Company has to comply, including a fixed charge ratio covenant and a leverage ratio covenant.  The Company was in compliance with all loan covenants and requirements throughout the first quarter of fiscal year 2013.

Other Terms:  The Company has pledged all of its U.S. tangible and intangible personal property and a majority of the common stock of its wholly-owned subsidiary, Transmation (Canada) Inc., as collateral security for the loans made under the Revolving Credit Facility.

NOTE 3 – STOCK-BASED COMPENSATION

The Transcat, Inc. 2003 Incentive Plan, as Amended and Restated (the “2003 Plan”), provides for, among other awards, grants of restricted stock and stock options to directors, officers and key employees at the fair market value at the date of grant.  At June 30, 2012, the number of shares available for future grant under the 2003 Plan totaled 0.1 million.

Restricted Stock:  The Company grants performance-based restricted stock awards as a primary component of executive compensation.  The awards generally vest following the third fiscal year from the date of grant subject to certain cumulative diluted earnings per share growth targets over the eligible period.

Compensation cost ultimately recognized for these performance-based restricted stock awards will equal the grant date fair market value of the award that coincides with the actual outcome of the performance conditions.  On an interim basis, the Company records compensation cost based on an assessment of the probability of achieving the performance conditions.  The Company achieved 75% of the target level for the performance-based restricted stock awards granted in the fiscal year ended March 27, 2010 (“fiscal year 2010”) and as a result, issued 52 thousand shares of common stock to executive officers during the first quarter of fiscal year 2013.  At June 30, 2012, the Company estimated the probability of achievement for the awards granted in fiscal years 2013 and 2012 to be 100% of the target levels and 75% of the target levels for the awards granted in the fiscal year ended March 26, 2011 (“fiscal year 2011”).  Total expense relating to performance-based restricted stock awards, based on grant date fair value and the estimated probability of achievement, was less than $0.1 million in the first quarter of fiscal years 2013 and 2012.  Unearned compensation totaled $0.8 million as of June 30, 2012.
 
7

 
On April 4, 2011, the Company granted restricted stock awards, which vested immediately, to its officers and certain key employees.  Total expense related to these restricted stock awards, based on grant date fair value, was $0.1 million in the first quarter of fiscal year 2012.

Stock Options:  Options generally vest over a period of up to four years, using either a graded schedule or on a straight-line basis, and expire ten years from the date of grant.  The expense relating to options is recognized on a straight-line basis over the requisite service period for the entire award.

The following table summarizes the Company’s options as of and for the first quarter ended June 30, 2012:

   
Number
Of
Shares
   
Weighted
Average
Exercise
Price Per
Share
   
Weighted Average
Remaining
Contractual
Term (in years)
   
Aggregate
Intrinsic
Value
 
Outstanding as of March 31, 2012
    597     $ 5.94                  
Granted
    -       -                  
Exercised
    (10 )     4.03                  
Cancelled/Forfeited
    (20 )     6.65                  
Outstanding as of June 30, 2012
    567       5.95       4     $ 516  
Exercisable as of June 30, 2012
    560       5.94       4       516  

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the first quarter of fiscal year 2013 and the exercise price, multiplied by the number of in-the-money stock options) that would have been received by the option holders had all holders exercised their options on June 30, 2012.  The amount of aggregate intrinsic value will change based on the fair market value of the Company’s stock.

Total unrecognized compensation cost related to non-vested stock options as of June 30, 2012 was less than $0.1 million, which is expected to be recognized over a weighted average period of less than one year.  The aggregate intrinsic value of stock options exercised in the first quarter of fiscal year 2013 was less than $0.1 million.  Cash received from the exercise of options in the first quarter of fiscal year 2013 was less than $0.1 million.

 
8

 
NOTE 4 – SEGMENT INFORMATION

Transcat has two reportable segments:  Distribution Products (“Product”) and Calibration Services (“Service”).  The Company has no inter-segment sales.  The following table presents segment information for the first quarters ended June 30, 2012 and June 25, 2011:

   
First Quarter Ended
 
   
June 30,
2012
   
June 25,
2011
 
Net Revenue:
           
Product Sales
  $ 16,365     $ 17,182  
Service Revenue
    8,732       8,423  
Total
    25,097       25,605  
                 
Gross Profit:
               
Product
    4,210       4,268  
Service
    1,997       2,030  
Total
    6,207       6,298  
                 
Operating Expenses:
               
Product (1)
    3,358       3,447  
Service (1)
    2,255       2,281  
Total
    5,613       5,728  
                 
Operating Income
    594       570  
                 
Unallocated Amounts:
               
Interest and Other Expense, net
    47       45  
Provision for Income Taxes
    186       200  
Total
    233       245  
                 
Net Income
  $ 361     $ 325  
 
(1) Operating expense allocations between segments were based on actual amounts, a percentage of revenues, headcount, and management’s estimates.
 

NOTE 5 – ACQUISITIONS

In connection with certain of its business acquisitions, the Company entered into earn out agreements with the former owners of the acquired businesses.  These agreements entitle the former owners to receive earn out payments subject to continued employment and certain post-closing financial targets, as defined in the agreements.  During the first quarter of fiscal year 2012, payments totaling $0.1 million were earned and recorded as compensation expense in the Consolidated Statements of Operations.  There were no amounts earned in the first quarter of fiscal year 2013.  Earn out consideration unpaid as of June 30, 2012 totaled less than $0.1 million and was included in other current liabilities in the Consolidated Balance Sheet.

In addition, certain of these business acquisitions contain holdback provisions, as defined in the respective purchase agreements.  The Company accrues contingent consideration relating to the holdback provisions based on their estimated fair value as of the date of acquisition.  During the first quarter of fiscal years 2013 and 2012, the Company paid less than $0.1 million in contingent consideration.  There was no unpaid contingent consideration as of June 30, 2012.

 
9

 
ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements:  This report and, in particular, the Management’s Discussion and Analysis of Financial Condition and Results of Operations section of this report, contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995.  These include statements concerning expectations, estimates, and projections about the industry, management beliefs and assumptions of Transcat, Inc. (“Transcat”, “we”, “us”, or “our”).  Words such as “anticipates”, “expects”, “intends”, “plans”, “believes”, “seeks”, “estimates”, and variations of such words and similar expressions are intended to identify such forward-looking statements.  These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to forecast.  Therefore, our actual results and outcomes may materially differ from those expressed or forecasted in any such forward-looking statements.  When considering these risks, uncertainties and assumptions, you should keep in mind the cautionary statements contained elsewhere in this report and in any documents incorporated herein by reference.  New risks and uncertainties arise from time to time and we cannot predict those events or how they may affect us.  For a more detailed discussion of the risks and uncertainties that may affect Transcat’s operating and financial results and its ability to achieve its financial objectives, interested parties should review the “Risk Factors” sections in Transcat’s reports filed with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the fiscal year ended March 31, 2012.  We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Accounts Receivable:  Accounts receivable represent amounts due from customers in the ordinary course of business.  These amounts are recorded net of the allowance for doubtful accounts and returns in the Consolidated Balance Sheets.  The allowance for doubtful accounts is based upon the expected collectibility of accounts receivable.  We apply a specific formula to our accounts receivable aging, which may be adjusted on a specific account basis where the formula may not appropriately reserve for loss exposure.  After all attempts to collect a receivable have failed, the receivable is written-off against the allowance for doubtful accounts.  The returns reserve is calculated based upon the historical rate of returns applied to revenues over a specific timeframe.  The returns reserve will increase or decrease as a result of changes in the level of revenues and/or the historical rate of returns.

Stock-Based Compensation:  We measure the cost of services received in exchange for all equity awards granted, including stock options and restricted stock, based on the fair market value of the award as of the grant date.  We record compensation cost related to unvested stock awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period of each award.  Excess tax benefits from the exercise of stock awards are presented in the Consolidated Statements of Cash Flows as a financing activity.  Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards.  We did not capitalize any stock-based compensation costs as part of an asset.  We estimate forfeiture rates based on our historical experience.

We grant performance-based restricted stock awards as a primary component of executive compensation.  The awards generally vest following the third fiscal year from the date of grant subject to certain cumulative diluted earnings per share growth targets over the eligible period.  Compensation cost ultimately recognized for these performance-based restricted stock awards will equal the grant-date fair market value of the award that coincides with the actual outcome of the performance conditions.  On an interim basis, we record compensation cost based on an assessment of the probability of achieving the performance conditions.  We achieved 75% of the target level for the performance-based restricted stock awards granted in fiscal year 2010 and as a result, issued 52 thousand shares of common stock to executive officers during the first quarter of fiscal year 2013.  At June 30, 2012, we estimated the probability of achievement for the awards granted in fiscal years 2013 and 2012 to be 100% of the target levels and 75% of the target levels for the awards granted in fiscal year 2011.

Revenue Recognition:  Product sales are recorded when a product’s title and risk of loss transfer to the customer.  We recognize the majority of our service revenue based upon when the calibration or other activity is performed and then shipped and/or delivered to the customer.  Some service revenue is generated from managing customers’ calibration programs in which we recognize revenue in equal amounts at fixed intervals.  We generally invoice our customers for freight, shipping, and handling charges.  Provisions for customer returns are provided for in the period the related revenues are recorded based upon historical data.

 
10

 
RESULTS OF OPERATIONS

The following table presents, for the first quarter of fiscal years 2013 and 2012, the components of our Consolidated Statements of Operations:

   
(Unaudited)
 
   
First Quarter Ended
 
   
June 30,
   
June 25,
 
   
2012
   
2011
 
Gross Profit Percentage:
           
Product Gross Profit
    25.7 %     24.8 %
Service Gross Profit
    22.9 %     24.1 %
Total Gross Profit
    24.7 %     24.6 %
                 
As a Percentage of Total Net Revenue:
               
Product Sales
    65.2 %     67.1 %
Service Revenue
    34.8 %     32.9 %
Total Net Revenue
    100.0 %     100.0 %
                 
Selling, Marketing and Warehouse Expenses
    13.7 %     14.2 %
Administrative Expenses
    8.7 %     8.2 %
Total Operating Expenses
    22.3 %     22.4 %
                 
Operating Income
    2.4 %     2.2 %
                 
Interest and Other Expense, net
    0.2 %     0.1 %
                 
Income Before Income Taxes
    2.2 %     2.1 %
Provision for Income Taxes
    0.8 %     0.8 %
                 
Net Income
    1.4 %     1.3 %

FIRST QUARTER ENDED JUNE 30, 2012 COMPARED TO FIRST QUARTER ENDED JUNE 25, 2011 (dollars in thousands):

Revenue:
 
   
First Quarter Ended
 
   
June 30,
   
June 25,
 
   
2012
   
2011
 
Net Revenue:
           
Product Sales
  $ 16,365     $ 17,182  
Service Revenue
    8,732       8,423  
Total
  $ 25,097     $ 25,605  

Net revenue decreased $0.5 million, or 2.0%, from the first quarter of fiscal year 2012 to the first quarter of fiscal year 2013.

Our product net sales accounted for 65.2% of our total net revenue in the first quarter of fiscal year 2013 and 67.1% of our total net revenue in the first quarter of fiscal year 2012.  Product segment sales decreased $0.8 million, or 4.8%, in the first quarter of fiscal year 2013, primarily due to sluggish economic conditions and compared with unusually strong product sales in the first quarter of fiscal year 2012.  Direct sales to end users and sales to resellers were down in the first quarter of fiscal year 2013.  Our fiscal years 2013 and 2012 product sales growth in relation to prior fiscal year quarter comparisons is as follows:

   
FY 2013
     
FY 2012
 
      Q1         Q4       Q3       Q2       Q1  
Product Sales (Decline) Growth
    (4.8 %)       19.2 %     17.0 %     26.0 %     32.4 %
 
 
 
11

 
Our average product sales per business day decreased to $260 in the first quarter of fiscal year 2013 compared with $268 in the first quarter of fiscal year 2012.  Our product sales per business day for each quarter during the fiscal years 2013 and 2012 are as follows:
 
   
FY 2013
     
FY 2012
 
      Q1         Q4       Q3       Q2       Q1  
Product Sales Per Business Day
  $ 260       $ 295     $ 308     $ 269     $ 268  

Customer product orders include orders for instruments that we routinely stock in our inventory, customized products, and other products ordered less frequently, which we do not stock.  Pending product shipments are primarily backorders, but also include products that are requested to be calibrated in our laboratories prior to shipment, orders required to be shipped complete or at a future date, and other orders awaiting final credit or management review prior to shipment.  Our total pending product shipments for the first quarter of fiscal year 2013 decreased by $0.2 million, or 6.5%, from the first quarter of fiscal year 2012.  This decrease was primarily driven by reduced backorders and fewer pending shipments requiring management review.  Overall, variations in pending product shipments can be impacted by several factors, including the timing of when product orders are placed in relation to the end of the fiscal period, specialized product orders that are not stocked, or production issues experienced by manufacturers.  The following table presents the percentage of total pending product shipments that are backorders at the end of the first quarter of fiscal year 2013 and our historical trend of total pending product shipments:

   
FY 2013
     
FY 2012
 
      Q1         Q4       Q3       Q2       Q1  
Total Pending Product Shipments
  $ 2,806       $ 2,670     $ 3,572     $ 3,368     $ 3,002  
% of Pending Product Shipments
                                         
     that are Backorders
    68.8 %       70.9 %     65.6 %     73.6 %     67.9 %

Service revenue increased $0.3 million, or 3.7%, from the first quarter of fiscal year 2012 to the first quarter of fiscal year 2013.  The growth can be attributed to incremental revenue associated with recent business acquisitions, partially offset by the loss of $0.3 million in low margin revenue from services we were outsourcing for a customer.  The remainder of our organic Service segment revenue and volume were essentially flat when compared with the first quarter of fiscal 2012.  Within any year, while we add new customers, we also have customers from the prior year whose calibrations may not repeat for any number of reasons.  Among those reasons are variations in the timing of customer periodic calibrations on instruments and other services, customer capital expenditures and customer outsourcing decisions.  Because the timing of calibration orders and segment expenses can vary on a quarter-to-quarter basis, we believe a trailing twelve-month trend provides a better indication of the progress of this segment.  Service segment revenue for the twelve months ended June 30, 2012 were $36.7 million, up 14.4% when compared with $32.1 million for the twelve months ended June 25, 2011.  Our fiscal years 2013 and 2012 service revenue growth in relation to prior fiscal year quarter comparisons is as follows:

   
FY 2013
     
FY 2012
 
      Q1         Q4       Q3       Q2       Q1  
Service Revenue Growth
    3.7 %       20.1 %     24.0 %     10.3 %     10.1 %

Within the calibration industry, there is a broad array of measurement disciplines making it costly and inefficient for any one provider to invest the needed capital for facilities, equipment and uniquely trained personnel necessary to address all measurement disciplines with in-house calibration capabilities.  Our strategy has been to focus our investments in the core electrical, temperature, pressure and dimensional disciplines.  Accordingly, over the long-term, we expect to outsource 15% to 20% of Service segment revenue to third party vendors for calibration beyond our chosen scope of capabilities. During any individual quarter, we could fluctuate beyond these percentages.  We will continue to evaluate the need for capital investments that could provide more in-house capabilities for our staff of technicians and reduce the need for third party vendors in certain instances.  The following table presents the source of our Service segment revenue and the percent of Service segment revenue for each quarter during fiscal years 2013 and 2012:

   
FY 2013
     
FY 2012
 
      Q1         Q4       Q3       Q2       Q1  
Percent of Service Revenue:
                                         
Depot/Onsite
    79.1 %       80.5 %     77.9 %     79.0 %     77.7 %
Outsourced
    18.3 %       16.7 %     19.7 %     18.5 %     19.8 %
Freight Billed to Customers
    2.6 %       2.8 %     2.4 %     2.5 %     2.5 %
      100.0 %       100.0 %     100.0 %     100.0 %     100.0 %
 
 
12

 
Gross Profit:
 
   
First Quarter Ended
 
   
June 30,
   
June 25,
 
   
2012
   
2011
 
Gross Profit:
           
Product
  $ 4,210     $ 4,268  
Service
    1,997       2,030  
Total
  $ 6,207     $ 6,298  

Total gross profit dollars in the first quarter of fiscal year 2013 decreased $0.1 million, or 1.4%, from the first quarter of fiscal year 2012.  Total gross margin in the first quarter of fiscal year 2013 increased 10 basis points from the first quarter of fiscal year 2012.
 
We evaluate product gross profit from two perspectives.  Channel gross profit includes net sales less the direct cost of inventory sold.  Our total product gross profit includes channel gross profit as well as the impact of vendor rebates, cooperative advertising income, freight billed to customers, freight expenses and direct shipping costs.  In general, our product gross margin can vary based upon the mix of products sold, price discounting and the timing of periodic vendor rebates and cooperative advertising income received from suppliers.

Product segment gross profit declined 1.4% to $4.2 million in the first quarter of fiscal year 2013 compared to the first quarter of fiscal year 2012.  As a percent of net sales, gross profit improved to 25.7% in the first quarter of fiscal year 2013 compared with 24.8% in the first quarter of fiscal year 2012.  The gross margin expansion was the result of increased cooperative advertising income. The following table reflects the quarterly historical trend of our product gross margin as a percent of total product sales:

   
FY 2013
     
FY 2012
 
      Q1         Q4       Q3       Q2       Q1  
Channel Gross Margin (1)
    22.7 %       23.3 %     22.5 %     23.1 %     23.0 %
Total Product Gross Margin (2)
    25.7 %       24.7 %     25.6 %     25.4 %     24.8 %
 
(1)  Channel gross margin is calculated as net sales less purchase costs divided by net sales.
(2)  Includes vendor rebates, cooperative advertising income, freight billed to customers, freight expenses, and direct shipping costs.

Service segment gross profit was $2.0 million in the first quarter of fiscal years 2013 and 2012.  Service segment gross margin decreased 120 basis points over the same time period in the prior fiscal year to 22.9% as a result of revenue growth from acquisitions rather than organic sales efforts.  The incremental gross margin on acquired business revenue is generally lower than the incremental gross margin on our organically-generated revenue primarily due to the lower per unit pricing historically charged by smaller acquired companies.  Because of the impact of acquisitions and calibration orders with existing customers, segment expenses can vary on a quarter-to-quarter basis.  We believe a trailing twelve month trend provides a better indication of the progress of this segment.  Service segment gross profit for the twelve months ended June 30, 2012 was $8.6 million, up 5.9% when compared with $8.1 million for the twelve months ended June 25, 2011.  The following table reflects the quarterly historical trend of our calibration services gross margin as a percent of net revenues:

   
FY 2013
     
FY 2012
 
      Q1         Q4       Q3       Q2       Q1  
Service Gross Margin
    22.9 %       27.3 %     20.1 %     22.4 %     24.1 %


 
13

 
Operating Expenses:
 
   
First Quarter Ended
 
   
June 30,
   
June 25,
 
   
2012
   
2011
 
Operating Expenses:
           
Selling, Marketing and Warehouse
  $ 3,441     $ 3,626  
Administrative
    2,172       2,102  
Total
  $ 5,613     $ 5,728  

Operating expenses decreased $0.1 million, or 2.0%, from the first quarter of fiscal year 2012 to the first quarter of fiscal year 2013.  The decrease reflected lower stock-based compensation expense which was partially offset by a one-time Service segment sales organization restructuring charge.  As a percentage of total net revenue, operating expenses were 22.3% and 22.4% in the first quarter of fiscal years 2013 and 2012, respectively.

Taxes:
   
First Quarter Ended
 
   
June 30,
   
June 25,
 
   
2012
   
2011
 
Provision for Income Taxes
  $ 186     $ 200  

Our effective tax rates for the first quarter of fiscal years 2013 and 2012 were 34.0% and 38.1%, respectively.  We continue to evaluate our tax provision on a quarterly basis and make adjustments, as deemed necessary, to our effective tax rate given changes in facts and circumstances expected for the entire fiscal year.

LIQUIDITY AND CAPITAL RESOURCES

We believe that amounts available under our current credit facility and our cash on hand are sufficient to satisfy our expected working capital and capital expenditure needs as well as our lease commitments for the foreseeable future.
 
Cash Flows:  The following table is a summary of our Consolidated Statements of Cash Flows:

   
First Quarter Ended
 
   
June 30,
   
June 25,
 
   
2012
   
2011
 
Cash (Used in) Provided by:
           
Operating Activities
  $ (2,094 )   $ (565 )
Investing Activities
    (453 )     (735 )
Financing Activities
    2,553       1,308  
 
Operating Activities:  Net cash used in operations was $2.1 million for the first quarter of fiscal year 2013 compared to $0.6 million in the first quarter of fiscal year 2012.  Significant working capital fluctuations were as follows:
 
·  
Inventory/Accounts Payable:  Inventory at June 30, 2012 was $7.2 million, up from $6.4 million at March 31, 2012.  Our inventory strategy includes making appropriate larger quantity, higher dollar based purchases with key manufacturers for various reasons, including maximizing on-hand availability of key products, reducing backorders for those products with long lead times and optimizing vendor volume discounts.  As a result, inventory levels from quarter-to-quarter will vary based on the timing of these larger orders in relation to the quarter-end. In general, our accounts payable balance increases or decreases as a result of timing of vendor payments for inventory receipts. However, this correlation may vary at a quarter-end due to the timing of vendor payments for inventory receipts and inventory shipped directly to customers, as well as the timing of product sales.
 
 
14

 
·  
Receivables:  Our quarter-end days sales outstanding continue to reflect strong collections.  The following table illustrates our days sales outstanding for the fiscal quarters ended June 30, 2012 and June 25, 2011:
 
   
June 30,
   
June 25,
 
   
2012
   
2011
 
Net Sales, for the last two fiscal months
  $ 18,131     $ 18,468  
Accounts Receivable, net
  $ 11,905     $ 11,983  
Days Sales Outstanding
    39       39  

·  
Accrued Compensation and Other Liabilities:  During the first quarter of fiscal year 2013, we used $2.1 million in cash to pay accrued compensation and other liabilities compared with $0.5 million in the first quarter of fiscal year 2012.  The primary components of accrued compensation were performance-based management bonuses and employee profit sharing.

Investing Activities:  During the first quarter of fiscal years 2013 and 2012, we invested $0.5 million and $0.6 million, respectively, in additional service capabilities, information technology enhancements and facility improvements.

Financing Activities:  During the first quarter of fiscal year 2013, financing activities provided approximately $2.6 million in cash, which was used for capital expenditures, to help reduce accounts payable and to pay employee profit sharing and performance-based management bonuses.  During the first quarter of fiscal year 2012, financing activities provided approximately $1.3 million in cash, which was used for capital expenditures and to pay employee profit sharing and performance-based management bonuses.

OUTLOOK

Coming off a strong fourth quarter to end fiscal year 2012, we experienced a slower than expected start in our first quarter of fiscal year 2013.  The sluggish economy clearly impacted both of our business segments. We expect, at least for the near term, for this economic environment to remain unchanged.  We continue to remain optimistic regarding our long-term growth expectations.  We expect our Product segment growth rate to be mid-single digits and our Service segment growth rate to be greater than 10%.  Our Service segment remains a priority as we look to leverage our current capabilities and execute on our acquisition strategy to increase our geographic footprint, enhance our service capabilities and deepen our relationships in our targeted industries.  As we acquire additional service businesses, our focus is to increase cash flow and earnings rather than gross margin.  We believe the impact will be more evident in our gross profit dollars and earnings before interest, taxes, depreciation and amortization than in our gross margin as these businesses typically operate at a lower gross margin, but generate sufficient cash flow to provide a good return on our investment.  In July 2012, we acquired Anacor Compliance Services, Inc.  This acquisition expands our reach into the targeted life sciences industry.


INTEREST RATES

Our exposure to changes in interest rates results from our borrowing activities.  In the event interest rates were to move by 1%, our yearly interest expense would increase or decrease by less than $0.1 million assuming our average-borrowing levels remained constant.  As of June 30, 2012, $15.0 million was available under our credit facility, of which $5.9 million was outstanding and included in long-term debt on the Consolidated Balance Sheet.

Under our credit facility, described in Note 2 of our Consolidated Financial Statements included in this report, interest is adjusted on a quarterly basis based upon our calculated leverage ratio.  We mitigate our interest rate risk by electing the lower of the Base Rate available under the credit facility or the LIBOR plus a margin.  As of June 30, 2012, the Base Rate and the LIBOR were 3.3% and 0.2%, respectively.  Our interest rate for the first quarter of fiscal year 2013 ranged from 1.1% to 2.8%.  On June 30, 2012, we had no hedging arrangements in place to limit our exposure to upward movements in interest rates.

FOREIGN CURRENCY

Over 90% of our net revenue for the first quarter of fiscal years 2013 and 2012 was denominated in U.S. dollars, with the remainder denominated in Canadian dollars.  A 10% change in the value of the Canadian dollar to the U.S. dollar would impact our net revenue by less than 1%.  We monitor the relationship between the U.S. and Canadian currencies on a continuous basis and adjust sales prices for products and services sold in Canadian dollars as we believe to be appropriate.

 
15

 
We utilize foreign exchange forward contracts to reduce the risk that future earnings would be adversely affected by changes in currency exchange rates.  We do not apply hedge accounting and therefore the change in the fair value of the contracts, which totaled less than $0.1 million during the first quarter of fiscal years 2013 and 2012, was recognized as a component of other expense in the Consolidated Statements of Operations.  The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged.  On June 30, 2012, we had a foreign exchange forward contract, which matured in July 2012, outstanding in the notional amount of $1.6 million. We do not use hedging arrangements for speculative purposes.


(a)  Conclusion Regarding the Effectiveness of Disclosure Control and Procedures:  Our principal executive officer and our principal financial officer evaluated our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this quarterly report.  Disclosure controls and procedures are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our principal executive officer and principal financial officer to allow timely decisions regarding required disclosure.  Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of such date.

(b)  Changes in Internal Control over Financial Reporting:  There has been no change in our internal control over financial reporting that occurred during the last fiscal quarter covered by this quarterly report (our first fiscal quarter) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


PART II.  OTHER INFORMATION

ITEM 6.  EXHIBITS

See Index to Exhibits.
 
 
16

 



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
TRANSCAT, INC.
   
   
   
Date:  August 10, 2012
/s/ Charles P. Hadeed
 
Charles P. Hadeed
 
President and Chief Executive Officer
(Principal Executive Officer)
   
   
Date:  August 10, 2012
/s/ John J. Zimmer
 
John J. Zimmer
 
Senior Vice President of Finance and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)

 
17

 

   
(10)
Material contracts
     
 
10.1
Transcat, Inc. Post-Retirement Benefit Plan for Officers (Amended and Restated Effective April 2, 2012)
     
 
10.2
Agreement for Severance Upon Change in Control by and between Transcat, Inc. and Lee D. Rudow dated as of May 7, 2012 is incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 11, 2012.
     
(31)
Rule 13a-14(a)/15d-14(a) Certifications
     
 
31.1
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
 
31.2
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
(32)
Section 1350 Certifications
     
 
32.1
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
(101)
Interactive Data File
     
   * 101.INS
XBRL Instance Document
     
   * 101.SCH
XBRL Taxonomy Extension Schema Document
     
   * 101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document
     
   * 101.DEF
XBRL Taxonomy Extension Definition Linkbase Document
   
   * 101.LAB
XBRL Taxonomy Extension Label Linkbase Document
   
   * 101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document
   
*Pursuant to Rule 406T of Regulation S-T, the information in this exhibit is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
 
 
18

EX-10.1 2 exh_101.htm EXHIBIT 10.1 exh_101.htm
EXHIBIT 10.1
 












Transcat, Inc. Post-Retirement Benefit Plan
For Officers

(Amended and Restated Effective April 2, 2012)




 
 

 
Introduction

The Transcat, Inc. Post-Retirement Benefit Plan for Officers (the “Plan”) is a group health plan that provides benefits to eligible retired Corporate Officers and their eligible spouses.  There are three kinds of benefits provided under the Plan:  (i) long term care insurance coverage; (ii) medical and dental insurance coverage; and (iii) medical premium reimbursement benefits.  In this document, Transcat, Inc. is referred to as the "Company."

This document, together with the subscriber contracts and coverage certificates issued by the insurance carriers and health maintenance organizations (“HMO”) through which coverage is provided, is the summary plan description of the Plan.  This document, together with the subscriber contracts and coverage certificates, is also considered the written instrument for the Plan for purposes of Section 402(a)(1) of the Employee Retirement Income Security Act of 1974 ("ERISA").

The original effective date of the Plan is December 23, 2006.  This amendment and restatement is effective April 2, 2012.

Eligibility Requirements

Corporate Officer Eligibility.  Corporate Officers who retire from active employment with the Company on or after December 23, 2006 at age 55 or older with 5 or more years of Qualifying Service and who do not work in any full-time employment (as defined below) after retirement are eligible to participate in the Plan.  In this document, a Corporate Officer who retires and is eligible to participate in the Plan may also be referred to as a “Retiree.”

For purposes of eligibility to participate in the Plan, an individual will be considered a Corporate Officer if the individual has the title of Vice President or higher or is the Corporate Controller.

Qualifying Service means an individual’s most recent period of continuous, uninterrupted employment with the Company on or after the date the individual reaches age 50.  Service prior to age 50 does not count as years of Qualifying Service for purposes of determining eligibility to participate in the Plan.  Service with a business acquired by the Company on or after December 23, 2006 (the original effective date of the Plan) is not counted as Qualifying Service.  An employee is considered to be employed by the Company during any period of absence for which the employee is paid his or her regular compensation or receives short-term disability benefits under a Company-sponsored plan and during any other Company-authorized paid or unpaid leave of absence, provided that the employee returns to active employment with the Company at the expiration of such period of absence.

A Retiree will be considered to be working in full-time employment after retirement if the Retiree regularly works 30 or more hours per week at a job at which the Retiree is eligible for medical benefits.  The Company, in its sole discretion, will determine whether an individual is working in such full-time employment after retirement for purposes of determining eligibility to participate in the Plan.  As a condition to participating in the Plan, a Retiree is required to report to the Company when the Retiree begins working in full-time employment (as defined above)

 
1

 
after retirement.  If the Company determines that a Retiree has commenced full-time employment after retirement and has not reported such employment to the Company, the Retiree will cease to be eligible to participate in the Plan and may be required to reimburse the Company for the cost of any benefits (including premiums paid for long term care coverage, dental and medical coverage and premium reimbursement payments) provided during the period the Retiree was working in full-time employment.
 
Spousal Eligibility.  A Retiree’s spouse is eligible for benefits under the Plan as described in more detail below and subject to the following:

1)  
the spouse and Retiree must be legally married under the law of the State in which they reside;

2)  
a spouse who becomes the spouse of a Retiree after the date the Retiree retires from the Company is not eligible for benefits under the Plan;

3)  
long term care coverage is not available to a spouse who is not the original spouse with respect to whom the Company provided long term care coverage on or after the date the Corporate Officer reached age 55 with 5 years of Qualifying Service;

4)  
long term care coverage is not available to a spouse who becomes the spouse of a Corporate Officer after the Corporate Officer’s long term care coverage began.

A Retiree’s spouse who is eligible for benefits under the terms of the Plan is referred to as an “Eligible Spouse.”

No Guarantee of Coverage.  Eligibility for medical and dental coverage and for long term care coverage is subject to the eligibility provisions contained in the subscriber contracts and coverage certificates through which benefits are provided under the Plan. In the event that an insurance carrier or HMO through which coverage is provided determines that a retiree or spouse is not eligible for that coverage under a contract with the carrier or HMO, the individual shall not be eligible for that coverage under the Plan.  The Company does not guarantee that coverage will be available to a Retiree or Eligible Spouse under any carrier or HMO contract, or that a Retiree or Eligible Spouse will be eligible to obtain any individual coverage.

Description of Benefits

Long Term Care Insurance Coverage. During active employment, the Company provides long term care insurance coverage for Corporate Officers who reach age 55 and have 5 years of Qualifying Service.  An actively employed eligible Corporate Officer may enroll the Officer’s spouse in long term care insurance coverage on the date the Officer is first eligible for coverage.  Once a Corporate Officer has enrolled a spouse in long term care insurance coverage, no subsequent spouse of that Corporate Officer may be enrolled in long term care insurance coverage through the Company.

 
2

 
The long term care insurance coverage benefit under this Plan consists of the continuation of the Company’s payment of the premium for the long term care insurance coverage that commenced at the time the Officer first qualified for coverage.  The Company’s payment for coverage continues through the end of the ten year period measured from the commencement of long term care insurance coverage, provided that the Company may at any time elect to fully pay up a Retiree’s and/or Eligible Spouse’s policy prior to the end of the ten year period. The long term care insurance coverage will be provided under individual insurance policies owned by the Retiree and Eligible Spouse.  Such policies will be designed to be fully paid up policies after ten years of premium payments.  Eligibility for coverage under a policy is subject to the discretion of the insurance carrier through which coverage is provided and the Company does not guarantee that any Retiree or Eligible Spouse will qualify for coverage.  In the event that a Retiree’s or Eligible Spouse’s long term care insurance policy is terminated solely due to the Company’s failure to pay the required premium payments during the ten year period and, before the Company has acquired a comparable replacement policy, the Retiree or Eligible Spouse incurs expenses that would have been covered under the terminated policy, the Company will pay the benefits that would have been payable under the terminated policy if it had remained in effect.

Example:  Corporate Officer continues in active employment after reaching age 55 with 5 years of Qualifying Service.  Long term care coverage for the Officer and the Officer’s spouse begins during active employment when the Officer reaches age 55.  The Officer retires from the Company at age 58.  Long term care coverage commences immediately (continues) upon retirement under the Plan and, subject to the terms of the Plan, the Company pays the premiums for the Officer’s and Eligible Spouse’s coverage until the Officer reaches age 65, the end of the ten year period that began when coverage commenced.

Medical and Dental Insurance Coverage.   Company subsidized medical and dental insurance coverage benefits are provided under the Plan to eligible Retirees and their Eligible Spouses beginning when the Retiree reaches age 60.  A Retiree who retires prior to reaching age 60 may elect to purchase medical and dental coverage under this Plan for the Retiree and Eligible Spouse until subsidized coverage begins at age 60 by paying 100% of the applicable premium for coverage, subject to the insurance carrier’s determination that the Retiree and Eligible Spouse are eligible for coverage. To the extent possible, medical and dental coverage under this Plan shall be provided through the same insurance contract through which such coverage is provided to active employees of the Company.  Benefits are provided under contracts with insurance carriers and HMOs and are fully described in the subscriber contract or coverage certificate issued to the Retiree and/or spouse upon enrollment.  The Company does not pay or otherwise guarantee any of the benefits under the contracts with the insurance carriers or HMOs. The subscriber contracts or coverage certificates are considered part of the summary plan description for the Plan.

A Retiree who retires prior to reaching age 60 and is not enrolled for medical and/or dental benefits at the time the Retiree reaches age 60, must contact the Company at least 90 days in advance of the Retiree’s 60th birthday to request enrollment material and must complete and return the appropriate enrollment forms on a timely basis (as specified in the enrollment information) in order for coverage to be effective on the first coverage entry date on or after the Retiree’s 60th birthday (subject to the insurance carrier’s determination as to eligibility and effective date of coverage).  Subsidized coverage for an Eligible Spouse who reaches age 60 prior to the date the Retiree reaches age 60 cannot begin until the Retiree reaches age 60.  An Eligible Spouse may not be enrolled for medical or dental insurance coverage under the Plan

 
3

 
unless the Retiree is enrolled for such coverage under the Plan or is eligible for medical premium reimbursements, as described below.
 
Example: Corporate Officer retires from the Company immediately upon reaching age 55 with 5 years of Qualifying Service.  The Officer does not elect to purchase coverage under the Plan. The Officer must notify the Company 90 days prior to the Officer’s 60th birthday that the Officer wishes to enroll for medical and dental coverage under the Plan effective as of the Officer’s 60th birthday.  If the Officer completes and returns the enrollment material in a timely manner and the insurance carrier(s) and/or HMO(s) approve the enrollment, Company subsidized medical and dental coverage will commence on the first coverage entry date on or after the Officer’s 60th birthday.  Even if the Officer’s Eligible Spouse reached age 60 prior to the Officer reaching age 60, subsidized coverage for the Eligible Spouse would not begin until the Officer reached age 60.

Subsidized medical insurance coverage for a Retiree under the Plan terminates when the Retiree reaches age 65 or, if later, the age at which the Retiree is first eligible to enroll in Medicare on the basis of age (referred to as “Medicare-Eligible Age”).  Subsidized medical insurance coverage for the Eligible Spouse of a Retiree terminates when the Eligible Spouse reaches Medicare-Eligible Age, provided, however, that if the Retiree reaches Medicare-Eligible Age before the Eligible Spouse reaches Medicare-Eligible Age, the amount of the Company’s contribution toward the cost of an Eligible Spouse’s subsidized medical insurance coverage will be reduced at the time the Retiree reaches Medicare-Eligible Age, as described below.

Subsidized dental insurance coverage for a Retiree and Eligible Spouse continues after the date the Retiree and Eligible Spouse reach Medicare-Eligible Age, subject to the terms of the Plan.

Example 1:  Corporate Officer retires from the Company at age 60 with 10 years of Qualifying Service.  The Officer’s Eligible Spouse is age 63 at the time the Officer retires.  Medical and dental coverage for the Officer and Eligible Spouse begin immediately upon the Officer’s retirement.  The Eligible Spouse becomes eligible to enroll in Medicare at age 65, so the Eligible Spouse’s subsidized medical insurance coverage terminates on the Eligible Spouse’s 65th birthday and the Eligible Spouse becomes eligible for medical insurance premium reimbursements (described below).  The Eligible Spouse is responsible for taking steps to obtain individual medical insurance coverage.  The Officer’s medical insurance coverage continues until the Officer reaches Medicare-Eligible Age, subject to the terms of the Plan. The Officer's and Eligible Spouse's subsidized dental insurance coverage continues subject to the terms of the Plan.

Example 2:  Corporate Officer retires from the Company at age 63 with 13 years of Qualifying Service.  The Officer’s Eligible Spouse is age 61 at the time the Officer retires.  Medical and dental coverage for the Officer and Eligible Spouse begin immediately upon the Officer’s retirement. The Officer becomes eligible to enroll in Medicare at age 65, so the Officer’s subsidized medical insurance coverage terminates on the Officer’s 65th birthday.  The Eligible Spouse is age 63 on the Officer’s 65th birthday and remains eligible for continued subsidized medical insurance coverage (at a reduced Company contribution rate beginning on the date of the Officer’s 65th birthday, as described below) until the Eligible Spouse reaches Medicare-Eligible Age, at which time the Eligible Spouse’s subsidized medical insurance coverage terminates and the Eligible Spouse becomes eligible for medical insurance premium

 
4

 
reimbursements (described below). The Officer's and Eligible Spouse's subsidized dental insurance coverage continues subject to the terms of the Plan.
 
The Company will contribute toward the cost of coverage up to a maximum “capped” amount determined by the Company.  The capped amount applicable to a Retiree or Eligible Spouse beginning in the first year in which the Retiree or Eligible Spouse is eligible for subsidized medical and dental insurance coverage is based on the capped amount that was in effect for the year in which the Retiree retired, or, in the case of an Officer who had satisfied the eligibility requirements to participate in the Plan but died before retiring, the capped amount in effect for the year in which the Officer died, increased by 3% each year beginning after the year in which the Officer retired or died.  Effective April 2, 2012, the annual increase in the capped amount will be equal to 50% of the increase in the applicable insurance premium from the prior year.

The capped amount is equal to 72% of the applicable premium for one-person or two-person coverage under a base coverage plan determined by the Company for the year in which the Retiree retires.  For Retirees who retire in 2007, the base plan used for determining the Company contribution amount is the Preferred Care TriVantage plan for medical coverage and the Business Council of New York State Dental Plan for dental coverage.  For Retirees who retire in 2007, the maximum monthly Company contribution is equal to $230.48 for Retiree-only medical insurance coverage, $518.57 for Retiree and Eligible Spouse medical insurance coverage, $20.28 for Retiree-only dental insurance coverage and $58.14 for Retiree and Eligible Spouse dental insurance coverage. The base plans selected by the Company for purposes of determining the Company contribution amount may change from year to year in the discretion of the Company, but will be plans that provide benefits at a substantially comparable level to the benefits provided under the Preferred Care TriVantage plan and the Business Council of New York State Dental Plan. The Company’s contribution toward the cost of coverage for a Retiree and/or Eligible Spouse will increase to reflect any increase in the cost of the base plan coverage, but the increase in the Company’s contribution for any year will not exceed 3%. Effective April 2, 2012, the increase in the Company’s contribution for any year will be equal to 50% of the increase in the applicable insurance premium from the prior year.

Example:  Officer 1 is not married and retires from the Company in 2007 at age 63 with 13 years of Qualifying Service.  Medical and dental coverage for Officer 1 begins immediately and the Company contribution toward the cost of coverage is equal to$230.48 per month for medical insurance coverage and $20.28 per month for dental insurance coverage.  The 2007 Company contribution amounts represent 72% of $320.11, the monthly cost for one-person medical coverage under the base medical plan and 72% of $28.17, the monthly cost for one-person coverage under the base dental plan.

Officer 2 is not married and retires from the Company in 2008 at age 63 with 13 years of Qualifying Service.  Medical and dental coverage for Officer 2 begins immediately.  For 2008, assume that the monthly cost for one-person coverage under the base medical plan is $400 and the monthly cost for one-person coverage under the base dental plan is $45.  For Officer 2, the Company contribution toward the cost of coverage is equal to $288 per month for medical insurance coverage (72% of $400) and $32.40 for dental insurance coverage (72% of $45).  For Officer 1, the Company contribution toward the cost of coverage for 2008 is equal to $237.39 for medical insurance coverage and $20.89 for dental insurance coverage.  The reason for the difference in the Company’s contribution toward the cost of coverage for Officer 1 and Officer 2

 
5

 
in 2008 is that the increase in the Company’s contribution toward the cost of coverage for Officer 1 in 2008 is limited by the 3% cap on increases.
 
In the event that an Eligible Spouse remains eligible for subsidized medical insurance coverage after the date the Retiree reaches Medicare-Eligible Age (see Example 2 above), the amount of the Company’s contribution toward the cost of medical insurance coverage for the Eligible Spouse will be reduced beginning on the date the Retiree reaches Medicare-Eligible Age.  The reduced contribution amount is an amount equal to the maximum medical premium reimbursement the Retiree is eligible to receive, as described below in the “Medical Premium Reimbursements” section.

The Retiree and/or Eligible Spouse are required to pay any additional cost of coverage over and above the amount paid by the Company.  If the coverage option selected costs less than the applicable maximum monthly Company contribution, the Company contribution will be equal to the cost of the coverage selected.  The Company will not pay the Retiree or Eligible Spouse the difference between the cost of coverage selected and the maximum monthly Company contribution.  Nor will the Company pay any amount to a Retiree or Eligible Spouse who is eligible for but does not elect coverage under the Plan.  The Retiree’s and/or Eligible Spouse’s contributions toward the cost of coverage must be paid on a timely basis as specified by the Company.  If required contributions are not paid on a timely basis, coverage may be terminated.

Example:  Corporate Officer retires from the Company in 2007 at age 63 with 10 years of Qualifying Service.  Officer’s Eligible Spouse is age 58 at the time the Officer retires.  The cap amounts applicable for Officers who retire in 2007 are $230.48 for Retiree-only medical insurance coverage, $518.57 for Retiree and Eligible Spouse medical insurance coverage, $20.28 for Retiree-only dental insurance coverage and $58.14 for Retiree and Eligible Spouse dental insurance coverage. The medical and dental coverage for the Officer and Eligible Spouse begin immediately upon the Officer’s retirement and the Officer and Eligible Spouse are covered under two-person medical and two-person dental coverage. The maximum Company monthly contribution toward the cost of their coverage during 2007 is $518.57 for medical insurance coverage and $58.14 for dental insurance coverage. Assume that for 2008 and 2009, the total cost of medical and dental insurance coverage increases by 10% each year, so the amount of the increase in the Company’s contribution for the Officer and Spouse is 3% each year.  For 2008, the maximum Company monthly contribution cap amounts for the Officer and Eligible Spouse increase by 3% to $534.13 and $59.88 and increase by 3% again for 2009 to $550.15 and $61.68.  The Officer reaches Medicare-Eligible Age in 2009.  The Eligible Spouse is age 60 at that time.

The Officer’s subsidized medical insurance coverage terminates at Medicare-Eligible Age and the Officer becomes eligible for medical insurance premium reimbursements (described below).  The Officer is responsible for taking steps to obtain individual medical insurance coverage.  The Eligible Spouse’s subsidized medical insurance coverage may continue (at the reduced Company contribution amount, which is equal to the amount of the Retiree’s premium reimbursement, as described below) until the date the Eligible Spouse reaches Medicare-Eligible Age.  When the Eligible Spouse reaches Medicare-Eligible Age, the Eligible Spouse’s subsidized medical insurance coverage terminates and the Eligible Spouse becomes eligible for medical insurance premium reimbursements.  The Eligible Spouse is responsible for taking steps to obtain individual medical insurance coverage.

 
6

 
Medical Premium Reimbursements.  When a Retiree reaches Medicare-Eligible Age, the Retiree is eligible for limited reimbursement from the Company of premiums paid by the Retiree for an individual policy of medical insurance coverage purchased by the Retiree.  Such medical premium reimbursements are available to the Eligible Spouse of an age 60 or older Retiree when the Eligible Spouse reaches Medicare-Eligible Age. The Retiree and/or Eligible Spouse is responsible for obtaining such policies of individual insurance.

Example 1:  Corporate Officer retires from the Company at age 60 with more than 5 years of Qualifying Service.  The Officer’s Eligible Spouse is age 64 at the time the Officer retires.  Immediately upon retirement, medical and dental insurance coverage begins for the Officer and Eligible Spouse.  The Eligible Spouse reaches Medicare-Eligible Age and the Eligible Spouse’s medical insurance coverage under the Plan terminates.  The Eligible Spouse is responsible for obtaining individual medical insurance coverage and the Eligible Spouse becomes eligible for medical premium reimbursements (in the amount described below) for individual medical insurance coverage purchased by the Eligible Spouse.  The Officer’s medical insurance coverage under the Plan continues, subject to the terms of the Plan, until the Officer reaches Medicare-Eligible Age, at which point the Officer’s medical insurance coverage under the Plan terminates and the Officer becomes eligible for medical premium reimbursements.  Dental coverage continues subject to the terms of the Plan.

Example 2: Corporate Officer retires from the Company at age 62 with more than 5 years of Qualifying Service.  The Officer’s Eligible Spouse is age 54 at the time the Officer retires.  Immediately upon retirement, medical and dental insurance coverage begins for the Officer and Eligible Spouse.  When the Officer reaches Medicare-Eligible Age, the Officer’s medical insurance coverage under the Plan terminates and the Officer is responsible for obtaining individual medical insurance coverage and becomes eligible for medical premium reimbursements (in the amount described below) for individual medical insurance coverage purchased by the Officer.  The Eligible Spouse may continue to receive subsidized medical insurance under the Plan (at the reduced Company contribution amount beginning when the Officer reaches Medicare-Eligible Age) until the Eligible Spouse reaches Medicare-Eligible Age. When the Eligible Spouse reaches Medicare-Eligible Age, the Eligible Spouse’s medical insurance coverage terminates and the Eligible Spouse is responsible for obtaining individual medical insurance coverage and becomes eligible for medical premium reimbursements (in the amount described below) for individual medical insurance coverage purchased by the Eligible Spouse. As described above, although the Eligible Spouse’s subsidized medical insurance coverage continues until the Eligible Spouse reaches Medicare-Eligible Age (subject to the terms of the Plan), the amount of the Company’s contribution toward the cost of the Eligible Spouse’s medical insurance coverage is reduced beginning on the date the Officer reaches Medicare-Eligible Age. Dental coverage continues subject to the terms of the Plan.

The maximum amount of reimbursement available to a Retiree or Eligible Spouse for any month is a “capped” amount determined by the Company.  The capped amount applicable to a Retiree or Eligible Spouse beginning in the year when the Retiree or Eligible Spouse reaches Medicare-Eligible Age is based on the capped amount that was in effect for the year in which the Retiree retired, or, in the case of an Officer who had satisfied the eligibility requirements to participate in the Plan but died before retiring, the capped amount in effect for the year in which the Officer died, increased by 3% each year beginning after the year in which the Officer retired or died.  

 
7

 
Effective April 2, 2012, the increase in the maximum reimbursement for any year will be equal to 50% of the increase in the applicable premium from the prior year.
 
Example:  Corporate Officer retires from the Company in 2007 at age 60 with 10 years of Qualifying Service.  In 2007, when the Officer retires, the capped amount for medical premium reimbursements is $53.28 (as described below).  Medical and dental coverage for the Officer begins immediately upon the Officer’s retirement.  When the Officer reaches Medicare-Eligible Age in 2012, the Officer’s medical insurance coverage terminates and the Officer is responsible for obtaining individual medical insurance coverage and becomes eligible for medical insurance premium reimbursements. The maximum monthly reimbursement amount for the Officer in 2012 is $61.78, determined by increasing the $53.28 capped amount 3% each year after 2007.

The capped amount is equal to 72% of the applicable premium for a base Medicare supplemental coverage plan determined by the Company.  For Retirees who retire in 2007, the maximum reimbursement amount is $53.28 per month per individual, which is equal to 72% of $74, the 2007 monthly premium for the Excellus Medicare Blue Choice HMO Optimum Plan, the base plan selected by the Company for 2007.  The maximum monthly reimbursement amount will be adjusted on an annual basis, but in no case will the amount of the maximum monthly reimbursement amount for an individual increase by more than 3% over the preceding year’s maximum monthly reimbursement amount.  Effective April 2, 2012, the increase in the maximum reimbursement for any year will be equal to 50% of the increase in the applicable premium from the prior year.

The base Medicare supplemental plan selected by the Company for purposes of determining the maximum reimbursement amount may change from year to year in the discretion of the Company, but will be a plan that provides benefits at a substantially comparable level to the benefits provided under the Excellus Medicare Blue Choice HMO Optimum Plan.

If a Retiree or Eligible Spouse purchases coverage that costs more than the maximum reimbursement amount available under the Plan, the Retiree or Eligible Spouse is responsible for paying the additional cost of coverage over and above the maximum reimbursement amount.  If the coverage purchased by a Retiree or Eligible Spouse costs less than the applicable maximum monthly reimbursement amount, the reimbursement from the Plan will be equal to the cost of the coverage.  The Plan will not reimburse the excess of the maximum monthly reimbursement over the actual cost of coverage.

A Retiree or Eligible Spouse may claim reimbursement on an annual or periodic basis (not more frequently than quarterly) for premiums paid by the individual for coverage. The individual claiming reimbursement must provide the Company with adequate verification of the premium payments for which he or she is claiming reimbursement.

Example:  Corporate Officer retires from the Company in 2007 at age 60 with 10 years of Qualifying Service.  In 2007 when the Officer retires, the capped amount for medical premium reimbursements is $53.28.  The Officer’s Eligible Spouse is age 63 at the time the Officer retires.  Medical and dental coverage for the Officer and Eligible Spouse begin immediately upon the Officer’s retirement.  When the Eligible Spouse reaches Medicare-Eligible Age in 2009, the Eligible Spouse’s medical insurance coverage terminates and the Eligible Spouse is responsible for obtaining individual medical insurance coverage and becomes eligible for medical insurance
 
 
8

 
premium reimbursements. The maximum monthly reimbursement amount for the Eligible Spouse in 2009 is $56.53.
 
Surviving Spouse Benefits

The surviving spouse of a Retiree or of an Officer who had satisfied the eligibility requirements to participate in the Plan but died before retiring is eligible for surviving spouse benefits as described below.  An eligible surviving spouse is referred to as a “Surviving Spouse.”

Long Term Care Insurance Coverage.   Long term care insurance coverage is available under the Plan only to a spouse who was the Officer’s spouse on the date the Officer first becomes eligible to enroll for long term care insurance coverage through the Company.  If a Corporate Officer who has satisfied the eligibility requirements to participate in the Plan but dies before retirement or if a Retiree dies before the end of the period during which the Company pays for long term care insurance coverage, the Company will continue to pay for long term care insurance coverage for the Surviving Spouse through the end of the applicable ten year period for the Surviving Spouse’s coverage (subject to the insurance carrier’s determination as to the Surviving Spouse’s continued eligibility for coverage).  A spouse who becomes the spouse of an Officer after the date the Officer first becomes eligible to enroll for long term care insurance through the Company is not eligible for long term care insurance coverage and is not eligible for coverage as a surviving spouse after the Retiree’s death.

Example:  Corporate Officer continues in active employment after reaching age 55 with 5 years of Qualifying Service.  Long term care coverage for the Officer and the Officer’s spouse begins during active employment when the Officer reaches age 55. At that time, the Officer’s spouse is age 50. The Officer retires from the Company at age 58.  Long term care coverage commences immediately (continues) upon retirement under the Plan and the Company pays the premiums for the Officer’s and spouse’s coverage.  The Officer dies at age 62.  The Company pays the premiums for the Surviving Spouse’s coverage until the Surviving Spouse reaches age 60, which is the end of the 10 year period during which the Company pays for coverage.

Medical and Dental Insurance Coverage.  The spouse of a Corporate Officer who was eligible to retire but had not retired as of the date of his or her death is eligible for continued medical and dental insurance coverage under the Plan.  Medical insurance coverage for the Surviving Spouse may continue through the date the Surviving Spouse reaches Medicare-Eligible Age, provided that the Company’s contribution toward the cost of the Surviving Spouse’s medical coverage is reduced on the date the Corporate Officer would have reached Medicare-Eligible Age to the amount of the maximum medical premium reimbursement the Corporate Officer would have been eligible to receive at Medicare-Eligible Age, with such amount determined as if the Corporate Officer had retired on the Corporate Officer’s date of death.  Dental insurance coverage continues subject to the terms of the Plan.  When the Surviving Spouse's medical insurance coverage terminates on the date the Surviving Spouse reaches Medicare-Eligible Age, the Surviving Spouse will be eligible for medical premium reimbursements as described below.

A spouse who was the Retiree’s spouse on the date the Retiree retired from the Company is eligible for continued medical and dental insurance coverage under the Plan after the retiree’s death.  Medical insurance coverage continues through the date the Surviving Spouse reaches

 
9

 
Medicare-Eligible Age, provided that the Company’s contribution toward the cost of the Surviving Spouse’s medical coverage is reduced beginning on the date the Retiree would have reached Medicare-Eligible Age to the amount of the maximum medical premium reimbursement the Corporate Officer would have been eligible to receive at Medicare-Eligible Age.  Dental insurance coverage continues subject to the terms of the Plan.  When the Surviving Spouse’s medical insurance coverage terminates on the date the Surviving Spouse reaches Medicare-Eligible Age, the Surviving Spouse will be eligible for medical premium reimbursements as described below.
 
A spouse who was not the Retiree’s spouse on the date the Retiree retired from the Company is not eligible for medical and dental insurance coverage after the Retiree’s death.  A Surviving Spouse who is eligible for coverage is eligible only for self-only coverage under the Plan.

Medical Premium Reimbursements.  A spouse who was the Retiree’s spouse on the date the Retiree retired from the Company or who is the spouse of a Corporate Officer who was eligible to retire but had not retired as of the date of his or her death is eligible for continued reimbursements for premiums paid by the Surviving Spouse for an individual policy of medical insurance purchased by the Surviving Spouse after the date the Surviving Spouse reaches Medicare-Eligible Age.  The maximum amount of reimbursements available and the requirements for obtaining such reimbursements are as set forth in this Plan.  A spouse who was not the Retiree’s spouse on the date the Retiree retired from the Company is not eligible for medical premium reimbursements after the Retiree’s death.  A Surviving Spouse is eligible only for reimbursement for self-only coverage purchased by the Surviving Spouse.

Provisions Applicable to Medical and Dental Insurance Coverage

The following provisions are applicable to the medical and dental insurance coverage provided through the Plan to Retirees and Eligible Spouses.  These provisions are not applicable to long term care insurance coverage or to the individual policies of medical insurance purchased by a Retiree or Eligible Spouse when the Retiree or Eligible Spouse is eligible for medical premium reimbursement benefits under the Plan.

Annual Enrollment Period.   If there is more than one subsidized coverage option available in a Retiree’s/Eligible Spouse’s geographic area, before the beginning of each plan year, the Retiree/Eligible Spouse will be given the opportunity to change coverage options under the Plan.  If there is more than one coverage option available in the Retiree’s/Eligible Spouse’s geographic area, more detailed coverage, cost and election material will be furnished each year during the annual open enrollment period.

Certificate of Creditable Coverage.   A certificate of creditable coverage is a document that reports the period of time that a Retiree or Eligible Spouse has had medical benefits coverage under the Plan without a 63-day break in coverage.  This information may be helpful if the Retiree or Eligible Spouse becomes covered under a group health plan other than the Plan and that other group health plan contains a preexisting condition limitation.  Under Federal law, the Retiree’s or Eligible Spouse’s coverage under the Plan may reduce or eliminate the application of the other plan’s preexisting condition limitation.

 
10

 
A certificate of creditable coverage will be provided automatically when a Retiree’s or Eligible Spouse’s coverage under the Plan terminates.  A Retiree or Eligible Spouse also has the right to request a certificate of creditable coverage from the Plan at any time, as long as the request is made within 24 months after their coverage under the Plan terminates.  Requests should be directed to the insurance carrier or HMO through which the coverage was provided.

Medicaid-Eligible Individuals.  In determining whether an individual is eligible for coverage and in making benefit payments, the Plan will not take into account the fact that an individual is eligible for or is covered by Medicaid.  In addition, the Plan will make benefit payments in accordance with any assignment of rights made by or on behalf of an individual as required by a state Medicaid Plan and in accordance with any state law, which provides that the state has acquired rights to payment with respect to a participant.

Mastectomy Benefit Coverage.  Under Federal law, group health plans, insurance companies, and health maintenance organizations (HMOs) that provide coverage for medical and surgical benefits for mastectomy must also provide coverage for reconstructive surgery in a manner determined in consultation with the attending physician and the patient.  Required coverage includes reconstruction of the breast on which the mastectomy was performed, surgery and reconstruction of the other breast to produce a symmetrical appearance, and prostheses and treatment of physical complications at all stages of the mastectomy, including lymphedemas.  These benefits are subject to the normal deductible and coinsurance provisions that apply to other benefits under the individual’s coverage.

Minimum Stay for Mothers and Newborns.  Group health plans and health insurance issuers generally may not, under Federal law, restrict benefits for any hospital length of stay in connection with childbirth for the mother or newborn child to less than 48 hours following a vaginal delivery, or less than 96 hours following a cesarean section.  However, Federal law generally does not prohibit the mother's or newborn's attending provider, after consulting with the mother, from discharging the mother or her newborn earlier than 48 hours (or 96 hours as applicable).  In any case, plans and issuers may not, under Federal law, require that a provider obtain authorization form the plan or the insurance issuer for proscribing a length of stay not in excess of 48 hours (or 96 hours).

COBRA Continuation Coverage for Spouses.  A Retiree’s spouse will be eligible to purchase temporary continuation of medical and/or dental coverage under the Plan if the spouse loses medical and/or dental insurance coverage under the Plan as a result of divorce from the retiree or the retiree’s death.  In the event of the Retiree’s death, the spouse may be eligible for surviving spouse benefits as described above and may choose either surviving spouse coverage or to purchase temporary COBRA continuation coverage.  COBRA continuation coverage may be purchased for a maximum of 36 months from the date of death or divorce.

A spouse is required to notify the Company in writing not later than 60 days after a divorce from the Retiree.  If written notice is not provided to the Company on a timely basis, the spouse will not be eligible for COBRA continuation coverage.

A spouse who is eligible to purchase COBRA continuation coverage must make written election for continuation coverage no later than the date that is 60 days after the later of the date coverage would otherwise end or the date the Company provides written notice of the right to purchase

 
11

 
continuation coverage.  The election form must be hand-delivered to the Company or postmarked on or before the 60th day or the spouse will not be permitted to purchase continuation coverage.
 
In considering whether to elect continuation coverage, a spouse should take into account that a failure to continue group health coverage will affect the spouse’s future rights under Federal law.  First, the spouse can lose the right to avoid having pre-existing condition exclusions applied to the spouse by other group health plans if the spouse has more than a 63-day gap in health coverage, and election of continuation coverage may help the spouse not have such a gap.  Second, a spouse will lose the guaranteed right to purchase individual health insurance policies that do not impose such pre-existing condition exclusions if the spouse does not get continuation coverage for the maximum time available.  Finally, a spouse has the right to request special enrollment in another group health plan for which the spouse is otherwise eligible (such as a plan sponsored by the spouse’s employer) within 30 days after their group health coverage ends because of a qualifying event listed above.  The spouse will also have the same special enrollment right at the end of continuation coverage if the spouse gets continuation coverage for the maximum time available.

COBRA continuation coverage will end as of the date any of the following occurs:

1)  
The required premiums are not paid on a timely basis.

2)  
The maximum 36 month continuation coverage period expires.

3)  
The Company ceases to provide any group health coverage to any employees.

4)  
The date the spouse becomes covered under another group health plan that does not contain any exclusion or limitation with respect to a preexisting condition of the spouse.

5)  
The date the spouse becomes entitled to Medicare.

Termination of Participation

A Retiree’s participation in the Plan (or a specific benefit under the Plan) will terminate on the earliest of the following dates:

1)  
all participation for the Retiree terminates on the date the Retiree dies;

2)  
with respect to medical and/or dental insurance coverage under the Plan, coverage terminates on the last day of the period for which the Retiree has paid the required contribution for coverage, if the Retiree fails to timely make a required contribution (the Company shall establish a policy regarding the payment of required contributions, which policy shall provide a 60 day grace period following notification to the Retiree before coverage is terminated);
 
 
12

 

 
3)  
with respect to the Company’s continued payment of long term care premiums, the Company’s payment of such premiums terminates on the date the Retiree begins to work in full-time employment after retirement from the Company; or

4)  
with respect to subsidized medical and dental coverage and medical premium reimbursements under the Plan, benefits terminate on the date the Retiree begins to work in full-time employment at which the Retiree is eligible for medical benefits after retirement from the Company.

A Retiree’s Eligible Spouse will cease to participate in the Plan (or a specific benefit under the Plan) on the earliest of the following dates:

1)  
the date the Retiree ceases to participate in the Plan, unless the Retiree’s participation ceases due to the Retiree's death and the Eligible Spouse is eligible for surviving spouse benefits;

2)  
in the case of an Eligible Spouse’s  medical and/or dental insurance coverage, coverage terminates on the last day of the period for which the Eligible Spouse has paid the required contribution for coverage, if the Eligible Spouse fails to timely make a required contribution (the Company shall establish a policy regarding the payment of required contributions, which policy shall provide a 60 day grace period following notification to the Eligible Spouse before coverage is terminated);

3)  
in the case of a surviving spouse’s coverage, the date the surviving spouse remarries;

4)  
all participation for the Eligible Spouse terminates on the date the Eligible Spouse dies or is divorced from the Retiree.

A Retiree’s or Eligible Spouse’s long term care insurance coverage and/or medical and dental insurance coverage under the Plan may terminate prior to the date the Retiree’s or Eligible Spouse’s participation in the Plan terminates in the event that the insurance carrier or HMO determines that the individual ceases to be eligible for coverage under the applicable insurance contract.

A Retiree may at the time of retirement elect to delay the commencement of medical and dental insurance coverage under the Plan for the Retiree and/or the Retiree’s Eligible Spouse.  A Retiree who elects to delay commencement of medical and dental insurance coverage under the Plan must notify the Company when the Retiree and/or Eligible Spouse desires to later enroll in medical and dental insurance coverage and such coverage will become effective as soon as administratively practicable after such notice is provided, subject to the insurance carriers/HMOs agreement to make such coverage available to the Retiree and/or Eligible Spouse.  Delayed enrollment in medical and dental insurance coverage does not extend the time period during which a Retiree and/or Eligible Spouse is eligible for such coverage under the Plan. A Retiree or Eligible Spouse whose medical and/or dental insurance coverage under the Plan terminates after
 
 
13

 
having become effective (regardless of the reason for such termination) are not eligible to later re-enroll for medical or dental insurance coverage and are not eligible for medical premium reimbursements.
 
Amendment or Termination of Plan

Except for Corporate Officers who have attained age 55 with 5 years of Qualifying Service and Retirees who have retired from the Company and qualified for benefits, no Corporate Officer or spouse has a vested right to benefits under the Plan.  This means that Corporate Officers who have not attained age 55 with 5 years of Qualifying Service (and their spouses) do not have a non-forfeitable right to qualify for coverage under the Plan and the Company reserves the right to amend the Plan at any time to change or terminate the Plan with respect to such Corporate Officers and their spouses. If the Plan is so amended, any Corporate Officer (and spouse) who is not age 55 with 5 years of Qualifying Service at the time of the amendment may be ineligible for benefits under the Plan or may be eligible for reduced or changed benefits under the Plan.  Such an amendment to the Plan may change the benefits under the Plan in a way that changes, reduces or increases benefits or reduces or increases the amount that retirees and spouses pay for benefits, either as a share of the premium cost or as deductibles, co-payments, co-insurance or other cost-sharing provisions.  The Plan may not be terminated or modified in a manner that reduces benefits for any Retiree or Corporate Officer who has attained age 55 with 5 years of Qualifying Service.



Claim Procedures

Claims for the payment of medical, dental or long term care insurance benefits are subject to the claim procedures contained in the insurance contract through which such coverage is provided and are not the responsibility of the Company.

For medical premium reimbursements under the Plan, if you disagree with the amount of a medical premium reimbursement, you have the right to appeal to the Company.  All appeals must be made in writing within 180 days after the date the reimbursement in question was paid.  Appeals should be addressed to the Company at the address specified below.  You may submit written comments, documents, records and other information relating to your claim and you will be provided, upon request and free of charge, reasonable access to, and copies of, all documents, records and other information relevant to your claim for benefits.  The review of your appeal will take into account all comments, documents, records and other information you submit, without regard to whether such information was considered in the initial benefit determination.

You will be notified in writing of the Company’s decision on your appeal not later than 60 days after the Company receives your request for review.  If the decision is adverse, the notification will set forth:  (1) the specific reason or reasons for the adverse determination; (2) reference to the specific plan provisions on which the determination is based; (3) a statement that you are entitled to receive, upon request and free of charge, reasonable access to, and copies of, all documents, records, and other information relevant to your claim; and (4) a statement of your right to bring an action under section 502(a) of ERISA.  Please refer to the claim section of your

 
14

 
subscriber contract or coverage certificate for a description of the specific claim procedures applicable to your claims for benefits.
 
Discretionary Authority

The insurance carriers and HMOs through which coverage is provided under the Plan have full discretionary authority to interpret the terms of the subscriber contracts and coverage certificates that they issue and to determine eligibility for benefits in accordance with the terms of such subscriber contracts and coverage certificates.  In carrying out its responsibilities under the Plan as the plan administrator, the Company has full discretionary authority to interpret the terms of the Plan.  Any interpretation or determination made by an insurance carrier or HMO, or by the Company pursuant to such discretionary authority shall be given full force and effect unless found by a court of competent jurisdiction to be arbitrary and capricious.

Statement of Rights

As a participant in the Plan, you are entitled to certain rights and protections under the Employee Retirement Income Security Act of 1974 (ERISA).  ERISA provides that all Plan participants be entitled to:

Receive Information About Your Plan and Benefits

Examine, without charge, at the plan administrator's corporate office all documents governing the Plan including insurance contracts.

Obtain upon written request to the plan administrator, copies of documents governing the operation of the Plan, including insurance contracts and updated summary plan description.  The plan administrator may make a reasonable charge for the copies.
 
Prudent Actions by Plan Fiduciaries
 
In addition to creating rights for Plan participants, ERISA imposes duties upon the people who are responsible for the operation of the employee benefit plan.  The people who operate your Plan, called "fiduciaries" of the Plan, have a duty to do so prudently and in the interest of you and other Plan participants and beneficiaries.  No one, including your employer or any other person, may fire you or otherwise discriminate against you in any way to prevent you from obtaining a welfare benefit or exercising your rights under ERISA.
 
Enforce Your Rights
 
If your claim for a welfare benefit is denied or ignored, you have a right to know why this was done, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all within certain time schedules.

Under ERISA, there are steps you can take to enforce the above rights.  For instance, if you request a copy of Plan documents or the latest annual report from the Plan and do not receive them within 30 days, you may file suit in a Federal court.  In such a case, the court may require
 
 
15

 
the Plan Administrator to provide the materials and pay you up to $110 a day until you receive the materials, unless the materials were not sent because of reasons beyond the control of the Plan Administrator.  If you have a claim for benefits, which is denied or ignored, in whole or in part, you may file suit in a state or Federal court, provided that you have exhausted all your administrative appeal rights.  If it should happen that Plan fiduciaries misuse the Plan's money, or if you are discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a Federal court.  The court will decide who should pay court costs and legal fees.  If you are successful the court may order the person you have sued to pay these costs and fees.  If you lose, the court may order you to pay these costs and fees; for example, if it finds your claim is frivolous.
 
Assistance With Your Questions
 
If you have any questions about your Plan, you should contact the plan administrator.  If you have any questions about this statement or about your rights under ERISA, or if you need assistance in obtaining documents from the plan administrator, you should contact the nearest Area Office of the Employee Benefits Security Administration, U.S. Department of Labor, listed in your telephone directory or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue N.W., Washington, D.C. 20210.  You may also obtain certain publications about your rights and responsibilities under ERISA by calling the publications hotline of the Pension and Welfare Benefits Administration.

In order to protect your family's rights, you should keep the plan administrator informed of any charges in the addresses of family members.  You should also keep a copy, for your records, of any notices you send to the plan administrator.

Plan Name

The legal name of the Plan is the Transcat, Inc. Post-Retirement Benefit Plan for Officers.

Plan Number

511

Employer

Transcat, Inc.
35 Vantage Point Drive
Rochester, New York 14624
(585) 352-7777

Employer Identification Number

16-0874418

Type of Plan
 
16

 
The Plan is a welfare benefit plan that provides medical, dental and long term care insurance benefits through contracts issued by insurance carriers and health maintenance organizations.  A list of the carriers and health maintenance organizations that provide coverage under the Plan is attached to the end of this document.  The Plan also provides limited reimbursement of premiums paid by Retirees and spouses for individual medical and dental insurance coverage obtained by the Retiree and/or spouse.

Plan Administrator

Transcat, Inc.
35 Vantage Point Drive
Rochester, New York 14624
(585) 352-7777                                

Type of Administration

The Plan is administered by Transcat, Inc.  The insurance carriers and health maintenance organizations through which benefits are provided administer claims under the contracts through which such benefits are provided.

Agent for Service of Legal Process

Transcat, Inc.
35 Vantage Point Drive
Rochester, New York 14624
(585) 352-7777                                

Contributions/Funding

The Company and participants contribute toward the cost of coverage under the Plan.

Plan Year

The plan year for the Plan is the calendar year.

 
17

 
Insurance Carriers and Health Maintenance Organizations
Providing Medical and Dental Insurance Coverage
(Excluding Carriers/HMOs providing individual coverage)
































 
18

 

Acknowledgment of Receipt

By signing below, the authorized representative of the Company certifies that a copy of this summary plan description/plan document for the Transcat, Inc. Post-Retirement Benefit Plan for Officers was provided to the below-named Corporate Officer and Eligible Spouse (if any), and the Corporate Officer and Eligible Spouse (if any) acknowledge that the Company provided the Corporate Officer and Eligible Spouse with a copy of this summary plan description/plan document for the Transcat, Inc. Post-Retirement Benefit Plan for Officers.

 

 
Transcat, Inc.
     
         
By:        
      Date  
         
       
Signature of Retiree   Date  
         
         
Print Name of Retiree      
         
         
Signature of Eligible Spouse   Date  
         
         
Print Name of Eligible Spouse      
         
         
         
 




19

EX-31.1 3 exh_311.htm EXHIBIT 31.1 exh_311.htm
Exhibit 31.1


CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, Charles P. Hadeed, President and Chief Executive Officer of Transcat, Inc., certify that:

1.  
I have reviewed this quarterly report on Form 10-Q of Transcat, Inc.;

2.  
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 
(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
(c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
(d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.  
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 
(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: August 10, 2012
/s/ Charles P. Hadeed
 
Charles P. Hadeed
 
President and Chief Executive Officer
(Principal Executive Officer)
 
EX-31.2 4 exh_312.htm EXHIBIT 31.2 exh_312.htm
Exhibit 31.2


CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002


I, John J. Zimmer, Senior Vice President of Finance and Chief Financial Officer of Transcat, Inc., certify that:

1.  
I have reviewed this quarterly report on Form 10-Q of Transcat, Inc.;

2.  
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))) for the registrant and have:

 
(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
(c)
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
(d)
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.  
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 
(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:  August 10, 2012
/s/ John J. Zimmer
 
John J. Zimmer
 
Senior Vice President of Finance and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
 
EX-32.1 5 exh_321.htm EXHIBIT 32.1 exh_321.htm
Exhibit 32.1


CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q of Transcat, Inc., Charles P. Hadeed, the Chief Executive Officer of Transcat, Inc. and John J. Zimmer, the Chief Financial Officer of Transcat, Inc. certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of their knowledge, that:

1.  
This quarterly report on Form 10-Q for the first quarter ended June 30, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.  
The information contained in this quarterly report on Form 10-Q for the first quarter ended June 30, 2012 fairly presents, in all material respects, the financial condition and results of operations of Transcat, Inc.



Date:  August 10, 2012
/s/ Charles P. Hadeed
 
Charles P. Hadeed
 
President and Chief Executive Officer
(Principal Executive Officer)



Date:  August 10, 2012
/s/ John J. Zimmer
 
John J. Zimmer
 
Senior Vice President of Finance and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)



A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Transcat, Inc. and will be retained by Transcat, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
EX-101.INS 6 trns-20120630.xml XBRL INSTANCE DOCUMENT 0000099302 2012-04-01 2012-06-30 0000099302 2011-03-27 2011-06-25 0000099302 2012-06-30 0000099302 2012-03-31 0000099302 2011-03-26 0000099302 2011-06-25 0000099302 us-gaap:CommonStockMember 2012-03-31 0000099302 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0000099302 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-03-31 0000099302 us-gaap:RetainedEarningsMember 2012-03-31 0000099302 us-gaap:TreasuryStockMember 2012-03-31 0000099302 us-gaap:CommonStockMember 2012-04-01 2012-06-30 0000099302 us-gaap:AdditionalPaidInCapitalMember 2012-04-01 2012-06-30 0000099302 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-04-01 2012-06-30 0000099302 us-gaap:RetainedEarningsMember 2012-04-01 2012-06-30 0000099302 us-gaap:CommonStockMember 2012-06-30 0000099302 us-gaap:AdditionalPaidInCapitalMember 2012-06-30 0000099302 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-06-30 0000099302 us-gaap:RetainedEarningsMember 2012-06-30 0000099302 us-gaap:TreasuryStockMember 2012-06-30 0000099302 2012-08-06 0000099302 trns:LessThanMember 2012-04-01 2012-06-30 0000099302 trns:LessThanMember 2011-03-27 2011-06-25 0000099302 trns:BaseRateMember 2012-06-30 0000099302 trns:LIBORMember 2012-06-30 0000099302 trns:LessThanMember 2012-06-30 0000099302 trns:ProductSegmentMember 2012-04-01 2012-06-30 0000099302 trns:ProductSegmentMember 2011-03-27 2011-06-25 0000099302 trns:ServiceSegmentMember 2012-04-01 2012-06-30 0000099302 trns:ServiceSegmentMember 2011-03-27 2011-06-25 0000099302 trns:TotalMember 2012-04-01 2012-06-30 0000099302 trns:TotalMember 2011-03-27 2011-06-25 0000099302 2012-03-25 2012-06-30 0000099302 trns:LessThanMember 2012-03-25 2012-06-30 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure Operating expense allocations between segments were based on actual amounts, a percentage of revenues, headcount, and management's estimates. 16365000 17182000 8732000 8423000 25097000 25605000 12155000 12914000 6735000 6393000 18890000 19307000 6207000 6298000 3441000 3626000 2172000 2102000 5613000 5728000 594000 570000 -47000 -45000 547000 525000 186000 200000 361000 325000 0.05 0.04 7375000 7277000 0.05 0.04 7681000 7608000 -5000 -2000 82000 -3000 -4000 -91000 1000 270000 326000 44000 32000 11905000 13800000 97000 99000 1041000 845000 7224000 6396000 1067000 1064000 857000 1041000 22138000 23178000 5426000 5306000 13384000 13390000 2265000 2449000 315000 849000 654000 44377000 44977000 6248000 7516000 2873000 5171000 219000 366000 9340000 13053000 5852000 3365000 139000 1382000 1042000 16574000 17599000 3953000 3920000 0.50 0.50 30000000 30000000 7905461 7840994 7406679 7341007 10932000 10810000 357000 448000 14755000 14394000 2194000 2194000 498782 498782 27803000 27378000 44377000 44977000 -218000 -8000 600000 670000 70000 66000 75000 258000 -1662000 297000 808000 1028000 346000 163000 -1254000 213000 -2089000 -543000 -147000 -58000 -2094000 -565000 453000 610000 125000 -453000 -735000 -2487000 -1296000 6000 14000 58000 -80000 -70000 6000 2553000 1308000 6000 2000 12000 10000 32000 32000 44000 42000 22000 18000 553000 262000 100000 7840000 3920000 10810000 448000 14394000 499000 -2194000 13000 7000 73000 80000 52000 26000 49000 75000 -91000 -91000 361000 7905000 3953000 10932000 357000 14755000 499000 -2194000 TRANSCAT INC 10-Q --03-30 7409652 false 0000099302 Yes No Smaller Reporting Company No 2013 Q1 2012-06-30 <div style="DISPLAY: block; TEXT-INDENT: 0pt"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 1 &#8211; GENERAL</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Description of Business:&#160;&#160;</font>Transcat, Inc. (&#8220;Transcat&#8221; or the &#8220;Company&#8221;) is a distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair, inspection and other compliance services primarily for pharmaceutical and FDA-regulated, industrial manufacturing, energy and utilities, chemical manufacturing and other industries.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Basis of Presentation:</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-STYLE: italic">&#160;</font>Transcat&#8217;s unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (&#8220;SEC&#8221;).&#160;&#160;Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements.&#160;&#160;In the opinion of the Company&#8217;s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included.&#160;&#160;The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year.&#160;&#160;The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended March 31, 2012 (&#8220;fiscal year 2012&#8221;) contained in the Company&#8217;s 2012 Annual Report on Form 10-K filed with the SEC.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Fair Value of Financial Instruments:</font>&#160;&#160;Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy.&#160;&#160;The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels.&#160;&#160;Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions.&#160;&#160;The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to variable interest rate pricing, and the carrying amounts for cash, accounts receivable and accounts payable approximate fair value due to their short-term nature.&#160;&#160;Investment assets, which fund the Company&#8217;s non-qualified deferred compensation plan are included as a component of other assets (non-current) on the Consolidated Balance Sheets, consist of mutual funds and are valued based on quoted market prices in active markets.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Stock-Based Compensation:&#160;&#160;</font>The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock, based on the fair market value of the award as of the grant date.&#160;&#160;The Company records compensation cost related to unvested stock awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period of each award.&#160;&#160;Excess tax benefits from the exercise of stock awards are presented in the Consolidated Statements of Cash Flows as a financing activity.&#160;&#160;Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards.&#160;&#160;The Company did not capitalize any stock-based compensation costs as part of an asset.&#160;&#160;The Company estimates forfeiture rates based on its historical experience.&#160;&#160;During the first quarter of the fiscal year ending March 30, 2013 (&#8220;fiscal year 2013&#8221;) and fiscal year 2012, the Company recorded non-cash stock-based compensation cost of less than $0.1 million and $0.3 million, respectively, in the Consolidated Statements of Operations.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Foreign Currency Translation and Transactions:</font>&#160;&#160;The accounts of Transmation (Canada) Inc., a wholly-owned subsidiary, are maintained in the local currency and have been translated to U.S. dollars.&#160;&#160;Accordingly, the amounts representing assets and liabilities, except for equity, have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period.&#160;&#160;Gains and losses arising from translation of Transmation (Canada) Inc.&#8217;s balance sheets into U.S. dollars are recorded directly to the accumulated other comprehensive income component of shareholders&#8217; equity.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Transcat records foreign currency gains and losses on Canadian business transactions.&#160;&#160;The net foreign currency loss was less than $0.1 million in the first quarter of fiscal years 2013 and 2012.&#160;&#160;The Company utilizes foreign exchange forward contracts to reduce the risk that its earnings would be adversely affected by changes in currency exchange rates.&#160;&#160;The Company does not apply hedge accounting and therefore the change in the fair value of the contracts, which totaled less than $0.1 million during the first quarter of fiscal years 2013 and 2012, was recognized as a component of other expense in the Consolidated Statements of Operations.&#160;&#160;The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged.&#160;&#160;On June 30, 2012, the Company had a foreign exchange contract, which matured in July 2012, outstanding in the notional amount of $1.6 million. The Company does not use hedging arrangements for speculative purposes.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Earnings Per Share:</font>&#160;&#160;Basic earnings per share of common stock are computed based on the weighted average number of shares of common stock outstanding during the period.&#160;&#160;Diluted earnings per share of common stock reflect the assumed conversion of stock options and unvested restricted stock awards using the treasury stock method in periods in which they have a dilutive effect.&#160;&#160;In computing the per share effect of assumed conversion, funds which would have been received from the exercise of options and unvested restricted stock and the related tax benefits are considered to have been used to purchase shares of common stock at the average market prices during the period.&#160;&#160;The resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The average shares outstanding used to compute basic and diluted earnings per share are as follows:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style=""> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">First Quarter Ended</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 30,</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 25,</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Average Shares Outstanding &#8211; Basic</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,375</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,277</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effect of Dilutive Common Stock Equivalents</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">306</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">331</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Average Shares Outstanding &#8211; Diluted</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,681</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,608</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Anti-dilutive Common Stock Equivalents</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">428</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">475</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> </table><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Subsequent Event:</font>&#160;&#160;On July 16, 2012, the Company acquired Anacor Compliance Services, Inc., a nationally-recognized provider of specialized analytical, calibration, compliance and validation services to the life sciences sector including biotechnology, medical device and pharmaceutical industries.&#160;&#160;The acquisition is not considered material.</font> </div><br/> Basis of Presentation: Transcat's unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission ("SEC").Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements.In the opinion of the Company's management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included.The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year.The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended March 31, 2012 ("fiscal year 2012") contained in the Company's 2012 Annual Report on Form 10-K filed with the SEC. Fair Value of Financial Instruments: Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy.The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels.Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions.The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to variable interest rate pricing, and the carrying amounts for cash, accounts receivable and accounts payable approximate fair value due to their short-term nature.Investment assets, which fund the Company's non-qualified deferred compensation plan are included as a component of other assets (non-current) on the Consolidated Balance Sheets, consist of mutual funds and are valued based on quoted market prices in active markets. Stock-Based Compensation: The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock, based on the fair market value of the award as of the grant date.The Company records compensation cost related to unvested stock awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period of each award.Excess tax benefits from the exercise of stock awards are presented in the Consolidated Statements of Cash Flows as a financing activity.Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards.The Company did not capitalize any stock-based compensation costs as part of an asset.The Company estimates forfeiture rates based on its historical experience.During the first quarter of the fiscal year ending March 30, 2013 ("fiscal year 2013") and fiscal year 2012, the Company recorded non-cash stock-based compensation cost of less than $0.1 million and $0.3 million, respectively, in the Consolidated Statements of Operations 100000 300000 Foreign Currency Translation and Transactions: The accounts of Transmation (Canada) Inc., a wholly-owned subsidiary, are maintained in the local currency and have been translated to U.S. dollars.Accordingly, the amounts representing assets and liabilities, except for equity, have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period.Gains and losses arising from translation of Transmation (Canada) Inc.'s balance sheets into U.S. dollars are recorded directly to the accumulated other comprehensive income component of shareholders' equity 100000 1600000 Earnings Per Share: Basic earnings per share of common stock are computed based on the weighted average number of shares of common stock outstanding during the period.Diluted earnings per share of common stock reflect the assumed conversion of stock options and unvested restricted stock awards using the treasury stock method in periods in which they have a dilutive effect.In computing the per share effect of assumed conversion, funds which would have been received from the exercise of options and unvested restricted stock and the related tax benefits are considered to have been used to purchase shares of common stock at the average market prices during the period.The resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding Subsequent Event: On July 16, 2012, the Company acquired Anacor Compliance Services, Inc., a nationally-recognized provider of specialized analytical, calibration, compliance and validation services to the life sciences sector including biotechnology, medical device and pharmaceutical industries.The acquisition is not considered material <table cellpadding="0" cellspacing="0" width="100%" style=""> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">First Quarter Ended</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 30,</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 25,</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Average Shares Outstanding &#8211; Basic</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,375</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,277</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effect of Dilutive Common Stock Equivalents</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">306</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">331</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Average Shares Outstanding &#8211; Diluted</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,681</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7,608</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Anti-dilutive Common Stock Equivalents</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">428</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">475</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> </table> 306000 331000 428000 475000 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><a id="new_id" name="RANGEA1I12"> <!--EFPlaceholder--></a><a id="new_id-0" name="RANGEA4I7"><!--EFPlaceholder--></a>NOTE 2 &#8211; DEBT</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Description:&#160;&#160;</font>Transcat, through its credit agreement (the &#8220;Credit Agreement&#8221;) which matures in January 2014, has a revolving credit facility in the amount of $15.0 million (the &#8220;Revolving Credit Facility&#8221;).&#160;&#160;As of June 30, 2012, $15.0 million was available under the Credit Agreement, of which $5.9 million was outstanding and included in long-term debt on the Consolidated Balance Sheet.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Interest and Other Costs:</font>&#160;&#160;Interest on the Revolving Credit Facility accrues, at Transcat&#8217;s election, at either a base rate (the &#8220;Base Rate&#8221;), as defined in the Credit Agreement, or the London Interbank Offered Rate (&#8220;LIBOR&#8221;), in each case, plus a margin.&#160;&#160;Commitment fees accrue based on the average daily amount of unused credit available on the Revolving Credit Facility.&#160;&#160;Interest and commitment fees are adjusted on a quarterly basis based upon the Company&#8217;s calculated leverage ratio, as defined in the Credit Agreement.&#160;&#160;The Base Rate and the LIBOR as of June 30, 2012 were 3.3% and 0.2%, respectively.&#160;&#160;The Company&#8217;s interest rate for the first quarter of fiscal year 2013 ranged from 1.1% to 2.8%.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Covenants:</font>&#160;&#160;The Credit Agreement has certain covenants with which the Company has to comply, including a fixed charge ratio covenant and a leverage ratio covenant.&#160;&#160;The Company was in compliance with all loan covenants and requirements throughout the first quarter of fiscal year 2013.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Other Terms:</font>&#160;&#160;The Company has pledged all of its U.S. tangible and intangible personal property and a majority of the common stock of its wholly-owned subsidiary, Transmation (Canada) Inc., as collateral security for the loans made under the Revolving Credit Facility.</font> </div><br/> 15000000 5900000 0.033 0.002 0.011 0.028 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 3 &#8211; STOCK-BASED COMPENSATION</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Transcat, Inc. 2003 Incentive Plan, as Amended and Restated (the &#8220;2003 Plan&#8221;), provides for, among other awards, grants of restricted stock and stock options to directors, officers and key employees at the fair market value at the date of grant.&#160;&#160;At June 30, 2012, the number of shares available for future grant under the 2003 Plan totaled 0.1 million.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Restricted Stock:&#160;&#160;</font>The Company grants performance-based restricted stock awards as a primary component of executive compensation.&#160;&#160;The awards generally vest following the third fiscal year from the date of grant subject to certain cumulative diluted earnings per share growth targets over the eligible period.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Compensation cost ultimately recognized for these performance-based restricted stock awards will equal the grant date fair market value of the award that coincides with the actual outcome of the performance conditions.&#160;&#160;On an interim basis, the Company records compensation cost based on an assessment of the probability of achieving the performance conditions.&#160;&#160;The Company achieved 75% of the target level for the performance-based restricted stock awards granted in the fiscal year ended March 27, 2010 (&#8220;fiscal year 2010&#8221;) and as a result, issued 52 thousand shares of common stock to executive officers during the first quarter of fiscal year 2013.&#160;&#160;At June 30, 2012, the Company estimated the probability of achievement for the awards granted in fiscal years 2013 and 2012 to be 100% of the target levels and 75% of the target levels for the awards granted in the fiscal year ended March 26, 2011 (&#8220;fiscal year 2011&#8221;).&#160;&#160;Total expense relating to performance-based restricted stock awards, based on grant date fair value and the estimated probability of achievement, was less than $0.1 million in the first quarter of fiscal years 2013 and 2012.&#160;&#160;Unearned compensation totaled $0.8 million as of June 30, 2012.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On April 4, 2011, the Company granted restricted stock awards, which vested immediately, to its officers and certain key employees.&#160;&#160;Total expense related to these restricted stock awards, based on grant date fair value, was $0.1 million in the first quarter of fiscal year 2012.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Stock Options:</font><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt">&#160;</font> Options generally vest over a period of up to four years, using either a graded schedule or on a straight-line basis, and expire ten years from the date of grant.&#160;&#160;The expense relating to options is recognized on a straight-line basis over the requisite service period for the entire award.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table summarizes the Company&#8217;s options as of and for the first quarter ended June 30, 2012:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style=""> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Of</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Average</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Price Per</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted Average</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Remaining</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Contractual</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Term (in years)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aggregate</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intrinsic</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding as of March 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">597</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.94</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Granted</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercised</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cancelled/Forfeited</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.65</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding as of June 30, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">567</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.95</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">516</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercisable as of June 30, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">560</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.94</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">516</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> </table><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company&#8217;s closing stock price on the last trading day of the first quarter of fiscal year 2013 and the exercise price, multiplied by the number of in-the-money stock options) that would have been received by the option holders had all holders exercised their options on June 30, 2012.&#160;&#160;The amount of aggregate intrinsic value will change based on the fair market value of the Company&#8217;s stock.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Total unrecognized compensation cost related to non-vested stock options as of June 30, 2012 was less than $0.1 million, which is expected to be recognized over a weighted average period of less than one year.&#160;&#160;The aggregate intrinsic value of stock options exercised in the first quarter of fiscal year 2013 was less than $0.1 million.&#160;&#160;Cash received from the exercise of options in the first quarter of fiscal year 2013 was less than $0.1 million.</font> </div><br/> 100000 0.75 52000 1.00 0.75 100000 800000 100000 P4Y P10Y 100000 100000 100000 <table cellpadding="0" cellspacing="0" width="100%" style=""> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Number</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Of</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Average</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercise</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Price Per</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Weighted Average</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Remaining</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Contractual</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Term (in years)</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Aggregate</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intrinsic</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding as of March 31, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">597</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.94</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Granted</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">-</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="60%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercised</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(10</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.03</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="60%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cancelled/Forfeited</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(20</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.65</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: right"> &#160; </td> <td nowrap="nowrap" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Outstanding as of June 30, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">567</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.95</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">516</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="60%" style="PADDING-BOTTOM: 2px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Exercisable as of June 30, 2012</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">560</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.94</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">516</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> </table> 597000 5.94 -10000 4.03 -20000 6.65 567000 5.95 P4Y 516000 560000 5.94 P4Y 516000 <div style="DISPLAY: block; TEXT-INDENT: 0pt"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 4 &#8211; SEGMENT INFORMATION</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Transcat has two reportable segments:&#160;&#160;Distribution Products (&#8220;Product&#8221;) and Calibration Services (&#8220;Service&#8221;).&#160;&#160;The Company has no inter-segment sales.&#160;&#160;The following table presents segment information for the first quarters ended June 30, 2012 and June 25, 2011:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style=""> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">First Quarter Ended</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 30,</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 25,</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net Revenue:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product Sales</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,365</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,182</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service Revenue</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,732</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,423</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,097</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,605</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross Profit:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,210</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,268</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,997</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,030</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,207</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,298</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating Expenses:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product (1)</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,358</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,447</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service (1)</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,255</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,281</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating Income</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">594</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">570</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unallocated Amounts:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest and Other Expense, net</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">47</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision for Income Taxes</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">186</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">200</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">233</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">245</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net Income</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">361</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">325</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style=""> <tr> <td align="left" colspan="8" nowrap="nowrap" valign="bottom"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1)&#160;Operating expense allocations between segments were based on actual amounts, a percentage of revenues, headcount, and management&#8217;s estimates.</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> </table><br/> 2 <table cellpadding="0" cellspacing="0" width="100%" style=""> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">First Quarter Ended</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 30,</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2012</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">June 25,</font></font> </div> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2011</font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net Revenue:</font> </div> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product Sales</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16,365</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17,182</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service Revenue</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,732</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,423</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,097</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25,605</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross Profit:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,210</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,268</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,997</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,030</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,207</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,298</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating Expenses:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Product (1)</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,358</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,447</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service (1)</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,255</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,281</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,613</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,728</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating Income</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">594</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">570</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unallocated Amounts:</font> </div> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest and Other Expense, net</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">47</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Provision for Income Taxes</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">186</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">200</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-LEFT: 0pt; PADDING-BOTTOM: 2px; MARGIN-LEFT: 9pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">233</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">245</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net Income</font> </div> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">361</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">325</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font> </td> </tr> </table> 16365000 17182000 8732000 8423000 25097000 25605000 4210000 4268000 1997000 2030000 6207000 6298000 3358000 3447000 2255000 2281000 5613000 5728000 47000 45000 233000 245000 <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTE 5 &#8211; ACQUISITIONS</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In connection with certain of its business acquisitions, the Company entered into earn out agreements with the former owners of the acquired businesses.&#160;&#160;These agreements entitle the former owners to receive earn out payments subject to continued employment and certain post-closing financial targets, as defined in the agreements.&#160;&#160;During the first quarter of fiscal year 2012, payments totaling $0.1 million were earned and recorded as compensation expense in the Consolidated Statements of Operations.&#160;&#160;There were no amounts earned in the first quarter of fiscal year 2013.&#160;&#160;Earn out consideration unpaid as of June 30, 2012 totaled less than $0.1 million and was included in other current liabilities in the Consolidated Balance Sheet.</font> </div><br/><div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition, certain of these business acquisitions contain holdback provisions, as defined in the respective purchase agreements.&#160;&#160;The Company accrues contingent consideration relating to the holdback provisions based on their estimated fair value as of the date of acquisition.&#160;&#160;During the first quarter of fiscal years 2013 and 2012, the Company paid less than $0.1 million in contingent consideration.&#160;&#160;There was no unpaid contingent consideration as of June 30, 2012.</font> </div><br/> 100000 100000 100000 EX-101.SCH 7 trns-20120630.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Consolidated Balance Sheets (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Consolidated Statements of Shareholders' Equity (unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Note 1 - General link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Note 2 - Debt link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Note 3 - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Note 4 - Segment Information link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Note 5 - Acquisitions link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Note 1 - General (Tables) link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Note 3 - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Note 4 - Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Note 1 - General (Detail) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Note 1 - General (Detail) - Average Shares Outstanding Used to Compute Basic and Diluted Earnings Per Share: link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Note 2 - Debt (Detail) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Note 3 - Stock-Based Compensation (Detail) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Note 3 - Stock-Based Compensation (Detail) - Summary of the Company's Stock Options link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Note 4 - Segment Information (Detail) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Note 4 - Segment Information (Detail) - Business Segments - Operating Income: Distribution Products ("Products") and Calibration Services ("Service") link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Note 5 - Acquisitions (Detail) link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 trns-20120630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 trns-20120630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 trns-20120630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 trns-20120630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 2 - Debt
3 Months Ended
Jun. 30, 2012
Long-term Debt [Text Block]
NOTE 2 – DEBT

Description:  Transcat, through its credit agreement (the “Credit Agreement”) which matures in January 2014, has a revolving credit facility in the amount of $15.0 million (the “Revolving Credit Facility”).  As of June 30, 2012, $15.0 million was available under the Credit Agreement, of which $5.9 million was outstanding and included in long-term debt on the Consolidated Balance Sheet.

Interest and Other Costs:  Interest on the Revolving Credit Facility accrues, at Transcat’s election, at either a base rate (the “Base Rate”), as defined in the Credit Agreement, or the London Interbank Offered Rate (“LIBOR”), in each case, plus a margin.  Commitment fees accrue based on the average daily amount of unused credit available on the Revolving Credit Facility.  Interest and commitment fees are adjusted on a quarterly basis based upon the Company’s calculated leverage ratio, as defined in the Credit Agreement.  The Base Rate and the LIBOR as of June 30, 2012 were 3.3% and 0.2%, respectively.  The Company’s interest rate for the first quarter of fiscal year 2013 ranged from 1.1% to 2.8%.

Covenants:  The Credit Agreement has certain covenants with which the Company has to comply, including a fixed charge ratio covenant and a leverage ratio covenant.  The Company was in compliance with all loan covenants and requirements throughout the first quarter of fiscal year 2013.

Other Terms:  The Company has pledged all of its U.S. tangible and intangible personal property and a majority of the common stock of its wholly-owned subsidiary, Transmation (Canada) Inc., as collateral security for the loans made under the Revolving Credit Facility.

EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\S,3-A,#%C.%\U8C(S7S1B8SE?839C,5\Q,C(S M-C=C9C$R86,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;G-O;&ED871E9%]3=&%T96UE;G1S7V]F M7U-H83PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO M=&5?,5]'96YE#I% M>&-E;%=O#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?-5]!8W%U:7-I=&EO;G,\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K5\\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K M#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?,U]3=&]C:T)A#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S,3-A,#%C M.%\U8C(S7S1B8SE?839C,5\Q,C(S-C=C9C$R86,-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,S$S83`Q8SA?-6(R,U\T8F,Y7V$V8S%?,3(R,S8W M8V8Q,F%C+U=O'0O:'1M;#L@8VAA2!) M;F9O2!);F9O2!296=I'0^,3`M43QS<&%N/CPO'0^+2TP,RTS,#QS<&%N/CPO'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!6;VQU;G1A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\S,3-A,#%C.%\U8C(S7S1B8SE?839C,5\Q,C(S-C=C M9C$R86,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,S$S83`Q8SA? M-6(R,U\T8F,Y7V$V8S%?,3(R,S8W8V8Q,F%C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!4F5D($QO M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S,3-A,#%C M.%\U8C(S7S1B8SE?839C,5\Q,C(S-C=C9C$R86,-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,S$S83`Q8SA?-6(R,U\T8F,Y7V$V8S%?,3(R,S8W M8V8Q,F%C+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!,:6%B:6QI='D\+W1D/@T*("`@("`@("`\ M=&0@8VQA3L@-RPT,#8L M-C2!3=&]C:RP@870@8V]S="P@-#DX+#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,"PP M,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\S,3-A,#%C.%\U8C(S7S1B8SE?839C,5\Q M,C(S-C=C9C$R86,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,S$S M83`Q8SA?-6(R,U\T8F,Y7V$V8S%?,3(R,S8W8V8Q,F%C+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!297-E&5S(%!A>6%B;&4\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S6UE;G1S(&]N($]T:&5R($1E8G0@3V)L:6=A=&EO;G,\+W1D/@T*("`@ M("`@("`\=&0@8VQA&-E&-H86YG92!2 M871E($-H86YG97,@;VX@0V%S:#PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\S,3-A,#%C.%\U8C(S7S1B8SE?839C,5\Q,C(S-C=C9C$R86,-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,S$S83`Q8SA?-6(R,U\T8F,Y M7V$V8S%?,3(R,S8W8V8Q,F%C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0@ M0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX-"B`@ M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UE6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T* M("`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4 M.B!B;VQD)SY$97-C28C.#(R,3LI(&ES(&$-"B`-"B`@("`@(&1I6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/D)A0T*(`T*("`@("`@86-C97!T960@:6X@=&AE(%5N:71E9"!3=&%T97,@*"8C M.#(R,#M'04%0)B,X,C(Q.RD@9F]R#0H@("`@#0H@("`@("!I;G1E&-H86YG92!#;VUM:7-S:6]N#0H@("`@(`T* M("`@("`@*"8C.#(R,#M314,F(S@R,C$[*2XF(S$V,#LF(S$V,#M!8V-O2P@=&AE($-O;G-O;&ED871E9`T*("`@(`T*("`@("`@1FEN86YC:6%L M(%-T871E;65N=',@9&\@;F]T(&EN8VQU9&4@86QL(&]F('1H92!I;F9O28C.#(Q-SMS#0H@("`@#0H@("`@("!M86YA9V5M96YT+"!A;&P@861J M=7-T;65N=',@8V]N6EN9PT*(`T*("`@("`@0V]N6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`@ M("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B M;VQD)SY&86ER(%9A;'5E(&]F#0H@("`-"B`@("`@($9I;F%N8VEA;"!);G-T M2XF(S$V,#LF(S$V,#M4:&4-"B`@ M("`@#0H@("`@("!H:65R87)C:'DL('=H:6-H('!R:6]R:71I>F5S('1H92!I M;G!U=',@=7-E9"!I;B!M96%S=7)I;F<-"B`@("`-"B`@("`@(&9A:7(@=F%L M=64L(&-O;G-I&ES=',L(')E<75I6%B;&4-"B`@("`@#0H@("`@("!A<'!R;WAI;6%T M92!F86ER('9A;'5E(&1U92!T;R!T:&5I6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/E-T;V-K+4)A M"!B M96YE9FET&5R8VES92!O9@T*("`@#0H@("`@("!S=&]C M:R!A=V%R9',@87)E('!R97-E;G1E9"!I;B!T:&4@0V]N65A M0T*(`T*("`@("`@5')A M;G-L871I;VX@86YD(%1R86YS86-T:6]N2UO=VYE9"!S=6)S:61I87)Y+"!A2!A;F0@:&%V M92!B965N('1R86YS;&%T960@=&\-"B`@#0H@("`@("!5+E,N(&1O;&QA'!E;G-E(&%C8V]U;G1S M(&AA=F4@8F5E;B!T6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/@T*("`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)SY4F5S#0H@("`@#0H@("`@("!F;W)E M:6=N(&5X8VAA;F=E(&9O2!A9F9E8W1E9"!B>2!C:&%N9V5S(&EN#0H@#0H@("`@("!C M=7)R96YC>2!E>&-H86YG92!R871E2!D;V5S(&YO=`T*(`T*("`@("`@87!P;'D@:&5D9V4@86-C;W5N=&EN9R!A M;F0@=&AE65AF5D(&%S(&$@8V]M<&]N96YT(&]F(&]T:&5R(&5X M<&5N6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4 M+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/@T*("`@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5) M1TA4.B!B;VQD)SY%87)N:6YG"!B M96YE9FET"<^#0H@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M(&-O;'-P86X],T0V(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4 M.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\ M='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^2G5N90T*("`@("`-"B`@("`@("`@("`@("`@("`S,"P\+V9O;G0^/"]F M;VYT/@T*(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@ M("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O M;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@ M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H M="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^-RPS-S4\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T* M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^-RPR-S<\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^ M#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X,"4@"<^#0H@("`@(`T*("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SY%9F9E8W0-"B`@("`-"B`@("`@("`@("`@ M("`@;V8@1&EL=71I=F4@0V]M;6]N(%-T;V-K($5Q=6EV86QE;G1S/"]F;VYT M/@T*("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@ M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXS,#8\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI M9#L@5$585"U!3$E'3CH@"<^#0H@ M("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY!=F5R86=E M#0H@("`@(`T*("`@("`@("`@("`@("!3:&%R97,@3W5T"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T* M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^-RPV.#$\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!415A4+4%,24=. M.B!L969T)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@ M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@ M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C(U M<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^-RPV,#@\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@ M(`T*("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.#`E('-T>6QE/3-$)U!!1$1)3D"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@ M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C(U<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^-#(X/"]F;VYT/@T*("`-"B`@("`@("`@("`\ M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXT-S4\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD)SY3 M=6)S97%U96YT#0H@("`@(`T*("`@("`@179E;G0Z/"]F;VYT/B8C,38P.R8C M,38P.T]N($IU;'D@,38L(#(P,3(L('1H92!#;VUP86YY#0H@("`@(`T*("`@ M("`@86-Q=6ER960@06YA8V]R($-O;7!L:6%N8V4@4V5R=FEC97,L($EN8RXL M(&$-"B`-"B`@("`@(&YA=&EO;F%L;'DM71I8V%L+`T*("`@(`T*("`@("`@8V%L:6)R M871I;VXL(&-O;7!L:6%N8V4@86YD('9A;&ED871I;VX@2P@;65D:6-A;"!D979I8V4@86YD#0H@#0H@("`@("!P M:&%R;6%C975T:6-A;"!I;F1U'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/DEN=&5R97-T(&%N9`T*("`- M"B`@("`@($]T:&5R($-O65A2P@:6YC;'5D:6YG(&$@9FEX960@8VAA6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/D]T:&5R#0H@ M("`@(`T*("`@("`@5&5R;7,Z/"]F;VYT/B8C,38P.R8C,38P.U1H92!#;VUP M86YY(&AA2UO=VYE9"!S=6)S:61I87)Y+`T*("`@#0H@("`@("!4 M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T* M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!4:6UE2!E M;7!L;WEE97,@870@=&AE(&9A:7(@;6%R:V5T#0H@("`-"B`@("`@('9A;'5E M(&%T('1H92!D871E(&]F(&=R86YT+B8C,38P.R8C,38P.T%T($IU;F4@,S`L M(#(P,3(L('1H90T*("`@("`-"B`@("`@(&YU;6)E6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/E)E2!V97-T(&9O;&QO=VEN9PT*("`@ M("`-"B`@("`@('1H92!T:&ER9"!F:7-C86P@>65A2!R96-O9VYI>F5D(&9O M65A65A'!E;G-E#0H@#0H@("`@("!R96QA M=&EN9R!T;R!P97)F;W)M86YC92UB87-E9"!R97-T2!G65AF5S('1H92!#;VUP86YY)B,X,C$W M.W,@;W!T:6]N6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9"<^#0H@(`T*("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$8V5N=&5R/@T*("`-"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T* M("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^3V8\+V9O;G0^/"]F;VYT M/@T*("`@(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@ M("`\+V1I=CX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!T:6UE"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z M(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;B<^5V5I9VAT960\+V9O;G0^/"]F;VYT/@T*("`@("`-"B`@("`@ M("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`-"B`@("`@("`@("`@("`@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$8V5N=&5R/@T*("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^/&9O M;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^/&9O;G0@&5R8VES93PO9F]N=#X\+V9O;G0^#0H@("`@(`T*("`@("`@("`@("`@("`\ M+V1I=CX-"B`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@("`@#0H@("`@("`@ M("`@("`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E. M1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^ M#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T* M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P M86X],T0R(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!4 M15A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C M96YT97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4 M+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^0V]N=')A8W1U86P\+V9O;G0^/"]F;VYT M/@T*("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@("`@("`@("`@ M(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^5&5R;0T*(`T*("`@("`@("`@("`@("`H M:6X@>65A6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^26YT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY/=71S=&%N M9&EN9PT*("`@(`T*("`@("`@("`@("`@("!A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)#PO9F]N=#X- M"B`@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXU+CDT/"]F;VYT/@T*("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@ M("`@("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX- M"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXM/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T*("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXM/"]F;VYT/@T*("`@("`- M"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^ M#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@ M("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T* M("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R M:6=H="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^*#$P/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D M/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@ M("`@("`@("`F(S$V,#L-"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX-"B`@("`-"B`@("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\ M='(^#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#8P)2!S='EL93TS1"=0041$24Y'+4Q%1E0Z(#!P=#L@4$%$1$E.1RU" M3U143TTZ(#)P>#L@34%21TE.+4Q%1E0Z(#EP=#L@5$585"U)3D1%3E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#$X<'0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@ M("`@/&9O;G0@"<^#0H@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`P+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXH,C`\+V9O;G0^#0H@(`T*("`@ M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXI/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D/@T* M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D#L@5$585"U!3$E'3CH@;&5F M="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=. M.B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1) M3D#L@ M5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@ M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X.R!415A4+4%,24=..B!R:6=H="<^#0H@("`@(`T*("`@("`@("`@("`@ M)B,Q-C`[#0H@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U!!1$1)3D#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!R:6=H="<^ M#0H@("`@(`T*("`@("`@("`@("`@)B,Q-C`[#0H@("`-"B`@("`@("`@("`\ M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^ M#0H@("`@(`T*("`@("`@("`\='(@6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI M9#L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXU,38\+V9O M;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@ M("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0V,"4@"<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SY%>&5R8VES86)L90T*("`@(`T*("`@("`@("`@("`@("!A6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO M=&0^#0H@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXU+CDT/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C"<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@ M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P M+C6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXT/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\+W1D M/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@ M("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@"<^#0H@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXU,38\+V9O M;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@ M("`@/"]T86)L93X\8G(O/CQD:78@2!T:&4@;G5M8F5R M(&]F(&EN+71H92UM;VYE>2!S=&]C:PT*("`@("`-"B`@("`@(&]P=&EO;G,I M('1H870@=V]U;&0@:&%V92!B965N(')E8V5I=F5D(&)Y('1H92!O<'1I;VX@ M:&]L9&5R&5R8VES960@ M=&AE:7(@;W!T:6]NF5D(&-O;7!E;G-A=&EO M;B!C;W-T(')E;&%T960@=&\@;F]N+79E65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P M="<^#0H@("`@(`T*("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/@T*("`@("`-"B`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)SY46QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#`N-S5P="!S;VQI9"<^#0H@("`@#0H@("`@("`@("`@("`@(#QD M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@("`-"B`@("`@ M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@ M("`@("`@("`\=&0@8V]L6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*(`T*("`@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z M(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;B<^,C`Q,CPO9F]N=#X-"B`-"B`@("`@("`@("`@("`@/"]D:78^ M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@ M("`@("`@("`\=&0@8V]L6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*(`T*("`@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z M(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;B<^,C`Q,3PO9F]N=#X-"B`-"B`@("`@("`@("`@("`@/"]D:78^ M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@ M("`@(#QT6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXD/"]F M;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T* M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@#L@34%21TE.+4Q%1E0Z(#EP=#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G M/@T*(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXX+#6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^ M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@#L@34%21TE.+4Q% M1E0Z(#EP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[ M(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,S9P=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXR-2PP.3<\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@ M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXR-2PV,#4\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T* M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX- M"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@ M("`\+W1R/@T*("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#`E('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T* M("`@("`@("`@(#QT6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXQ+#DY-SPO9F]N=#X- M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@ M;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$ M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@ M5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXV+#(Y.#PO9F]N=#X-"B`-"B`@("`@ M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY/<&5R871I;F<-"B`@("`-"B`@ M("`@("`@("`@("`@("!%>'!E;G-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@ M("`@(#QT6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@#L@34%21TE.+4Q%1E0Z(#EP=#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G M/@T*(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXR+#(U-3PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX- M"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@#L@34%21TE.+4Q%1E0Z M(#EP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1% M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,S9P=#L@5$585"U) M3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXU+#8Q,SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N M-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX- M"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)V)A8VMG6QE/3-$)U!!1$1)3D"<^#0H@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@ M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`P+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N M-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@ M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^56YA;&QO8V%T960-"B`-"B`@ M("`@("`@("`@("`@("!!;6]U;G1S.CPO9F]N=#X-"B`@(`T*("`@("`@("`@ M("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@ M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@ M("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.#`E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP M=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXT-SPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@ M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A M8VMG6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SY0&5S/"]F;VYT/@T*(`T*("`@("`@("`@("`@ M("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXR,#`\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C6QE/3-$)U!!1$1)3D"<^#0H@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@ M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`P+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N M-S5P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)V)A8VMG6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@ M("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@ M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@P M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@#0H@("`@("`@ M("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY.970-"B`@(`T*("`@("`@("`@ M("`@("`@($EN8V]M93PO9F]N=#X-"B`-"B`@("`@("`@("`@("`@/"]D:78^ M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXS-C$\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!4 M15A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@-'!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@'!E;G-E(&%L;&]C871I;VYS M(&)E='=E96X@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@ M("`@("`@("`@/&9O;G0@'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`@#0H@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD M.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!4:6UE6UE;G1S('-U8FIE8W0@=&\@8V]N=&EN=65D(&5M<&QO>6UE M;G0@86YD(&-E2!A M8V-R=65S(&-O;G1I;F=E;G0-"B`@(`T*("`@("`@8V]N3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S,3-A M,#%C.%\U8C(S7S1B8SE?839C,5\Q,C(S-C=C9C$R86,-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,S$S83`Q8SA?-6(R,U\T8F,Y7V$V8S%?,3(R M,S8W8V8Q,F%C+U=O'0O:'1M;#L@8VAA2P@=&AE($-O;G-O;&ED871E M9"!&:6YA;F-I86P@4W1A=&5M96YT65A65A2!497AT($)L;V-K73PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^1F%I2P@=VAI8V@@<')I;W)I=&EZ97,@=&AE(&EN<'5T2!T;R!D979E;&]P(&ET6EN9R!A;6]U;G1S(&9O&EM M871E(&9A:7(@=F%L=64@9'5E('1O('1H96ER('-H;W)T+71E2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#Y3=&]C:RU"87-E9"!#;VUP96YS871I;VXZ M(%1H92!#;VUP86YY(&UE87-U2!R96-O&5R8VES92!O9B!S=&]C M:R!A=V%R9',@87)E('!R97-E;G1E9"!I;B!T:&4@0V]N"!D961U8W1I;VYS(&9O&5R8VES960@87=A2!;4&]L M:6-Y(%1E>'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#Y&;W)E:6=N($-U2UO=VYE9"!S=6)S:61I87)Y+"!A2P@=&AE(&%M;W5N=',@&-H86YG92!D=7)I;F<@=&AE('!E2!H879E(&$@9&EL=71I=F4@969F96-T+DEN(&-O;7!U=&EN9R!T:&4@ M<&5R('-H87)E(&5F9F5C="!O9B!A&5R M8VES92!O9B!O<'1I;VYS(&%N9"!U;G9E2!;4&]L:6-Y(%1E>'0@ M0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y3=6)S97%U M96YT($5V96YT.B!/;B!*=6QY(#$V+"`R,#$R+"!T:&4@0V]M<&%N>2!A8W%U M:7)E9"!!;F%C;W(@0V]M<&QI86YC92!397)V:6-E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P M(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4^#0H@("`-"B`@("`@("`@ M/'1R/@T*("`@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@"<^#0H@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O M;'-P86X],T0V(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B M;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U7 M14E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(^ M#0H@("`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@"<^ M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M2G5N90T*("`@("`-"B`@("`@("`@("`@("`@("`S,"P\+V9O;G0^/"]F;VYT M/@T*(`T*("`@("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\ M+V1I=CX-"B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@("`@ M("`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T* M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;B<^-RPS-S4\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX- M"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^-RPR-S<\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@(#PO='(^#0H@ M("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@("`@("`@/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X,"4@"<^#0H@("`@(`T*("`@("`@("`@("`@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M;&5F=#X-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SY%9F9E8W0-"B`@("`-"B`@("`@("`@("`@("`@ M;V8@1&EL=71I=F4@0V]M;6]N(%-T;V-K($5Q=6EV86QE;G1S/"]F;VYT/@T* M("`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@(#PO M=&0^#0H@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO M=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXS,#8\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^ M#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@ M5$585"U!3$E'3CH@"<^#0H@("`@ M(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X-"B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY!=F5R86=E#0H@ M("`@(`T*("`@("`@("`@("`@("!3:&%R97,@3W5T"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@ M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C(U<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(')I9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^-RPV.#$\+V9O;G0^#0H@("`@#0H@ M("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!415A4+4%,24=..B!L M969T)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C(U<'0@ M9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^-RPV,#@\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C(U<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T* M("`@("`@("`\+W1R/@T*("`@("`-"B`@("`@("`@/'1R/@T*("`@(`T*("`@ M("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.#`E('-T>6QE/3-$)U!!1$1)3D"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@ M("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C(U M<'0@9&]U8FQE.R!415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^-#(X/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D M/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXT M-S4\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!;5&%B;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@ M8VQA"<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D(&-O;'-P86X],T0R(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^4VAA6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)SX-"B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9"<^ M#0H@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`-"B`@("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$8V5N=&5R/@T*("`@(`T*("`@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1C96YT97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4 M+4E.1$5.5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT M97(^#0H@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^4')I8V4- M"B`-"B`@("`@("`@("`@("`@("!097(\+V9O;G0^/"]F;VYT/@T*(`T*("`@ M("`@("`@("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+V1I=CX-"B`@ M("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4 M.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE"<^ M#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M5V5I9VAT960-"B`@("`-"B`@("`@("`@("`@("`@("!!=F5R86=E/"]F;VYT M/CPO9F]N=#X-"B`@("`@#0H@("`@("`@("`@("`@(#PO9&EV/@T*("`-"B`@ M("`@("`@("`@(#PO9&EV/@T*("`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^4F5M86EN:6YG/"]F;VYT/CPO M9F]N=#X-"B`-"B`@("`@("`@("`@("`@/"]D:78^#0H@(`T*("`@("`@("`@ M("`@/"]D:78^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`- M"B`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*("`@(`T*("`@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E' M2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^/&9O;G0@"<^#0H@("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^06=G6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)V)A M8VMG6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M-3DW/"]F;VYT/@T*("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXD/"]F;VYT/@T* M("`@("`-"B`@("`@("`@("`\+W1D/@T*("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`F(S$V,#L- M"B`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@ M/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@ M("`@("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@(#PO='(^#0H@("`@(`T*("`@("`@("`\='(^#0H@("`@#0H@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8P)2!S='EL93TS M1"=0041$24Y'+4Q%1E0Z(#!P=#L@34%21TE.+4Q%1E0Z(#EP=#L@5$585"U) M3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M1W)A;G1E9#PO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]D:78^#0H@("`@ M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS M1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X- M"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@("`@ M("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^17AE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXH,3`\+V9O;G0^#0H@(`T*("`@("`@("`@(#PO=&0^ M#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS M1"=415A4+4%,24=..B!R:6=H="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^-"XP,SPO9F]N=#X-"B`@ M(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@("`-"B`@("`@ M("`@("`@("8C,38P.PT*("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^ M)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@ M("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX-"B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^0V%N8V5L;&5D M+T9O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^ M#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$58 M5"U!3$E'3CH@"<^#0H@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T M)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#6QE/3-$)U!!1$1)3D#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@"<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@ M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!4 M15A4+4%,24=..B!L969T)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@ M#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#6QE/3-$)U!!1$1)3D#L@5$585"U!3$E'3CH@;&5F M="<^#0H@("`@(`T*("`@("`@("`@("`@/&9O;G0@"<^#0H@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@ M("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)SX-"B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE M/3-$)U!!1$1)3D#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@"<^#0H@("`@(`T*("`@("`@("`@("`@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U) M3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X- M"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SY/=71S=&%N9&EN9PT*("`@(`T*("`@("`@("`@("`@("!A M6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@ M(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXU+CDU/"]F;VYT/@T*("`@#0H@("`@("`@("`@/"]T9#X-"B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P M+C"<^#0H@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T* M("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`P+C6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXT/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`\ M+W1D/@T*("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@"<^#0H@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P M="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/@T*("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@"<^#0H@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`P+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXU-C`\+V9O;G0^#0H@(`T*("`@ M("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX-"B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T M9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F M;VYT/@T*("`@(`T*("`@("`@("`@(#PO=&0^#0H@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@ M("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N M-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@("`@/"]T9#X-"B`@#0H@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^#0H@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@("`@#0H@("`@("`@ M("`@/"]T9#X-"B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P M="!S;VQI9#L@5$585"U!3$E'3CH@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!396=M96YT(%M486)L92!497AT($)L M;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'1A8FQE(&-E M;&QP861D:6YG/3-$,"!C96QL6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#`N-S5P="!S;VQI9"<^#0H@("`@#0H@("`@("`@("`@("`@(#QD M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U714E'2%0Z(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*("`@("`-"B`@("`@ M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,G!X)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@ M("`@("`@("`\=&0@8V]L6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*(`T*("`@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z M(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;B<^,C`Q,CPO9F]N=#X-"B`-"B`@("`@("`@("`@("`@/"]D:78^ M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/@T*("`@("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@ M("`@("`@("`\=&0@8V]L6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^#0H@ M("`@#0H@("`@("`@("`@("`@("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/@T*(`T*("`@("`@("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z M(&)O;&0[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;B<^,C`Q,3PO9F]N=#X-"B`-"B`@("`@("`@("`@("`@/"]D:78^ M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4.B!B;VQD.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT^#0H@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T M9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@ M("`@(#QT6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXD/"]F M;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T* M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!A;&EG M;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^#0H@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@#L@34%21TE.+4Q%1E0Z(#EP=#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G M/@T*(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXX+#6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^ M#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@#L@34%21TE.+4Q% M1E0Z(#EP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[ M(%1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,S9P=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXR-2PP.3<\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@ M("`-"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXR-2PV,#4\+V9O;G0^#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T* M("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX- M"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[ M/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@ M("`\+W1R/@T*("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#`E('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L M:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@(`T* M("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`- M"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX-"B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T* M("`@("`@("`@(#QT6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXQ+#DY-SPO9F]N=#X- M"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@ M;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$ M;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@ M5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D"<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@("`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@ M("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXV+#(Y.#PO9F]N=#X-"B`-"B`@("`@ M("`@("`@(#PO=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^#0H@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY/<&5R871I;F<-"B`@("`-"B`@ M("`@("`@("`@("`@("!%>'!E;G-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT M/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X-"B`@("`@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@ M("`@(#QT6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$58 M5"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T* M("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@ M/&9O;G0@#L@34%21TE.+4Q%1E0Z(#EP=#L@5$585"U)3D1% M3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G M/@T*(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXR+#(U-3PO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO M=&0^#0H@("`@#0H@("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX- M"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@#L@34%21TE.+4Q%1E0Z M(#EP=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1% M6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,S9P=#L@5$585"U) M3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE M9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M)SXU+#8Q,SPO9F]N=#X-"B`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@ M("`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N M-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX- M"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE M/3-$)V)A8VMG6QE/3-$)U!!1$1)3D"<^#0H@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF M(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@ M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`P+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N M-S5P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I% M.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\ M+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@ M("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@ M("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^ M#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@ M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@(#PO='(^#0H@(`T*("`@("`@("`@(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`P<'0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@ M("`@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1% M6%0M04Q)1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^56YA;&QO8V%T960-"B`-"B`@ M("`@("`@("`@("`@("!!;6]U;G1S.CPO9F]N=#X-"B`@(`T*("`@("`@("`@ M("`@("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@ M("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/@T*("`@ M("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX-"B`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@ M#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@("`@ M("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`\+W1R/@T*("`-"B`@("`@("`@ M("`\='(^#0H@#0H@("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.#`E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP M=#L@5$585"U)3D1%3E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M M04Q)1TXZ(&QE9G0G/@T*("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXT-SPO9F]N=#X-"B`@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`- M"B`@("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@ M(`T*("`@("`@("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X-"B`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@ M("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX-"B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\ M+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@ M("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A M8VMG6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SY0&5S/"]F;VYT/@T*(`T*("`@("`@("`@("`@ M("`\+V1I=CX-"B`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@ M("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXR,#`\ M+V9O;G0^#0H@("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`P+C6QE/3-$)U!!1$1)3D"<^#0H@#0H@("`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V M,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@ M("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P="!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^#0H@("`@(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q-C`[/"]F;VYT/@T*(`T*("`@("`@ M("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`P+C6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N-S5P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^#0H@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D(&%L:6=N/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX-"B`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@ M("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#`N M-S5P="!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)V)A8VMG6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@ M("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/@T*("`@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX-"B`-"B`@("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/@T*(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<^)B,Q M-C`[/"]F;VYT/@T*(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@ M("`@("`\+W1R/@T*("`-"B`@("`@("`@("`\='(^#0H@#0H@("`@("`@("`@ M("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#@P M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX-"B`@#0H@("`@("`@ M("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SY.970-"B`@(`T*("`@("`@("`@ M("`@("`@($EN8V]M93PO9F]N=#X-"B`-"B`@("`@("`@("`@("`@/"]D:78^ M#0H@(`T*("`@("`@("`@("`@/"]T9#X-"B`@("`-"B`@("`@("`@("`@(#QT M9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^#0H@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q M,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O M;G0^#0H@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/@T*(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<^)#PO9F]N=#X-"B`@#0H@("`@("`@("`@("`\+W1D/@T* M("`@(`T*("`@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX-"B`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXS-C$\+V9O;G0^#0H@ M("`@#0H@("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!4 M15A4+4%,24=..B!L969T)SX-"B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N)SXF(S$V,#L\+V9O;G0^#0H@#0H@ M("`@("`@("`@("`\+W1D/@T*("`@(`T*("`@("`@("`@("`@/'1D(&%L:6=N M/3-$;&5F="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@-'!X)SX-"B`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N)SXD/"]F;VYT/@T*("`-"B`@("`@("`@("`@(#PO=&0^#0H@("`@#0H@ M("`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N,C5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/@T*("`-"B`@("`@("`@("`@("`@/&9O;G0@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\S,3-A,#%C.%\U8C(S7S1B8SE?839C,5\Q,C(S-C=C9C$R86,-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,S$S83`Q8SA?-6(R,U\T8F,Y M7V$V8S%?,3(R,S8W8V8Q,F%C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D($=A:6X@*$QO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6UE;G0@07=A2!!8VAI M979M96YT(&]F(%!E65E(%-E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A2!3:&%R92UB87-E9"!087EM96YT M($%W87)D($9A:7(@5F%L=64@07-S=6UP=&EO;G,@17AP:7)A=&EO;B!497)M M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XQ,"!Y96%R'!E;G-E/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP+C$\65E(%-E6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S'0^-"!Y96%R&5R8VES86)L92!A&5R8VES86)L92!A&5R8VES86)L92!A&5R8VES960@*&EN($1O;&QA7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\S,3-A,#%C.%\U8C(S7S1B8SE?839C,5\Q,C(S-C=C9C$R86,- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,S$S83`Q8SA?-6(R,U\T M8F,Y7V$V8S%?,3(R,S8W8V8Q,F%C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'!E;G-E'!E;G-E(&%L;&]C871I;VYS M(&)E='=E96X@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\S,3-A,#%C.%\U8C(S7S1B8SE?839C,5\Q,C(S-C=C9C$R86,-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,S$S83`Q8SA?-6(R,U\T8F,Y M7V$V8S%?,3(R,S8W8V8Q,F%C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ XML 15 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 1 - General
3 Months Ended
Jun. 30, 2012
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
NOTE 1 – GENERAL

Description of Business:  Transcat, Inc. (“Transcat” or the “Company”) is a distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair, inspection and other compliance services primarily for pharmaceutical and FDA-regulated, industrial manufacturing, energy and utilities, chemical manufacturing and other industries.

Basis of Presentation: Transcat’s unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”).  Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements.  In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included.  The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year.  The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended March 31, 2012 (“fiscal year 2012”) contained in the Company’s 2012 Annual Report on Form 10-K filed with the SEC.

Fair Value of Financial Instruments:  Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy.  The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels.  Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions.  The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to variable interest rate pricing, and the carrying amounts for cash, accounts receivable and accounts payable approximate fair value due to their short-term nature.  Investment assets, which fund the Company’s non-qualified deferred compensation plan are included as a component of other assets (non-current) on the Consolidated Balance Sheets, consist of mutual funds and are valued based on quoted market prices in active markets.

Stock-Based Compensation:  The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock, based on the fair market value of the award as of the grant date.  The Company records compensation cost related to unvested stock awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period of each award.  Excess tax benefits from the exercise of stock awards are presented in the Consolidated Statements of Cash Flows as a financing activity.  Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards.  The Company did not capitalize any stock-based compensation costs as part of an asset.  The Company estimates forfeiture rates based on its historical experience.  During the first quarter of the fiscal year ending March 30, 2013 (“fiscal year 2013”) and fiscal year 2012, the Company recorded non-cash stock-based compensation cost of less than $0.1 million and $0.3 million, respectively, in the Consolidated Statements of Operations.

Foreign Currency Translation and Transactions:  The accounts of Transmation (Canada) Inc., a wholly-owned subsidiary, are maintained in the local currency and have been translated to U.S. dollars.  Accordingly, the amounts representing assets and liabilities, except for equity, have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period.  Gains and losses arising from translation of Transmation (Canada) Inc.’s balance sheets into U.S. dollars are recorded directly to the accumulated other comprehensive income component of shareholders’ equity.

Transcat records foreign currency gains and losses on Canadian business transactions.  The net foreign currency loss was less than $0.1 million in the first quarter of fiscal years 2013 and 2012.  The Company utilizes foreign exchange forward contracts to reduce the risk that its earnings would be adversely affected by changes in currency exchange rates.  The Company does not apply hedge accounting and therefore the change in the fair value of the contracts, which totaled less than $0.1 million during the first quarter of fiscal years 2013 and 2012, was recognized as a component of other expense in the Consolidated Statements of Operations.  The change in the fair value of the contracts is offset by the change in fair value on the underlying accounts receivables denominated in Canadian dollars being hedged.  On June 30, 2012, the Company had a foreign exchange contract, which matured in July 2012, outstanding in the notional amount of $1.6 million. The Company does not use hedging arrangements for speculative purposes.

Earnings Per Share:  Basic earnings per share of common stock are computed based on the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share of common stock reflect the assumed conversion of stock options and unvested restricted stock awards using the treasury stock method in periods in which they have a dilutive effect.  In computing the per share effect of assumed conversion, funds which would have been received from the exercise of options and unvested restricted stock and the related tax benefits are considered to have been used to purchase shares of common stock at the average market prices during the period.  The resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding.

The average shares outstanding used to compute basic and diluted earnings per share are as follows:

   
First Quarter Ended
 
   
June 30,
2012
   
June 25,
2011
 
Average Shares Outstanding – Basic
    7,375       7,277  
Effect of Dilutive Common Stock Equivalents
    306       331  
Average Shares Outstanding – Diluted
    7,681       7,608  
Anti-dilutive Common Stock Equivalents
    428       475  

Subsequent Event:  On July 16, 2012, the Company acquired Anacor Compliance Services, Inc., a nationally-recognized provider of specialized analytical, calibration, compliance and validation services to the life sciences sector including biotechnology, medical device and pharmaceutical industries.  The acquisition is not considered material.

XML 16 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Jun. 30, 2012
Jun. 25, 2011
Product Sales $ 16,365 $ 17,182
Service Revenue 8,732 8,423
Net Revenue 25,097 25,605
Cost of Products Sold 12,155 12,914
Cost of Services Sold 6,735 6,393
Total Cost of Products and Services Sold 18,890 19,307
Gross Profit 6,207 6,298
Selling, Marketing and Warehouse Expenses 3,441 3,626
Administrative Expenses 2,172 2,102
Total Operating Expenses 5,613 5,728
Operating Income 594 570
Interest and Other Expense, net 47 45
Income Before Income Taxes 547 525
Provision for Income Taxes 186 200
Net Income $ 361 $ 325
Basic Earnings Per Share (in Dollars per share) $ 0.05 $ 0.04
Average Shares Outstanding (in Shares) 7,375 7,277
Diluted Earnings Per Share (in Dollars per share) $ 0.05 $ 0.04
Average Shares Outstanding (in Shares) 7,681 7,608
XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Jun. 30, 2012
Jun. 25, 2011
Cash Flows from Operating Activities:    
Net Income $ 361 $ 325
Used in Operating Activities:    
Deferred Income Taxes (218) (8)
Depreciation and Amortization 600 670
Provision for Accounts Receivable and Inventory Reserves 70 66
Stock-Based Compensation Expense 75 258
Changes in Assets and Liabilities:    
Accounts Receivable and Other Receivables 1,662 (297)
Inventory (808) (1,028)
Prepaid Expenses and Other Assets (346) (163)
Accounts Payable (1,254) 213
Accrued Compensation and Other Liabilities (2,089) (543)
Income Taxes Payable (147) (58)
Net Cash Used in Operating Activities (2,094) (565)
Cash Flows from Investing Activities:    
Purchases of Property and Equipment (453) (610)
Business Acquisition   (125)
Net Cash Used in Investing Activities (453) (735)
Cash Flows from Financing Activities:    
Revolving Line of Credit, net 2,487 1,296
Payments on Other Debt Obligations   (6)
Payments of Contingent Consideration (14) (58)
Issuance of Common Stock 80 70
Excess Tax Benefits Related to Stock-Based Compensation   6
Net Cash Provided by Financing Activities 2,553 1,308
Effect of Exchange Rate Changes on Cash 6 2
Net Increase in Cash 12 10
Cash at Beginning of Period 32 32
Cash at End of Period 44 42
Cash paid during the period for:    
Interest 22 18
Income Taxes, net 553 262
Supplemental Disclosure of Non-Cash Investing and Financing Activities:    
Contingent Consideration Related to Business Acquisition   $ 100
XML 18 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 4 - Segment Information (Detail)
3 Months Ended
Jun. 30, 2012
Number of Reportable Segments 2
XML 19 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 5 - Acquisitions (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2012
Earn Out Payments Related To Business Acquisitions Earned And Recorded As Compensation Expense $ 0.1
Less Than [Member]
 
Earn Out Consideration Unpaid Related To Business Acquisitions 0.1
Business Acquisition Contingent Consideration Paid $ 0.1
XML 20 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 21 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Shareholders' Equity (unaudited) (USD $)
In Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Total
Balance at Mar. 31, 2012 $ 3,920 $ 10,810 $ 448 $ 14,394 $ (2,194) $ 27,378
Balance (in Shares) at Mar. 31, 2012 7,840       499  
Issuance of Common Stock 7 73       80
Issuance of Common Stock (in Shares) 13          
Stock-Based Compensation 26 49       75
Stock-Based Compensation (in Shares) 52          
Other Comprehensive Loss     (91)     (91)
Net Income       361   361
Balance at Jun. 30, 2012 $ 3,953 $ 10,932 $ 357 $ 14,755 $ (2,194) $ 27,803
Balance (in Shares) at Jun. 30, 2012 7,905       499  
XML 22 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Comprehensive Income (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Jun. 30, 2012
Jun. 25, 2011
Net Income $ 361 $ 325
Other Comprehensive (Loss) Income:    
Currency Translation Adjustment (5) (2)
Unrecognized Prior Service Cost, net of tax (82) 3
Unrealized Loss on Other Assets, net of tax (4)  
(91) 1
Comprehensive Income $ 270 $ 326
XML 23 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 1 - General (Detail) (USD $)
3 Months Ended
Jun. 30, 2012
Jun. 25, 2011
Share-based Compensation (in Dollars) $ 75,000 $ 258,000
Notional Amount of Foreign Currency Derivatives (in Dollars) 1,600,000  
Less Than [Member]
   
Share-based Compensation (in Dollars) 100,000 300,000
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge (in Dollars) $ 100,000  
XML 24 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document And Entity Information
3 Months Ended
Jun. 30, 2012
Aug. 06, 2012
Document and Entity Information [Abstract]    
Entity Registrant Name TRANSCAT INC  
Document Type 10-Q  
Current Fiscal Year End Date --03-30  
Entity Common Stock, Shares Outstanding   7,409,652
Amendment Flag false  
Entity Central Index Key 0000099302  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Filer Category Smaller Reporting Company  
Entity Well-known Seasoned Issuer No  
Document Period End Date Jun. 30, 2012  
Document Fiscal Year Focus 2013  
Document Fiscal Period Focus Q1  
XML 25 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 1 - General (Detail) - Average Shares Outstanding Used to Compute Basic and Diluted Earnings Per Share:
In Thousands, unless otherwise specified
3 Months Ended
Jun. 30, 2012
Jun. 25, 2011
Average Shares Outstanding – Basic 7,375 7,277
Effect of Dilutive Common Stock Equivalents 306 331
Average Shares Outstanding – Diluted 7,681 7,608
Anti-dilutive Common Stock Equivalents 428 475
ZIP 26 0001171843-12-003077-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-12-003077-xbrl.zip M4$L#!!0````(`"YB"D&FD5K1EU(``&.Q!0`1`!P`=')N*L"&`@P%E:?2 MTF02*,[YG6<=ZL6G_^ETT%?L8$\/L(EF&V0=_Q*L?D4==.RNUK>&AW]]_,*"I;U@>]MW0,[!/+J!.9XS(O__^KT^$ MR;&'"8LC=.99:!(ND"PA63N2Y"-51M^GQTB19"5Z")YXF'DV>EC9CO_Y(,6( M7/[@>HNN(DEJUW+\0'<,?!"U/")W+8[V@9GR(-]:H]:)`_$ MSK)]H,AY=MA96>]52E@>C49=>G?;U"]J!P#D[A_?+FZ-)5[IG:T'C,')$/I$ M"!SY]-X-GB-*\(A(^OG`MU9KFRB17EMZ>/[Y@#A,)_&-#P^^>="-"1DN1,E# M@"SS\X$A_3CSW)4\67ND[=15I?\-'?+KP3@*"/+S$W8"*]B,MQ?@DF62BW,+ MXHN"PAF1$I\[/O_M8"R1?Z.1*BF?NKO'TO2[.P;)I37V+-?,L`1]>,$)1.8X M,FT/K/NIN[N*4+HU=LQ46ZVC2H1-=&W+=\!/?_)@^0?CI%E.PD_=0A8[$)!D$US/ M'ID#QEX3T[0"4(-N7^N6>>XT8&'ET13=_C<@=H4;^WZMHQ:5_`]!GZ9)AXQ)K[!@6XYV#S5/<=R M%OX;S;'%8KZJ1"M+C.FF'M;]T-LP?>-;2[`%8KZRM"K+9>_`Q=7-V[+?$Y8W MS__^KI1:ND9=]+;L_FR%T?-[@5KN!1P5U1MSAY=14CV_<_1*G:.\%GM;KO#4 MQ=CSV[R?':A\[_8?L=@6,L@J:XS%WKOOYQG7$&/-`6O-]V[X)8ULB#'RD#'R M>W?Z>M+MB+'=^]C&*TFM2C0JI4W"Q:N8C1R"W.V%+A_0N<"^/UWJSBOTV1O= M6>#(/\G:CJ.L*&_\M4Q12I=>Y&WZ;L^7OS1$97J4+[J/;X#@*PI,:C6ZXA#[ M`<%^@GW#L]:D+$_9-2O9JZO;E!YCJ8OS+UQRKY1LW6-N^&_?5Q6T\--2/%]YE]S`]C3D;!H)*Y7_*0%!+ M=?4^C-8^L3V%/4/'BHP9^F8Z8:WH5`4>QSL8C[[?GGSJ)A?1CAYY/O5WFMPU M]ORE[F$_U>0R7)%MN&XZA=0!L5,Y2R5+_P0[[LIRDGM%/.@. MVJ,(<(&D.RXLK:VN=[)5Z&:K%4;7)1#V$UM#F\P\3)8:N9W768XDY=]W` M<0-,-L9F-H2"PX!G83/9$NJY=C9&L[M>R6VZ%S=E^`R##/%D]RL/\810\HRM MS[#]^6`>.,&/:.)E1=(](V$.OU:8/6[1G8,U.JSY MYX!.J#("=^=,KF=B[_.!3,029B/>$9X:1N(EF1/G6>W44"'EAA)E*<[AF1J& MXJ3XDJ*IF3(>/9IXQU5J&(F7Y,N*IH8*J8@FIL\B9<*NCDS>)'4;^S=1C_C5 M=4W_$@>(%!LW1->DR$1Q"4HO[#DP`IG8@,[2]C\?=-2#L:RI6A^*_T_=?:S2 M%5)#1'M.96`A#>2A4@-2*9S8%L)T-!RHY7A2S"JT5!-6?44->XI:#U!J3IWJUK5-,3&ER/TL!H9+@3(X<'!$ MDC*2>_N!%(!(/$>(+K2!6J2*A,>X4`UU$-37@J:.U/T02DTQ<AJIQ;8G**IC!84@S&C5AS^(PR&I;S M9O(8MJ$#7X!Z@.Y?.%4S"%&#VNO)V816RH]-](V`U5>2JBE:;62,P>@!<3:T MG)@KR['\@!1;=UBDXA1YD.VV*YBR/M4<(D=W)4N<&".0=!"5[CT0J;&^)D>9 M,D>^$=_Z:N@/E&$IXZQ9MG5YM,_B`L)2C.RC;$]9P&?<"@F/-J1J*`P6HK)+ MUW&S344Z1Z>7S<;[6>;MUAAA?<5U>GU.B%F,._T2CL<`PG)">"PV@.OX7_#< M]>(M/E/]`?O?+,?UK&"3K%Z$P,U2B?8N?,/!TH4[=]`D&@P5XK.,29X0/^N` M+T1U'$&F])]1=T7*`YJQ9WZ!3D!4%24/M0(Y<[S*@H$+%$>_)TFU465AP2N< MX,RO:MGZ*L,AKY?:`#@**<87\PBR$))-:M?8NR736E]TWS(R4':3A`V4HAR, MI0]2?X>GD-]8%*9Z>HI`]2I!95']CJW%,L#FY`ZB>($O0S(N!^]^%,=5&)"U MPR908=`VUQTQYT`=9.W)A>(Q1:COD@-E,&@EPW[O.+'LD!P/_70^&W.L$4T\ MV`3Y[A9<'M`34#_LFD-,3'_'49%`*3XJSGT=V)*\X*R5SC2?$_X M]!KA>!50GDHE]71R`N6,@\VXKKFV=0>(7'N6Z\5C:F2@S3_VL&D%$\_RP0%/ M0@]^7M.E1D+=95A/-X(@UXVC)]`0A_NH3ZRBU/#*=\?#NFW]C4WBG5<.93[Q M?1SX8K-&;S?D4H,G._I1HI(=I:^ZY4343D#:.SJ,Y3^V;W=&8 M^3V@5C2[6,&$/0X_)U\=)A.#+M+S;["!P7]F-A$ZZE7WCAI42"C+(V9&=Q^C ML1A,%0J1U2$S@,&#R;;=>_+-$"@\3MQP%LQ#._]X>\4Q$_)<;-D0$H:Y0K&C M47O,NSF$79,V_B?%\V]%=+,]-P?3"CT,XY'L$I[,0-T=2.]ZFXI%%!5R#A2E MQXS)[>@6#%G68UHAIZ:.V.')/4RO/;S6+3,>(X3J/%6F"$@TDI:-F!KL\B]% M+3%6)1Y)Z[7'"&4KAELF]$?;&J^]_H;]K/KV<&%=N"&@2F4Q,^?[$3$93Y!7 M*4K46:226M8XS;A6B*ZH\J`^UVN/S)`%&_("0V8QR+S%.G[1;2%ZO\?41?OX M%!0436%5Z*:O2JU@D<4P]Y9MMTDUJCK,QG%"E%V$4(-79:VB,NN-2GB=.X'N M+"SH8;;!XUP1$U:O7FIS!1)1#)7.EH[@POM8W8EX@-*4W+'S)R7+(=YW<0"HT,.C+&@\06C5#&R_$)GD7A])( MC\=SJ7M<6/K,LJW`VK_$M"JA#0>IU5+UV.UJ,4$8J_HZ>2`WQYA2-WDNM?1! M0%TDCUB3%O,H`7"J7_P:PA'3,\A:?]`KBR'6(&(2O3SH,V-G>UBF M/BOP+]T.VXR.J:,^N[DB2SL_35";=55PCI3Z=^71TUE,VC)9AU%K MS<<>C="%'OUB2&4\\]VM**![]"<<:+1\8A(&2])KBVJ.RQ\!U[OMA:UT-1E*_I\E[($5L:MBO%IXJ'0V&/6DTZHG` M4W]=4*62>I*F#49[0&67_HA#5JDNE8Q2#IHB*_G$2(I(JR'Q$3/W5\TN7Z^W M0EC9U=/%:BT15G_/@\R,UYDTKNHNF3%R3LX%K_RB@%<.0N2&`MH`9S^WD2)' MUM08^]>95WEM;\#LOZUFE_.)=@BKO+:G,MN-&B#,?/>B;1T'K^-90'GJ!6^> M?!"J1E_;0XCR9)^>$EHPF/ MN2.IH\C#PB&,TDU`HB!RK/_D1%B@2.@.#8N.L<+O-HX'6R1.HP?`2_'UOI!$\"[,?-KS[VSR.F29ZZ77PM$]^#%2TANL(^].T$'6<2H M&T)X/`$X%*^UDX#)\_&>J^QT@AA5,P>X%')BNQUN.#QGR@QK`N<.&KU%^\Y"SI$PN7G@DZ^22W=;D!E$J-MY6'PQ2: M*D2@NC$:3X\+RBU*GUT?6L&W4O,<.'F.5*E2<@YFDTGYXR4YTMH':M0HT*+F M1`Y'G2P-1[R3]WMA-5D@T5A.CF*[W^->2%%/SKT^P$SPBPV6_,D<=0'4[87Y MX?-8I*K+X(%/5MGJ_I+6G"8VOVR^^^3)[;$V$R.P[H3.05!]`X7$/`L#S MJ%[+'0;1&#S8A)XX,G4G!KSQ>[ATJ:L0S?>8N>#Z[-D^30QPCG&5''-P2QQJ^B8FD<(2M8WZO-_).@<(8FNIHGJXDNB*6NYM$^84$YL#?,]D"5?,<"<7+H5E:8'4`U@)8CCFA%&&.(5M-QH$)X.F14@OX'7[SP6\\<2,FO">?B M0:TSR]$=XQ%R:C:B6@&J7;-Q"L-Q^'6]OJT$^R-`YZ@C5&;TB@\[XU?S.38@ MKL&<]/6,?,KYRB'DH&(B_R-5TYUN"SL`D?$B#O:/!Y[O$+P6Z/-;_/,-HR,; MV-'*(T7?@2UVRUUZ+R5FD9.V;F,Z-G5#:T6_(FB-$V5&H-._<$-EN M($J0Z&RWSO`H/\:U&@-')Y&?T6-!I(KYDHKZ!M.59%,W&16@@P2^):Z^EZ74 M_'@#%$4KF>HO2=:R"?1'JO9-/L7#3#$/F8U6^Q46>]99B<7A_;+$ MX,JL%"S1%+-;*.O_+734!$PGM_2S4$-Y5!'>].EDD1R7^)[>JEJ"*!;G!4."1?.8M8 MW6##73B42F4EWD9PYE2;QQ:C8$/-,^I-4*@RIX<\A0Y?D!:;+H5\$C7E]V>W MV%8DJ^7^TK3*JWO&*[,!2:Q@PD^D9=$V_NQ$KU3C]>K5RN]A-*Y3^]D1FAKE M"7OT9^XUK56IRHTGM]N]5B7/!TIC0'&^JK$;-FM6TO7Q#5A\3<.8W0LI'.F0 M05KW=8W=/5ABY.9Q,&*`/>O[6@,P/.]K)K:.3IT`KMS@!?V3R]OCR12=7QY_ZI:1V^8ETN#$!9>$3G*Z6=?G(TN=?T;TTX_OPIG88[CCZ?:Y8^*'W_"F-@-WA-=AXY"W(&1NC79OLG]C/\"JFE,L>NZ;]<.W0" MW=N<638$4&V.EVZ:(4.ED!.]=0P^MG"]^@J]!8>!Y]!6%D22O.YLTNPSI,<% MO'_'MOV;X]X[MY!@7,C#-'MY#:4MH3;.9X%=?)W!E?K:A9]J-B$PE$IY1<4U M'[=_RD6\4I0*,UQTGS<+D9\=2=LFHD)J^8K96^A.O"&/C.N[MF4FR[.O(4T` M`?KGU3Q>+`#O(N04&?JZ<@+BV"[T*W@*"+_89#5,7;@_V\%'T[I#?K"Q\>>? M_Q.ZP<>3\]OKB\F?1VA&2'U$T],_IIWSRY/3R^D1DM9!U.KG!?SWTX/Y<1L+ MY!^A-P?>Q00MQX8BX2,ZN[J<=GX_/?_Z#Z`X@ZXMOG1[_G^G1T@&'O&%L\FW M\PMX<&JML(\N\3VZ<5>ZLT-P>34]35`D&&3TL[Y:?_QIJ,CR1_3U]/+T9G)! M@'4)LAWNJ#V]`2J@U^'WF==-?JU2S+?)S=?SR\[%Z5FDF+RJMFUN(EFWVD.Z M;2VT'UJJ_)$95I&W+[26PL^LA*)%1JE6<2%.-?D66C_2T]1$R2:5C MS<(`"+ASM/;<.:"E+P5HX>DF1DOHGY?8-E&`?0"WHC4<#;T88T(*VM'`\UP; M%`=DP^BCFN2Z;AATA254L.MH_8^WTU9"`+*2-8LF]`X1W:[D'1)*:TR_F40) MN73H$4K_M6V1X_N1'W\XG%78VH-BQ+/L#9J#:&LH-U:Z@ M?/2S[A(Z>A@%S:Y7A#^VG2#:]8(0IG<8S3!V\D9:DUB"\`/\)!!=SZ21,+CM_%'@&T2N6VQ`\-*ED(1"LFZ.U*8KBV;'O)+3TM^>'J>% M_U"4^R=4+M"[O3FD3-,FSJFJT.2FBQPW`/')N>$8XM8F$A):*3WFD1*1YJX; MP+,@H(?II@X3S3:(6(VF2YI?,=1]6]/DR?A;((7RG40H2`L_0!J3SN$>.G3S7/=&"&/S+ MP]2(B32DPX*^`3H2\I4L@O1^J0>44DPY;PEZ-OT,;UG.:8&/-O`V40J3A!4U M1:Z/JDXU_M(-H1Z8$4@Z"5)6.%#UOT,GZK23H$7[4QE+(L5.)RD\]MJ<@-`9 M@S70-]TSEDB5#Q$I[/<53^EG:=MTEB+E"QW(BS-3S>EQ40F`WHL`,47`&>0%%,V;Y;/]SK_/=Q4K4Q(4 M15#<=4-BR.1)V5\+^+^&I*\-I,J/ M*@*:&J&Z_PL'?H$_1EP4RB6A%JD[@'Z\C&`63TR=/!'0)(TM2L&$OM((($F[ MM(;___:^A;EM(UGWK^#H)E5.+27S(5*28ZN*EF6ODEA4)#K>[*E3KB$PI)"` M`#T`],BOO_,`0#P&)`B2T(#L5.V6+%*#GI[NKQ_3Z([^%9$OH8<=MZ"I$[*> MNJ6&F/#)MNC;V>U3NOA7TQ)+PPV/?HL^WG8"*C6*I4C#3^P8&J%!=^/VEGI% MZ74,1I`SH\XJ9QLJ/CAD-/2@/UM"4.8T9N0CEV[$S'HWV'EG< MB;N[QXRO:$;CP"<:HC$?9&ZZHZ6$PACT?]2A>Z!V,>"-J-/5"$M*L1/D`1EC ML!>C+[U70:ZPR3IR[QNAV\O(QXYX%05L:^V%Z*0S)39#OVX7=JA\RQ25EN M!+T^N#L7-2Z:T7-@$IV4]]"O8>*(^!\X-B.%'JE0'4&3]HH](NAP_E-PT!G" M2/>[M0\]$2C$?Y^)P5YXDSY8_`3)KKI MRMR^!">8=0]"Q7EJ(P%BL6`DD[3D`W`_6LZC*Z!S'+[.*$")"N`2RE/K1?M@ M9(43E-.[H_NE6!VF/*+<2KA&N',CW*+0#O;`0`@CT\"6XM">D2#DB<0PMXU4 MC#C/#@449^1/V%;FLJ63PIR`I8)MF`8/@W51@D+WK#';)CNV?!(0,]O$$]%B M*G/%MKB4"M9C(?!('#*F'I_/SH#](KE:9(_8B=Q31;J?.J?/ MC504+G4P$KJI!;UKN!,+5G][,;5#,-V+)BH1]%2:F$?'UCR+R_^-!%@5B*V# M[!1SPU,QXE@L%22(7UT@&QGH)WY?1EUZZBX[EO5\2*,99NS\D6L:)B)4C+*. M)3-`B4R/1H^7:H0>;(C3/<_Z><&.N$%-+?7EZ.Y(,^B3$9'C7";3&X0C$IL= MF"%N/82_S>BPYOW'&AS'9QZ'6^'?-#B=&2N2I#I((0H[>XB9<\-QCEG"(JE?/U$ MSR]@D,.Z$=%C-GF>1-C(N1!*7)$%DI0(J$9!^.**J)4*C<,//+6[X/@#FQW` M990<$'$AXUA8SBABJJ1TZ_'J1N:7.KR4+1:(\3*LH!0N1F5&CH1<2`$0\"]Q M\Y8R+*%[/0[@+4*#25K4J-!PF3&11+I&P9V_D,$`^'*=#QM[F0=FDCZL,ON1 M^C^Q^7@E`]\YO MY`AS5K%P_DWW;YY5DV0\Z9=Q4$&K/89W#,B@N.%2=T!#O(^%N*H23W.CRX=( MB\(CBPCB0+?<`74P2Y]X*;=Q-J//O`[U>>F^Y*>;QIH(+;-^8_X)-YCX)&D*P[\%29\0[.-^V(I>6%XJ MD3-,EO66),T33-/XE?Z86D=R2!]\A@X6-:G\)]-^3I MX"E/*'(OYA>?RJI8UXE5\08^5 M6;.:3F>/*ZUSF)[_O)FEMESQ\]4"[P>E<.J^U M7NYXLVH9?0[`5(>%Q\$T4.>5V[+\$$^D$.&I^%X\63[I4I'>:F,N>>(6/$Q=F%M,SY(U;A^90,`QHB<9_DF:!(F.YY7!`E:66I MN9!_V4*Y*&^995]PWQ,E.6/Y/\F-#9?.J&Z$NB-STOA=)_U-V-PN(X0YF<-` M+`*A3MY'E!'2>>4(^U/F$J+HY:PY3>EZR;B:L%U&ES@!YE-?0`^KG=@A"G)3 MJRQ7.T#NA<%$-D$5RD7(VO@[-8'`!7#)4^HZ%VA#X%3J="2HQ?_'@A2+99W? MR`]GZ=F(O*Z.+6O&1,V>!&QI!OQEG[@SI&<_>30-[S[X7:O9_#'X=9RWBPY# M4.41";FQCPWFM\U/>.1XGC.5/.FF_^'#U?6GP_>#X7#P^8W6GCTM?OBFY,'C M\F!3>2`I2RZ_X]@"VV\TC0+/BE M^$?P23%6OA_``^[]=?;I^H\DMTDXHG_B, M`+@#N%<)[FT`]T7@_L(D98EZ`?FK^'DLL9>G>^P_EO-+OUNTT-1)C=VJUE`) M<7AI]X,7]B\%:'`NU`5_L(M@%\$N[J1=;'?!+KZ0*+#^VF`7:PC^A8+NQ)Y& ME%<3XOBV<4@-AD/>:/_OXN+R\N-'67)6@"O>R(7?SE:HNVN=?RMS_+N9HY'M.;&G+<)3;1AS MLHPQA-4(+'6=MLJ:DT;GI+LAKI2Q>AL0I%I+$J`-H,T^H4W[Y`30IFI)VLC- MU6;\XLUDL?;*@193#'/S*LY8^Q!6OXD^LYJ8C!H;<%8W][F$E-10+3=A^5XV M4U`;WDF-XXJ\4\!^=IH]&=O4L)T;$<5:RR)@'V"?>KS;%>SK2#/X@'WJAQ8* MYN<7HNPQQ"%;2.0'[R,MO?6L32`B%Y,:*O'6C''[J,T0T'!\UB!P1R%P:^9X M`??R['&UR;S>:8%+=<6,\NHB66N9!!0$%%21>[N$@LU30$$E9;(N]QX0;TCC M#=LS#\,7^^7ED:O<=T"042L#`>85S"M]Z'%;:ES!M*HBCX"`@(`J MGPD(J')P(3[D@S38YY9*W8'B-*K;UNW.'[GXNS^?MAFC_/*!_GIY7[=!T!JP MU6MDVPYF5T5Z,!"N;R/=(?R+P:S-NV#L0B-LN9P,1VPD&E99SX>QWI*Q>9^\ M+Z`9M+1'])O/?!QG(W,FB4F@L6&?K$\24U,Q'7@^!B+HL&N9XU2$Y.J\';M+ MOZI[?&1/..YA9#H>UN]MQW(FSVRLJ<%;N!N8#R2(>B&'"Z4&B,;'=^;VL*9\ M='D/+]:R,NHMFMCGO"T9ZSO/IH^6:K;U]O6V1BG/QVV'3P@GVL8&W]*U^:C- MP3C^B-7',8?S.I,#.H.&XGQ2YLQQ?W;+S<5<9PSFTLF77%_YT$O^$Y]W67J^ MY7H#+0M.L`R)9K,J!?O!A-6IPCY>HX M=IY"0C99D`\6C(%I;(S@#667_EP8_!)S"G,&$VKQP8/E!@T6GBO(1*KTR,!B M(P+CXP#7F`!86A/Q5IR!%PV]FP-=(9@Z3T(;KV'B4]WB<]P&(4I2]Y^- M*7G`-W0OJP)=;&1<N/$BDVNF.-G"2PLA*9464V!EKYK M'"3AL]W*P\]OO]&]#^G6/V/62?^`RJQ.S]]RWQT<=@_.6TWVWS+BS]-!?0D* MVYS"]@D5!]969NBTNX+$UA(2.X5)3+G;8C1&.',L/E6,'D-LZ%AP"*OG'])C MS19/,M/BD\K6&DZVUCBRY`"RO&%C:PT7*SM.;*T!8@5'AH5=]0M/`ULR_$OX MAGESOTI.^EIYN!>C(CB"F"-75@&RNG3!V7AE?[%#\\GX]QOEW,#^-Q]GRG:BS\U@\#A_)8;3#@@EL6P^!R88/*+MGRRBU9^D,MJL,2MEO=$HVDJS4,*#+S;II.QLDP+".-?6)2J7AI3Y M51R_>`M`MJR>SE<+[O&TA?=T*UW+E;^)6^?F;9W+M@7W:_*[--G56)*R\F"C!QI>[@#W81["+8 MQ9VTBS!QY<5$`2:NU!3\"P7="G9T4\)&#J0"'C6,.I`S!Q M1659!.P#[%./=[N"?3!Q14%9K&M^'CH@P\05:`6:YMG+]U[[M3"M0F+A2 M`YD$%`045)%[NX2",'%%49FLR[T'Q!LP<07,*YA7,*\P<:5N\@@("`BH(O=V M!P%AXHJ2\K@PN!`?AA-78AUQRC2W.8^6?NL1VWTC"H(&X[#L1WC!W`F.^<#S MAFJB&=-!T1XY\>YJ'=8GLL>;JZWPZ/--$]O*;7*9H;;36IU:06YX1BSN",.. M^0"'RR?1^(H15O: M='+7OSGV9(C)]`,>>>5:2;UD0!['FBV\V;5PF!+23",T)?CQ6_B2K&:C:4C! M;?_ZTV6_=17.D9`57;"E_N?P\/+C#34<0=O-P\/P(:]1[N,.FWD//+XZ29*Z M;/WKP?!2:\=O*E-0_^'R_7"1J4BD$BR59FN5$9$7&*X5&_WQ1C;&*<'\4[P@V,]L$OP@)@QTEF'W^>P=>)\ M.,0/K>Y1,VJ?S4C-*,J<\MMH7;$'[6.P;IQFZ3BL/FO(F,0.]LIRV$.\W4@1 M\L@V]H!,B_?+\VTC:%D?YUV&K>401:% M9C%7HMCD#.F\+M#/C>CG53AK)!K'%A$^X&V5+UB'_.43\*)U@M.,)#FU:$JN M61]GXK.^FLB+S2`+X/KD9U?#K#$M;Y6),BH=#)-!O(^NZ&"=Q@+6]%R[I9_$ M-:BAH6B23/;`PA;V@M*X\`L5H9Z%07?)=SQ"]M_:@+JBK$DF?TR*Q%7%/03'(S^$O2C M<%8"I92/X`BVYL]2FYO+5SB`)B9"81];^H=L*E+8[MQTXG(0''N2J+0,Y$XB MC,0L:@;,#YNNG^$_974"F;5'RARM<]3YD?]M\ZC]8R,M`O$9"[DTR+:>&"64 M4L7Y"+'44(KTG`GZQ_8D;)'<.FK]J'E.FL+VT>F/I>8J`E07A>H+YP';R"Z" MQL-E@LP=&QT3-A&!JF2PL)CC%G7B3@\P#1=C?^LYHG7Q M7.!I4G>FF'+D"#W(_$9DGOL@6:)98%],#2*)84([L_AP@W"&ICD__?G2?`0% M=60G9C@\CV)J"*(F^B\VLR^C*<&$GV2?=/[@W&$E MZ24633QATZXL9M@(:^PNDB?/(:YGE(,I`AOA:<3]_066?%6G>Y[3D>9>9#D: M>OR#L7AP^-S/Z,F<^M/W#B'.(Z7K`K%NW71;:\R0Z#930R16>7!FC(3LCX-I M%+$8J#RYW;,"U&8>F"&3,7\^@R[TP9B/PN8L(9.*#YS9$:CX#2QG22U MWYBKPU;)CAKI')PWCYJ=SISRXC2D$[6;HOXX13UWR_)(;[9+DEZ8>)&U9I.L MHC]GO[YE#E8@@`OW4RBW+#;3:A793`&"-K8_T][D_MJG:^]/$"397S2DFZI= M;K1CPP4/B^4BM&_3,/8GZ99E+>0$;R3.SQ&R:AD[BC9*[X>#BU\/W_;O+ M#]K%X//-Y?5=?W@UN):Z6^!M\?1I-K<8952YRT`=UF9'BZ;I:6R<'G83P4WD@%$.J_"5V)_G\QG!/-/^*#$!DLNL/G>:K52Z=6I9F(S/2F>4J%>6ACGT^1%!-$Y_X8XVMV+<9HNG\/ ML6';L7&,$'%O-?JXC80R2SF_:2YPI1$+00)IIX'#F,V[IVHH!G"FQ#IOGA:? MVCHCU`B2Y^1@._Q$??]L)6U\KF=N1!V.\,4VBR*L9XU-N:(2:EG<"\YNG`_T MNC=)Q!3_!@:&?GSRB;4)6<3YEE:(0K:HB`K M'+>+J>"%81J;@P7*L4`YXGY-^FS8"%@V/8Q-?;+FPY%9"E#$EB[.D^)E0OQH MBNG15&Z2PYR7`W1B'C0?**\[IJUS<\.S/6(N))_O[?@>G_\8WHDEI#=&.G/5 MQ&@T5ZHA`S:45&11S6DP!5IR.5ED#'64E`]&#+ON/`F>3AA0,SH2,T.?^>0U M_=[$#[$I;R'YD@38PNW$T4@L2DDZZ?X8/E
'E2FKF,?U`C#QNGW";VLQL+'Z/DDK!-1,7NCPAPY!23,!K:*;KLN'NW;;D MW!S?Y7Z&?**=Y\R1=>YAB'E[$K$JD"I<[$TD^9Z=3Q>.H3;R903'9"JVT_#T MDO/:V6'$:'1%LI\QA-]+T.V/)'X-FXV6E!1162RF M"OTU&EMEA#&*M9:KUGQ&JB/\B&*^;V-N/:4*Q'4@M=12/9!`-,CB5N,I'C-E MB1Z(`#]UG[.AC%3AXO`4->F(B$<9*`@M>+W$C`GQV/&)`,ZL7R@&($=%*E1R MF1US@S)Q5D["2QRHQ"-6+W[(MI3P,2.T%S/=31H)>=@.<%H><>6Y?5FEC2MD M8-["3(OIQGW^+)$I31.5&5$8QF]779,2%8RP#9D6>B$L^T125I;KN4S[0/5R M4GM1B*Z)F;>N/Z71$STQ-W%W'Z\&B<999XL%F8C)"T*$]Y6PV&_*G%/%DWG3 MKW/`^,;H?&!,55J7"K,&QE3!F"J5QU2)5\TRCM1"P8^$?T=G48$85BZ&@_%R M$=PK&:R2^>(UTUP7K3@WM_;JL3J-?I5T,L#_`O\+#%\M#5_XYG\!\[=7]@]$ ML7)1#%LZ@R.F$$G[*(B73YCHIEM$$D$4012W^;P;8NHY[28U[69YXF2?Q+/R MD+40)$#4JFIH!E$K1*U@%FMI%J.H-9\%Q:.)O3*2(*R5"^LMGB*3O2``SIHR M).VC'%[09Q'QN@',+ZCH&CI@I)^RB'5]1/,VW7U$$.7^;`_V"OZ$!VMX[.AOBL-B.@>^'+ M`4JX)TI,6HNU",NU`>*E3/&";:3FCLN<^I!Y54[8U!Y4'E0^7JK?*%TV+(,UXJI+.E%9RPWE;BI@![,%4`-0`U`#4%-C M,8*@&%`%@F)0^;W9-:@\J'S]5;Y0'FRC96&0-%,Z:1;V^)"GS2!QI@;6@A&J M<33[JM64\03,7)95\E?^`&$`80!A%K#F^*C967KM!1BCA(+ME_8`K$#T#"J_ M5Y(-*@\JOSLJ7RAA5G$.3-(T8XN)L7W-C%VP8:&6A8W7'QTRQF9>:9G*.;(2 MO59JJ*.;,%`O^^9X;7@GM6$K\DZ!@/E56^&4W$9$<7^S=H!Y:S!'-=%2">:6 MLBL/V*ID6.^HUU4X%5A6Y/9`YLKB%W`&P*M"\%(T^P#``L`"P`+``L!2J^K` MS32-*Q'RK9O5W)_NQJE_Y4\V5? MP#[`/L`^:9,]E1.D@'Z0U`",`XQ;KQY\4Q>R`''@X"G"LY<6N`IYIT)KY/J! M7K?5@Z!6.?TME%*&++$@4+DLAS^^<%HV3N.Z7!YR+E]3+M\FN3R\QVF<09,)P1/D8;JV1TS; M-74F>#[[M^;=8XWS2T,CYP%K!,\(=K'MN>RCI*?K.1ZR-/KYH8>>,HN]8DL9 MYGB,";9UK(VP]XBQ/5\F1M*%,YTA^UF(Q&F[=?*SJ^F6XYKVA'*%'@9]BDG7 M<`2!%G(]S2.(52)K!GK.GKLSYE\N9_8?O3D5C4M`_I+PZGCHV?!;D2@F:> MZ=CN3_1/D:<].KYE:/?H@;&%\H1@'9L/\[7%M[5[QS(P<5,B?X^8G;?"3R/2 M^49,$CZ*,2O,L*=%@"7GTD@WEB\ICZ9E)85!OT?VA&X' M,4*">@4YYC&T7<4G2':H'!%OT+*F8.-0$V8[PW]?NTO)E,2F=8#YX^8K@2$4IAAFA(>\3,PM-_ M4ZT@B(K2#!/3,9)R04F9/YCJ&]?D?$G.RF]*ER*I%"@3;GJN4@$DIH$DO<$, MKN2S2$KM!7+OLV<0P<*8VLX$3#&20V*W0>("BYRC>V]?^^[A!*'9FP_T012[ M?8('XXN8$-X*\;N@HNC>W2."WS.LN$'/4V9>AOC)>\]4]%P\Z&VXW/RK\<7Z MA#"\87_Z_CFS6O\1$>.:`_1@S#]U^P_(M)AA^^@0/O6-:HOIW>+QNP.7?^&` M*HGM42KX[_3VM[X[&'>:5/*9S!]H!M;-*;+<=P>'W8/S5I/]-]_TMJ@,N>$1 MVRW_D!M,Q@Z9LNY$0T0FV*._T.F'3,TB-LSHB:68T/SVD4I>JS\CC`=#1\J. M]L$Y\S/?OMX:C>?:IF1"I#ZH\LG M)F:"NM%PMKAU;N"-BW]R_B7_.C,:UX_V)Z38BQV'1-A>C]VEJ M+UNC\7SM\VKEP<_&CFLSR,K_[P_Z$!J3"`FQ(*4K#)_VZT M?.E1>NF/-)#Y@[F*?8K*4^%W40Z:A"\PQ&1:?*^MYI]Q4[D=QD:S(4[]>D^0>7+]Q]GDY*_O[]OC?_WZ>_>/3U_^ M_,_?#]]=0GZ_/NN^ONR3^]-?;YX&9\UC^\-_+O7?>K?D^J_.U;#W/$"CH>E] M^+7WNO/OJ^GC56_V1^M^X+WW;__Y]\7MAS/W4Z?S^]._[*\?NIY]]B]O?-KL M3'_Y_)O__>H7_W/_^//SY=>/N-\<-J]^?3[5IQ?>W_K7N_*ZP@C) ML^0\!K,P:W6'R&?*F';"ES,W/2I<\&<:^7#$ZB]TQ64*0 M$B1EB7H!^:OX>2+ME)3U98(?"7^R"'_5*GTESAS$4`DQ'(R7B^!>R6"5S!>) MQMQ+MN+!_@?\%AJ^6AN]K<-M=P/SME?T#4:Q<%/NBW@(< M,95(VD=!##.R@(E*D;2/HGC#JCYEP1#[[V9YXF2?Q+/RD+40)$#4JFIH!E$K M1*U@%FMI%J.H-9\%Q:.)O3*2(*R5"^LMGB+39L,*P%E3A:1]E,,+^BR"=,]' M%MRWOM2ALZ)(N;:_,FW^4HPK'TD*444]7&>(*B"J``-92P/9#U_3!$=-&9+V M40ZC>G:0PY`61WZ^ALB,_J-P92"?=$B;[=Q:<[?D9$O]9="0+*5#Y>JM\H738L@S7)F;5Q7)3B6S5 M6<%L5;D$YDJ)L];IQFBI-&$6-&>#_)>RT`DVI<;1Z>&F`G8P6P`U`#4`-0`U M-18C"(H!52`H!I7?FUV#RH/*UU_E"^7!-EH6!DDSI9-F4=?E`BXW),[`""G& MF#I$LZ]:31E/P,QE625_Y0\0!A`&$&;1%/"C9F?IM1=@C!(*ME_:`[`"T3.H M_%Y)-J@\J/SNJ'RAA%G%.3!)TXPM)L;V-3-VP4:!6A8V7G]TR!B;>:5E*N?( M2O1:J:&.;L)`O>R;X[7AG=2&K<@[!0+F5VV%4W(;$<7]S=H!YJW!'-5$2R68 M6\JN/&"KDF&]HUY7X51@69';`YDKBU_`&0"O"L%+T>P#``L`"P`+``L`2ZVJ M`S?3-*Y$R+=N5G-_NLO]XMM8ZS3SF\M!^K-6*`[IS[U/?W9["K>RJUWZ4\V7 M?0'[`/L`^Z1-]E1.D`+Z05(#,`XP;KUZ\$U=R`+$@8.G",]>6N`JY)T*K9'K M!WK=5@^"6N7TMU!*&;+$@D#ELL3!V^%H9&'($M=;$??1D$(4L5Z6&(ID%99% MP#[`/O5XMRO8I_8H%D`_R!(#Q@'&099XAR$.'#P`/_5XMR/@!]EB%65Q8;98 M?,ASD?3SMZ]]]W""T.S-G7Z/#=_"@_'=/2+X/7*Q<>%,9]AVD6?^4&/;-? M]1\1,8+'_(%=#QM]V[A\FF&=_CATV*]B1;?7_G2$B>;;IG>+Q^\.7+:<>Z#I ME'64+/X[O?.M[P[&G=9G1%A:]4`SL&Y.D>6^.SCL')QWSTZ:S6:,$151?:Y5 MSZ^OF&$&_JY*1B[9SGN(M$]\K MU_6Q\<$G]&_I#DW'X`2X<=F.6KDND:KFMX]4?5O]&6?$T.DT?_%MF7P=MII) M^5J9DO16EO'57<+8<&'WRA;/7ELL"C&#"@AKL;>"@&QT(YO7MZ"CB4_F!&Q, M:-K-C8*2A-3S5;FQ[#0DSZA,L-@+VQL4K!6WHJKE:PNTSA.R;@\L7V%)7,!+ M8?E6D;]*+1][TF@Y,:,<8O*?>HNGR+3I[R\HHPC2/1]90TRF[:(Z?'YS_&>* M:]42NC(&KGUP_%@[,G;Q\'M1P`%MU,(!X7;W?>]>X>8_V#CBVU@$O/";RPT M]S/YLK>,^!@)`:TO@8V5$U\17L8(K"U>+M^##"_QA"U_BV<.\2C_/YBN;CDN M]4.C+$MA^2E29IV[RPO=5>$KMYL_!-Z+?M'[^2:-NA'9!&3,B7->T.TP>*#BY:=+B MZP3?B:]S)"-O>(\UILC(?N9;LYU4?M2DZD,.@RUJ+K*PF[O0V+$LYY$JHB88 M,Z-PRQB3/;IP/=,>.V0JMD5_TCRVBDE<3_ON(T*?[&J8HK01E7IFLKM,>SF' M^#?:75X,VGI33K(%V:P#ZPP9S'<+A*H92"?[Q)TA/?M)(KW>E%;_+A+E*+D? M2T-G4^D+[TM6O7.KM*9W8:Y>4J6;2-7+;A548<4JV%WZ)J,LAW2'26O(HE[` MG3*W1RM=%"V]%JJVJ%W'#,(*$%7]P7]D4+>`GM\%"&J7#`.7EH9%LI&L<2\I M/%L7DS(=C6JOF]G+1C`!8`*J,@%M,`%%3,#+DI6EZ07$L>+G,><]1Q/9?\SQ M3ZA%$5.8\\+7RA93!9G(W5Z5AY3SEAVX(#6U#6`]P7J"]=Q]Z]GN@O54PGJV MP'K6WC9L((!?]1T+171+>L!KZ=7JAWF-,Q8O%*FM'J-CGRP887&<&U9JKV>`?*4TS!`GOHBSTFC=5JTHR4@SPOXY=6Z MVM)Y<%ORO_?:]P[+IO-\[R#%N%PSE7.]U^M&5A_EW821?/F;CSJQ<&O->2KE MWVGCI+.\NN5E#>X&Y++V,@E@N#U-!C`$,`S`\+C=`3!4529K?G%0JVBFTZMO M-#-T/&157`T!]KD,U\`^@WU>I9:PVVB>+1VG#!;ZY:42X'![N@QP"'`8PF&O MJ?Q%[1[#8?4W*O7G64DPW$L8J\=5MV(PKQ:&JU)\NK>WWH`W@#>`-X`W*OF$ MFTQBKQ6)2_S*'&W>I[?Q/A''E33WF_]W0YRQZ4E?R-M>!AKL%]BO-?D#]@OL M%^`-X`W@#>"-*ERK/H<*+X"^3-E&^`*HK'!#^=*-954F=5`UL&[[9MV.&^U6 M$PS;#M1*`/X`_M02?WJG@#_*.M903;V9:NHZN^7ANZ&U=,NAA!!*"+?#PMTH M(6PUSJ0%U2H9X#TN(`0P!#"L`PMW`PS;C69']6S('H.A>C`-Y4D,"&MSDW?L"#&2;(,^U)+DFJ?ANYJ_81\&=-_0+\V0'\.3Y6O31L5_%G M`YGJ?2ZUKK,/OFP4:$U]<*@]A-K#[;!P-VH/VXUV5S9*0B5KN\>UAP"&`(9U M8.'.@.%I"\!059FL^>U!K4(9>&MT-5T'^UR&:V"?P3ZOP+]NH]>".=WJRR2` MX?8T&<`0P#``PY.VZO>T>PR&U5^EU)]G4(X*-]U[=-,-Y:BJ<`WP!O!F3?X` MW@#>J);`WLQ;HZL&XNLGG_?@S=(K6W>FLN;JD*)60E4A*Z.$`:U?5N;L6'KS MI)1]W>.T#*`AH&$=6+@C:'@BZZLNY0R@H:(!"22I(6FT[N8A:01)HQAS(&FT M?97;2WT"O`&\D3`'\&8%KE6=I%XG&UTJ:UQ!]?3F2*DZ=_W%1A;=$/*P(>>% MIO6G]*R]G)Z(VTM?@_D#\[V88V\.XQ"1N/-^@ZGLS/5KQ*9%E$4`?%!%NX;[90VG9,K;O* M7;6"`#]KJA?`3_WA1]:'">!'%2=H:H2JQNVP<#>J&ENG/:FE5LI4[W%5(Z`AH&$=6+@;:-AN M0HVWRD*IW@5#K<(5:(2XFOJ"S2W#-;"Y8'-7L;D=61M$*6?`YD($4C>N`1H" M&JZ"ACDW)X"&:@BEXK791#S:HJ7`.\`;Q9DS^`-X`W%:2P M*VB%>`RM$#-"<(T7E+OO9`]$B1345>VVEH]I'[59V&LX_LC"BL6]/\A2"8HD M81;P36HEJ^5;G2?EC6)IF!7EL?X*#3"X/74&&"S'MYV!P79=L]'[`H.+ MP@GQ&:(,X!_3?XW(Z_!'_GM-QY8U0X9AVI-@C\V`P^P3=X;T[">)`VE*PXE% MZKY.B*,[C*;P@]/@MR6D:GEZ8MWW``[%[TH'-Q*RMBR5KUH_S04SW?<]2PL6 MK_5J08\=T[%=;82]1XQMS<63*;8]5WO$!&LCY&)#BUXTR"Z%=,]'EH9$,YZ& MAC3Z=)TN@"98<\8:P0_8]K';R(^_[C$R=/;G#?[F,=T8_5M&@]C2:;MU\K.K M89?N'GG8/:JXDJ@,\.U+DJT4A+U][;N'$X1F;^Z$K-WBF4.8P'XP7=UR7)_@ M(7[RWC-M/8_X\S;\JVM_.L)D,!9_QAYP%\JL;YMTM?&[@QE=XX!BCNW1A?AO M].:WCY01K?Z,M)NM]M#I-'_Q;?;C@69@G3S!N%2.CYW4?$ M8WU";`,;-;/++U^BI:)N;N".0PG<`Q.@M)CEF(`VF(`B)N!ER.LT&TFU*&(*I<:PA,54029RMU?E(;$XJ=)K7'!!MFH;P'J"]03K MN?O6L]T%ZZF$]9053H#UK)=M>($B145T2_E"PUMQ%Z;,Q(JEP%FK7,O&?*%= M2D#!Y24H""@(*,C6WG=0N!TI#!#86O=1P]>]7`?K#EG2=J-YC%/HE8IE#ED= MM'83=<+*H9HB=3#W_,B5(,2[73.5<;^@N!]WEML/"W>@N=]HX MZ2RO;GE9@[O'S>4`#`$,Z\#"70'#X[:L]3"`H1(R6?.+@UI%,S`88#5=!_M< MAFM@G\$^KU)+V&TTSZ1CC,%"JR65`(?;TV6`0X##$`Y[3>4O:O<8#JN_4:D_ MSTJ"X5["6#VNNA6#>;4P7)7BT[V]]0:\`;P!O`&\4S.C`18(08GD M3#5UG=WR\-W06KKE4$(()83;8>%NE!"V&F?2@FJ5#/`> M%Q`"&`(8UH&%NP&&[4:SHWHV9(_!4+V;@%K%(/!&YVKJ"R:W#-?`Y(+)78%_ MO4:["?&'^C()8+@]308P!#`,P?!,]=N0/09#Q2],ZL]@*"V%R^\]NOR&TE)5 MN`9X`WBS)G\`;P!O*DA@P]N<&S_@P0P3Y)GV))`-X`W@#>J,(UQ5.I\`;HRY1Y+!L!^JKU4QV+0):16@>- M!2.Y;T:RT^AT5;^-W%7["/BSIGX!_NP`_AP?JUX:MJOXLX%,]3Z76M?9!U\V M"K2F/CC4'D+MX798N!NUA^U&NRL;):&2M=WCVD,`0P##.K!P9\#PM`5@J*I, MUOSVH%:A#+PUNIJN@WTNPS6PSV"?5^!?M]%KP9QN]642P'![F@Q@"&`8@.%) M6_5[VCT&P^JO4NK/,RA'A9ON/;KIAG)45;@&>`-XLR9_`&\`;U1+8&_FK=%5 M`_'UD\][\&;IE:T[4UES=4A1*Z&JD)51PH#6+RMS=BR]>5+*ONYQ6@;0$-"P M#BS<$30\D?55EW(&T%#1@`22U)`T6G?SD#2"I%&,.9`TVK[*[:4^`=X`WDB8 M`WBS`M>J3E*ODXTNE36NH'IZ`-ZHPK7J4[#0Y3#'5]VRT%S9'B;8]?(?CVQ# M&WCWF(2-QQMT'4_F9RM>);(L(JB#8H(MW#=;*&T[IM9=Y:Y:08"?-=4+X*?^ M\"/KPP3PHXH3KDK.N^Z=1>KLPM\0Y\%T3<=>4-D]=DA0W:T-T1-VEPJG-V6+@;58VMTY[44BMEJO>XJA'0$-"P#BS<#31L-Z'&6V6A5.^"H5;A M"C1"7$U]P>:6X1K87+"YJ]CK,D?P!O`FPI2V!6T0CR&5H@9(;C& M"\K==[('HD0*ZJIV6\O'M(_:+.PU'']D8<7BWA]DJ01%DC`+^":UDM5RKM.3 MS&$^`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`E;EV_/)*ZG??<1\=@NQ_07 MKHZLU+$_T\UJ#%,:\^UY#.S8,C\TCUK:U+0L+A7T,#EK*&5T@YF-4>XYQ&`? MNI0K4X:2'.8T'!@]L1TJ'C:OK)TW,XXMFNX3PL3-,M'(M*A* M,OR#`XU#7B>.@QB)$C(L>#F-J'Z]Q3 MD\?JI[59Z#'(5)WJD#MC($Q!:.83_1ZY.,N!)1`PY,%).[,:+_?$"6CP.= M8$LRD:0_IU!MSL+U8"V!:R[78*Y/`N&\&&NXJLHU,"4#]&SF_$LR;!$LT2U3 M5!*8D(&6O`53X,'ISM'8Q2H[CPN*>9[G<7>;X=O`]VX"@W#+I`(;0R=%*%_@8BGTQ8^>5?XY+D11??@G*=J0Y]\\U1&Z87X^A?Q M\_G"CW/AHQ;F#;K?^NY@/(_%?Z-_/*3R)XE\<[:[*CG)/4F^<1&)8F+I&Z8? MBTZMDWMJJ^QJ-8)80/OV]=.(6&);_Q]02P,$%`````@`+F(*08,88%>5"P`` MQH$``!4`'`!TQ60X4V-OFGFHGFD%_#GMQJ_E6F(0D8LJD$F+A2*Q8\%\>_?__H@0)H4"HC3P@5%A;HU+E3*A,`60VJ\)71<.BR7JR7W MQH/5G:<+<<%W_U/5OKM2J]5*]J?/MS(4="-OME*ZO^[<:A,X!46$F0FP)@`8 M.F7VQ0[1@(D(CB%707J'^*OHWE84EXJ5PV*U\G;!](./*^8*A0^4&+`/1P5; M]%-S.8-G!PQ-9X:0R+XVH7!T=F!2S(J"P_)QM2S:^$U<^9MKC!$#Z8+[-N9Z M@;BO)#XLA7V]Y.HW6RF%W5$X@9AQBUMA M)I4TJ`E;VJQE;0!#V,;M!,+$=/J^6U*B\"9@DPN#/"7FS_T>%RL+F>K<:8`Q M[RK@+J)KF6)$Z0B/[QC432*T99FP`1C2^/46,OA?^CF@F-_">I#:WQN`H1'+ M$+(#*WW,1B4-BR$,&;N%8S%P6'OSL_8E*@5X)DF#1B:9=@W=C@I/KK@PH18A[I+F)`KI=]Q M!S)'-(CF0S&$8R;4!3'`$!IG!Q8KC@&8_7T+#,CZ<`ZQ!6_$@/7JSA'%]M$C MP(:VHW:^61(Z+4'#9.X56\O%ADA"TM`;E:7('4KNBYFL_T4KSFM(&0Y+QO`W_K@SJZ']&\$CZ6KA_84E,Q?TD)$T'%""EQG][F7T3,@_*`CLI<9=A\M<=="#.J39,IIO+X=MS<-2>0 MGB]F?!T7+]#V?:&4/DZ$!K\\YIV[!O0'%(%RH!09S?QRM'PL6G"(N5"A"I*(4*B8+<8ZU$LI6E2U];17:XTU"ACB"8G!UD2,]] MVO#ZT?!!L8>]"#"X$.^>SH3X#*C6>/P`VXCZTLP%9[%),&?.XN0Y+!+,&G!$ MJ)-N'(`%9-<($XK,I9U!A\SDP]+?ROFCQ3^^AN:$\$_F_!8[/:."B%V*[YUY M\S#L0*OR#LR=ZC++V?!9(&=(-KB_5Q11RZ#R3TC$5&\`2W+_9>LU[C)TN_8D_S`>+< M80J!@7Y"_1(@+'"[N`4IFMM1):M3Q+C;;%F4_]_CUXFNTNP42)GW5)70!%3H M29ZCS<,K^G9%MPC7ZHQ!DS4M2NV=[NR-T0^P360I=EN5>&G1;LXKI4`U^))) M=N=E2;"4NMP&)G]+S M?"?W[0PIF\%==-BK9A/]SSDFH4M%>Y"^]O.>&2.MUL^&P_.[+'CN43@#2'=6 M#WRE9VM5^8P2!W9_S3\1>8ZVCC+:%V[!$>0MZSR>60&I]?=A<'L_;$*YSQ0%FDHD7B:B5R3HEDA M%&]?HIM@3Q1&5,2R)_E&%2'Z$S(,)3M2;MO[3/<+`9*89XO4NPGP&/%XZMEC MG2\TPQ)5G2IICX6[KUXH'FF2L"G#>?B&8&VW4[$'<4_"I;CSL)3F5R`LJ3P2QLJDQ&PJ_Q`CG/I$M&1< M?^S`>K:%U0X,"5CNLUKLP2%C2QXA;NMB%?O6G*>R@(YZ&0_22];+SP[!XP&D MTQ8<*H[M)$A[-#,$ZD#"3\:NR!,^>@3:6;`=C+GGJHGF+,POV:>8__QZ_:7Z MUY_WVLQ:/."CFO[S9#Y^6.*[EO5T>4)K)U>'W^\&2V:.3^?ZNV>GI M#]^,ZA&^'W:;K?;R3A__/9H7DTH0"'"^[ M8#A`9NOJN%3]HSU]:A_/OE0F7;-A]7_^T>RW:NRR6OV\>(._MHY,7'MCCMZ7 MJ]-/UQWKL?W)NJZ_NUZ>?[V`]?*@W+Y:OM<:[^9#O6PT2T_FP[>'0;LQ[HRT M\=G97X7F;=\YV)U^(;(S@PU!VVL_'L92MBOV6Y-H/R;$X&VR506;"CT$H&RU M84ZF4X+M1K\`PU)2!+Z!D:_!R/7D/YFQ3DS6LW]=UY$0%1@]@'AHUP0S9`+# M`ZPD%(Y&S;G.(9Y^XK`GC1/2KEBLJ2`#ZK+:(5$MI+)J*ZD(>0<1,569E-@L M"P'ZT`0(OSRVP",,CW&0IJ8B.`;JJQB%<=C+=I8=4`B819=JIZP`E/R3.?%4 M$D309@*\F%$:5IQ:W$G<$XF9MZ^+2XHDR1`67[RR7@7=%7)8;M=G!=P'\J2< M,$2-!V^B1\D<<0D:2_$PG#9^/@%6%X_W4I8_2X#^_],#28[!)-3IC@X3N&F6 M'1Y6BH+,=_&VG:8BZ*_&]#97:E/"3713_NZ&AW&P'W=BHQ# M;$9;(_8VF2THX\U>$+I9Y&T?871J:/N003J/N9.8HMG<8X)TJDO-HG3]D#9/ M)YY*UP#,O^>I)%<7C)1WI+K=T)/1)Z]#3GT^5ZQD8`NN?K;Q6H6`FC*U*-#7 M'JS$H#6+RN4$I07-"GCTDT?E-7ISCE7YJZ&`\^7[4:IL23YQ;0=CWW7#"I9 MF8&D&ZOGZ^25MPQ"3Y^WY/.<_:"@`:EKCQ:B4'IL2447$Z#O:;`98@N^PV`) M:-Y,AA:W.$R\#MQP'L8.F?U\N)UH=1WS%]/E!J6R!SUEZ80N$`98R\L)!:&G M=T+G"XW3Q^-N)ZDL'F@6G#/94:^W$V@OL\0AS'F->TM51&[()JTTF3F#K3MR M*YL[8JQU1TT>!Z@J-(D"W=L%<$PEQZ!5^JRZK?6X2K)XRM15ZW`3<#^CXQ3* M"^!R1@,1ZHA)T.9. MS%9E1&[L<4$HMP.+:A/NE@6\T@+8&*BO>DC%837C>C`A;1W;E34B])\#0PBP M>CC>^OI7A4H3X>?]&HD47*T5F\3.1NSA^Q`4=3]PM1/QM+5?J/MAX>M&]4.Z M579 M/(/5CLI=9V!+B^;0$\=)7:YD\1*SJ?P3`ELH+!%GH>?#=N`Y&TK?)9JRT'%` M3&!XWU7"8PX^[W@K]SRE!;$,+V&36SUYW7EMC\)W&@7!Y!1Q;*&PC3/2Z\1E M^QSI?_3;-C)24^*J]==W^"/A@/_'OC4K\KTM@=1$#>F]ZDFJ09/BK30?2@)R MR-=BMDK_!U!+`P04````"``N8@I!Y%F6K7@?``"4*`(`%0`<`'1R;G,M,C`Q M,C`V,S!?9&5F+GAM;%54"0`#%S0E4!`L``00E#@``!#D!``#M75MS MVSBR?C]5YS]XLR_GU)3'W1)[*.^/SLZ[1V=OGS;.WU[=GKT M,!X^=/@]>8F\X-OYC8E!T]+1P,'WW+$;L:4*ZYV=1`\^"YY\ M^\0_2#S_>":>/GWSYLV)^';S*+73'F3-GIY\^?CAWIRCA7%L8^H9V.0$J/V6 MB@\_N*;AV2Z6X.LH\PG^UW'TV#'_Z/CT^?'9Z<]/U-JPR)ZQO`V9>`,O3H(O MGPG`CHY^(:Z#[M#T2/3QK;=>HG?/J+U8.IQU\=F,3!E&'!!G_`O3_)> M/XD402V77$$)FB-,F6H&-,MRFM:$X%8UK^>&PY7H?HY0:3@3[P980K+W[=8@ M3&ISY-FFX=!#N-UM"H;Y@4'GEX[[6%KXT7N,+14\W<]9;^>N8R%"+[[[MK<> MLR:>N^1,AK.K)T>ZK$(1J3)]M3"W.O#.F>RBDR M;+(,^8"^"N)]TW1][-EX=LN&F6DC>KX6OZUEV,EY6ZEPQL;$05(S6^QIA6H9 MM"@MH>AQ``SDU63SO$)5[3-CTI@A,?71D>]Q2\MBTG^@R/)TWO/-?\8 M+;EU2:6[)M>00L&=^]3&B-)[-.,6'ATMN0/!D`ILJ*%-/6)/?$[\EKB6;WHT M^LG`'1B./2'"@KY'9&4SCR'\*=UC6`94"9B/FR'R#-N1'67ATPKGFJ!%Z6$> M/:YTK@D;+NF0A M1H0,3[GO;Z`RB"G+8H:7'#FYW#U^(3BW[`7WUEQ\;*&IX3O,FPK)Q#G>M&%C M[X2]C34@)EU%X:-*_,:O!T3/02W<]8$,?T).MY0+L=P6@/Q$0P" ML8#F>($6$T1*XIMX=3OA0;!I.$XYYO@+6Y:8LMK8YJ/K`R.>8`L]>0A;R(H8 MXV]7C-.$XY;1CPSC.6W30N,.73-?J6I*(F^ M3@TZ$1T.7S[A\]():1@*^WL.E9AR565Q;R)L$-OM/]FP>I0@%"X#RH63.JGF"BNACZF"2B*T M+Z]=>5252$CF`=,E,NVIC:QAN(P!2"636*(':H6SOS[G2B9-,Q,"R@:L6$AJ M1?2M5[N0H"44F7LP(N*`A4(ZS1M)%>5D.(C>H17"/KIR78O>(`]$0&ET(`=0 MTOHZ8!%*!:A0(`<+(W+_:Y!'G%12ESH@DP1.H5B>JU]Q8A1KD$@+!D>^*F9) M(RZ%["6ED@@&+O5&4S$$[UW'@A#!+HDNS$][L(3HGT&@'VD"'/@;"F!.B6+D MMY"$P/]#_2(=DW$?6YO`,/PHV*4&9DP5RR1=`3-&PAY*$JY()$A@$0+^0K5;@1SV\8S)]Z-!_D!\7^7B:,YX'+$ZQ\1CS4&!?3$/UH8Y>(;5T/$43Y/F^RE2!#\2/RYB[[9L4>$6D8$'*OD_U&)UTY':I5 MFE$`3OWFPH:]4/G/V8H#9-YGD>I$$"X3IT@T`-'J&^3!KK!)`IV0PPXF$?JY M,=!JZ._F'(J41`@II!-JO2V?@4\DD>R(7$5Y?$;V;.XA*\P?O?%Y!T;3O3Q2 M,#F58Z`+=E!)2"/1YL3\E(RT,.FWCK$6D>K$W)>)4R28G/B3XE$7DM[3E!K' M728+'3`>2Z,:23@GB!6FJ)TD<]1B:7\PR6MI1_>J;@CK_#6=OZ;SUW3^FLY? MT_EK.G]-1P0.B0@HF\:V&RL)4X=3"^CV)WQ;QMR)F>7M+14UU%K?OP068,EI M^^1C0527,,L:#WQ"$#;78VZY\I(I##YLB;\<$9OM6[_[07"5:<]H.C:>P'9* MU'/:@':4'@-[NRT``@-:"[/8'7*PD14&?F\=`S-6;MD:0,+D&YZ10P<$6;;7 M)S9E?MO0)_P,/6(/64THFBJ6FXEE@2B=,BFJS8D6?7W`!!F._0-9O(\C+/K0 MIQ1Y-%U[,M88F78Z)%)Y;"36'*53PI:I*];C@+$ATY.52-*@+9D%#N"RD5`: MR+@_1%2%.<:5$UWWV(34CSQR'8B9YJ(E*:+:HZ.)FF$'A%!T9%1'1G5D5$=& M=6141T9U9#1%3H$KD!Z*4R.:'0KMST3>A40]^$$)4!&[\?($D%4\-/7-!H.? MZ7W8^*`9/959'BHZ"`:=@W@"O-TF%+A881(6O^@^'+QAF4MZATS$'$%F%#"' M(N0.9`;)H]?P7DNQ-/+1`II"3@#R9#MQG`I!61A M7+B2#(=HBA@!:VP\;0+1@+++(]>I$9:+&U2L%7QHI0VBQD0BH9K[GL*N#)0O M.K>$'[CSUGS7390L_>[;RW!/%V:VRZ'7>GLK'RV9](J*Y]I=UWJTMQ%/I0?8 MH[9;C_X6!8D9J;(1YAEX9K,)\''(2)6J4+?PW M+C;K7?MC%!LVV0K%50084/F4>(X`J'C2";5Z!&5@4UPKY1#S"\[N:A+L7#7; M-[,@(EHB>/#!-B:VPWJ.1$6HO7N,2L5FI1MK\SG'DK"H3A^*1SOC7%2(D:>] MWE0>:%D]VXV?IT(!Y7-$SNFML>:>:0W1W1U*S:50%6M>6GAW%RC5@HFNIV)O MB[.#"%,CS/<5$VF,7:D!(ME40PY'"4&4`@:F(F](/5:R!':\9!!K,#>U])C) MP@LFY!CC"U`R*52:]M>+%#,NE3208(KT?G#Q;(S(8H@FP`Y@!J7F%IZZS&N:W/8TVEV4W+%4!;;T-5=^=JDET.M2T:W#'@P];,SC3CE"U3C MCG^N4F8L2V`A@`.=_GPWOS-Z7P@%5&"8F>T+%XL;/S\9C@^2\[Y'HTN2R0:J M,`1``0S;^PG?X M\9F\H\.01Z7*LM!H_H64/,MB"A-@N./WI^+M?,87VL M5Q_KU<=Z"Z2BC_6J%)$^UMNN8[V.XS[RE??2)4/7GWA3W]D_;P"Y2UV*@38G M0U6$%"80$/.MF#4U(H)U2QB.475SX.!I)MDNR%`*/I@4A!CIH$YYW_?F+N&5 ME8`EMD>N&T6+LM$"K"N5)'I-J5^3>$)2G:@R\.CWD&A,&#GB&9]A<6205'XN1`4S=4&'1^R6R>9RJ"'CI2HR,U.E*C M(S4Z4J,C-3I2LSGD%"ZQXA;3S0W(?=.S5Q6./,DVUF9/O20L4'5F_AH7AE32 MP>([1!2?>=I<84#'[AUB)H=IBU(IX:D&E]?H8'TH-59*-]HU"56$#FB>>Z#\ M$,JA$UQQ*TU*J:J>;DOU%X,$E3H8G4^H\5;K(I)-I>=*JVK:^8ZBVZ[56^)# MM"3,6A$G'MGO#@J//O87+O'L'^)S&/%)T.V8#&60A+DFZY:X*YO;LI(2TEM(;H-0Z+O&"K@&\?LRRIRL`%8*8J#@U#X7T4P-=/(QGV!S);W5B3$! M($SRR3[1L(IL9/ZF5I.M1YQ2G/P9Y"P'.4P.2_;D$5:_J7=.CH@V&IM1/Q%O ML`0RA.1JY>1V3"[&IH!.@T946<&JP[8PC4;=X-VI#E/W,,X@_^<9T%GXRB3@ M5-ZYX/:_<(TM9)VO,WTSH&T-6>J-9B%6&`P[^Q[2((-LBB1VMC`IJ*%,:^Q;BV,N;!`':ZX0\M0G4;3J)`AYY?].2#(@JI@4D2T-7D= M$KJ:+&Q2""=4LD"<=.#9QNI20DMQGV!S03U%XDO!$&B7.2#)-,3%?"YFO_-\ M?S9/DY2MRJP]Y:)&6F**2`I$$ABP+:]HC;UT"=,)GYASYHUR1D`KK4E0[>2P MDD%3)JI:29073R:SC<;&4YCUP_E/W^-.Z16$E`]CJ*GDG4/D?Z`(8`*O&29Q M34I0@GJCSH:2T2/AB>0)7G&9\XOI%)EL56%=$T'E.V:FC[#(`<7B=!T/5JP, MA\]8(.._#/WV'Y\L!Z?,6>2*AY%3*=XB8KO6;EP90JREZ+=?K.7@A-LX2>>C MSR810M9LOH"K3"Q%N`M%&^005'U76E"VVE\N@U.HAC.T*6_2)]ST"ZV)<+8O M6=>[;*.M+@U0$:=07*_4K(T;$X_71Q[ZA*G%>(Z"T,N&YPJ::6P@Q%,U"QK)-^XPO;<[FQ@Z]#]!D6D6K\;H0K24."OU:96I,<`[Y"H&CYV MHTTPL2=&;>G`:95VFXK!J-7Y[9I6!5K);8Q:RN/LW]8Q9LT\=\G9LXH3O2Z0 MHPODJ"N0$^@D#Y:Y6/A>T(5R4@F"20NB8DXZ9$"Y0SO$X&KFI!.JH12+3+&< M/"U-!/S2T0(*UJ81@ZF5DRD<^%I&4I5R#I*/;+6<0^M`?DS8+D#%'T,BS6Z, MY,T9&24?(W!@ADK&)5=P$LDGV&2(6UHX!9A!U3&2N+\*4&S2Q!OP<\I+4!Y* MN!H#N_=9P0DO@U(WIL(LF&!N;4W4=8632!J93LQ]J?A`W27Z5[WN2]9AK71W MU`$%40"+J.]73F\Y^&G%TI6?0!(B#H@$\?0@F"XV7V_0H_@&*"@@0[@+XL2-0#S##_!3>3W02W.Q2$O]$](BO;#'?# M>$G!60`T6"H*.,\-&OJ2M_R`2ZTX@TG]K"$QS>F6<(*1*C%:FU77TY?4:;M.VW7:KM-VG;;KJMIU MO_SM^/CHWY\_?CK[S[^_F$O_Z2M^\<;Z\6HU^[K&#T/_\>H5>?/J_?/?'\9K MZKQ:F3]ZSC^]UP^##[?6UW\Y9R_PE\EH,+Q>7XV_?SES[P?^F\\WJZOGJ^__ M^NZ]GQ/#?G7SZ_?SY]/?WK_VXM/5P]?O_RQ^DX)^>WFS8N3BSZ9OWY_ M^S1ZT_L''GZY,#^\O",WOY]=CU^N1\9D;'O#]R]/SGZ]7CQ>OUQ^.IV/O'/_ M[L>O@[OA&WIU=O;;TT_X\_"%A]_\Y$U?]\X6__SXP?]^_4__8_\?']<7GR]1 MOS?N7;]?OS;QJX]?3WV/?/G^]*,WOOOTZ^/[Y:O9NW?_.1KI#( MDQ`YU`.7>G1;X&E3:Q;2ECJ4I4YLP!Z,NVP^:(U6F@CO:3M-VVG:3M-VFK;3 MM)VF[31UU]8&4^8=6O)[CO&LIFU8&;)=V%F5@J]EFZ6A0:4M*FU1:8M*6U3: MHM(6E;:HU%E4YV$9LX&[F-A8!%]J,JHD*7$=OOP,D>O8IHWH M^5K\MM8;C=KTN:7-+6UN09A;0T1-8B_#K/9S@]IT-(TGM]=B>I7@ MH@OAK2K@2D6[2HOYTK").$(?.Z-PC2EK4VQ@AE86@&3E"'>@KHDD@F"%:5)O MQ>K[0)0@\3D"'=@`$HB*'GC56T;@,(+IOK(I(Y*Z:B4CDKIJ)2. M2NFHE/*T*G..+-]AOO9G9J///63U5X@8,W3CTO:;M-6VO:7M-VVM@]MK.\;IK/'7)0I@.Y^OP MR[J,M%*L="&YJS+,[3G/&`;\PKLZ?(]Z!K98!QX8.Y[++4W?XU:G;;+/A[;# M_K)V]]N#%40?B-3FG#;GM#FGS3EMSFES3JDYE[L[%UNTQ3H-(;ER#'3!="L) MJ=J4?(]@^NUB.D6F-YH*H\I>H=CU\_QFV97A\(RXI#3YBT)&O9=G/2&A,DVU M>D^Z%":%*?8JAUEH]>ZI1HT#+9.%#N1XED85ZE[8/O9L*U2L>V3ZA&&%Z,63 MZ?C,7[ID70OT_BFS,8YUKZQ]HVU;ZQ]8^T;:]]8^\;JMCI2TR+ZA"W4,\'W M^7JO6G/_T2!6N#Y_0I0;I]BZ>&)LLU_'+O\H9I$&%BN(T.OBO?VV87UB[+(J M[OA2%T]L`;0INB6V"6-G-=NC]F=G-2SQXE(#U15Y4MRM24:WLOF_0QQY]OF` M6;[$,#W?`NC.BV=FB+&XB$7+[-98'_XD=JML MC_ZJTZFTQ(L+>BBT6X,MIK[OS5UB_T#6`V;$8R%Z4=,IP>`=AR'6F;#7[;-E MZ^]:=^W;!M0@5/-7G;!Y8QWMOLTKT1D]26?+.532XZ,>M5`#>4\YN:)RA:H+D1A_0:!YUHG?VHM@>= M4*^:A1J%Z97OZQTXJUZZ9(ILSR?;CK1Q74QCL]7Y?Z#RB92IB4V?HG&1PG#G MIKNR?>A`VF+]=AX?+P\!H=+1G/P=$V]@P:VI29C!-?>$[$ MM7S3H]%/`UL#P[$G)/"[$%FQ_M'PISXLIA/B6I,0MZODX(EQJ03!I`61(9<. M&5025D`$,#GF2G7I\HGPRD0!%`&W)XH6I'V5DD04BEOY8\, MA0ML2.HCVM_?RS@@E/IBPUYGVM#>'`1*[ZEJ[1:D0KND/*BI+[89U/2>2N3# ME0=U['J&4P++^/--!F9S\4MT2N*6EPJXW2#O#JT0]E%_0L5N@A1\*:^UVMG/ M["O,U4?WAH-H2(M1!5F]=D@T,P\4Z%!BO=K%!,ITN"(NY:[AU/;2=5J-`-+( MM#]])!4,3+M7R=2P9$^"%W.!GW`AB.^ M1E9PY#ICSLJP17->;VW*16&_99(OJVF]-T?D"F$F7B<<92!:GT*F":V75+"$ MZJ)-#J@$<&)A(7 M&]9;FWV(/,-V],V&<`SK#5H)>8C,:ZC-V&WC7=AXC4&A>)-5K!:B^;3]U8SU M,OY\#94I%[!D>^(0@;*Z'B-@K@QE1[2_5[2\+P MN&84"*+>G<&5D9K$%NGG^\Y3AG&5]S[5WT(=>8\I M3I6L*A4!+^UU*49>T@LKQKX9QTPM_+(%%\O+@%O5G&0)YVWGE<:<-ZF!N\%W MMZ/J]YL"K_'Z?'17QA../=_`5D0%(!,]E+N(M+0]PM?HT71`D&5[EX9I.[:W M_F@\V0M_<>X2XC[RX@S&DGWCK2&LE5+TV^]LE8,3KIQF&A^ABP!["8,%>>A;-OC'(F`:3AWUBEB&H=9F(RG"&ZAP846N&,#MTH*0H3^K%D1X%V>N M-1$OTY>_ZXB9SB_0^04ZOT#G%^C\@K;G%TA47TI>H-E?L46>SSB7+KEB[\(< MN83BM1.9I'"2@@D=5^:7&;=3ERP,S&L'D1GRLL(&6(%RW@97%$+5;!+Q8S'6;W\RF7?QQ;[<28UK4#2;VU,`AYYF3.-K5"6 MTZ:TY+3MBP\,V')QK/*1@"1QP".8&90ZL!QD821Q>JF23"X62\==(Q35*TI= MC6YXM\/7.K=N-Y77@S%=&>8)XU"B!6.V?8.\QH$57AU0O58 M;%7C1OS'*^AO:JN?MLK:3..OM98$C#04WUNP]:6JW):W24;O,WMX$15!7]I! M65Q^18B\_PI$O[7J`8]\X=4'K5N]XG6I6K67X2]QNT3/^"6?;2 M)>%'_#F0%;#F'G2A-E;=0I6X,*&1VS?V+A$1G6S_-552?'=!$>L1H,15")74 M[Y:X)D(6O60]K^V^J6*BG=APDL`N$EM>I+>A?*.>OG("BF&=<51&'O&%9W_SNV]0.8C3L67$5/(_R,EZL/HV'[U*S7K(RFM23;7$*#!C2 MZHWQ.*L#QHEMH6"_\P$O#=O*Y;J,Y$NWW>:P]F&@J3XX'Y0>V2?%..-I#JP3 M"1YO&8=2DBO99&N]J$KX2&0?U^=8#5U3'.-E$\0%X]E;7V.1"\G;_HM$J"UD M?POZ?H=F_!9I`WLWQB+'SZ+(_'GFKIA\[(!;]LLNDYFMMC>++AL(Q>8")Q0I MWI@]=SC2B=9:.UWL]UOYT29.(JA3Z5W:;*@[7Y%!+K`U9'P=#G-FRZW>,,S' MI'#-K#B9,"MKX6*Q,1F<0I$J$E1N:LFET7J9R."D]J*U+=5;?^+8YJ7C&CE' M0@%`24GW+A=/J,"XMS:?&2*SQ]4E\8GU_&Q9Y#UI>T@HDP,N\UV8Q3L M@2&1SE\1=T%AP-B:N439W)-LM".FXPX2$AGL%2'_C!SG/78?\3TRJ(N1)4Z4 M$U7@9S7?$3%DHJ,Z:3ON/P?)NLH\V_1FVS[W9(`AD:U\`/);'_J2?:)@WL]J MN.4K;R8>Q5G'!V(?G9$`0#_>=+MM_AQ((@'DN;-Y$?9?3C@E?HI/(/#_4$L# M!!0````(`"YB"D';T2K\*SX``.=#`P`5`!P`=')N&UL550)``,7-"50%S0E4'5X"P`!!"4.```$.0$``.T]_7/@QVPG]S+J[]Y0. M0B.B,/[],L@@N+^)XNP?7W"3W5^FT9=)>O7DZ>[NLR?%AU_0+U_>XQ_4OO_X MC'R]]^+%BR?DM^6G62CZ$('=>_+KVS?GRVMX$^R$<98'\1)/D(4O,_+#-\DR MR,,D5L`+2+_`_]HI/MO!/]K9>[KS;._+^VSUQ?>4<@#\/4TB>`;7@*#^,M_> MPG]\D84WMQ'&B/SL.H5K,291FC[!XY_$\`H3'\_R`L^R]PV>Y<_LQV^"2QA] M`?"7[\Z.I8MZ48-%!SVI$(WP#]X@A&JHPOLH__>P#C/%NO%+19QQ+/L71QL M5B'Z]?PRR[%@U^F(H>Q@6=S]YMDNH9(Q7$2<8@$8P]H2BKVB0Q>T[S+(F#7* MRO\=749D-R!`\15B5KSS[OR+[WE(H`(%DC6H@(%');C'?W]"$/D>U-8[3^M< M"])E@3?Z:\^"V1=/E@G:>[?Y3L0O>YTF-\/YG2<#*4>$?U0.1R,S=W<,[H+W M!`?C#7R=)*OL!.9"W4W(L@ZR M2T(;-OP)UD5/8)1GQ4^(=MK9W6-GQ9\[YWG2XI45(>W"0:)E3M-DM5GF@`SA M!,NE7*FP",M.[_*>?#^"<)S#]"Y$YI,#^>"G>E+8:1YDA,-#(B;L"\`&3$A0 M!.R2R4ISF;63PUA>',B))162)WD0B2P9"0X2V4"_:?.]<"HJY>X2@^*PN!*XMU6[&M.6@MKC&26RJ$^;QJ@#K0#TT9QO]UMMW M5LAQD4C,!88(6LHCB%<2(?*L223\E"@5$0T&W%Y>ITF6(1JM0RO&!@_>N>1P MDTM$A7P!Z">>34\!(W@):*YER(451NC'5TB0W@;I[S!'?S^\OX5Q)G8Y#C4W MY;.-+1"=MQ(I&M*+"1DP`^7W1(/\$J3P.MED$+#AF1_OF#HS:V9J-Q6&Z!$2 M9(@0Y/GJ)HQ#[%S!,06+DM4WI4OQZL%%(F/U;P42Y4D5J?&RIIX4UF\@7<2I MM\BO82J4(XDSOS9@?"_N*EENL%^1.!3[$.ZT4Y$`61VYL1E/IYD:[VO9?T";O+*RPMW5NN^CA>)C?P#;(4;.A;T32CWQ=[ MC3H!%I(]5@D#_=3[I;[PNE:UPR/61"-M)$B=UV!9/YYX9QW0XB2+7)F20 MR!')D(#H-HGMOYK*GH$8^KXWJ'&V)E_]1#!V6%4B>X2PW$]B!'^#IJ@"<*_@ M.DDA_>XBN(?9VS!.TC#?%F1&-D0=RN&'#?KU6YA?)^@W=^@3$M6S(;0NT7<3 M7O:P,NDVPF,!G8:I9$`F\KR#/,@LOQU=<\;4RBCG9XKB%3+Y+7F-9%.Y#F5* M\)!'O._"##$,(';)!-RCA$M9UY9&\9+-PYHG,+=KF]8G<'I%$:+0$=%L&:,^ M)$+($%X.VJLQY_YAD,9(H66G,#V_#E+X*LC"I0TI$$_DT@\DQ$`B#.1WH!@! MT!!`QH!'80P.DB@*T@R@0P!D^*>//4M,)Q-YR9&38(![\1<87EWCK*T[="A> MP9/-S25,%VLR0;;8Y#B)=X5FM29:>@C8R*F098<:82AS2-*Q5`XSP(TB0DE_ M[%L2C62!EU!]2AG?AYJ;X2",-CFT$K.53>7::)+@(9$X]EL3-3@%+=C@9Y<> MY.E@?I9*9)Q(NUI&DR'R-]S=I"N/E]B(-X@R_94_B>;PB_XI("&6^^L^&QD"0 M5EJL+X)[:R'O\3%UZ;^TLP29OG;%;M6/-X.S2ULNP.X#F.X M8G&A4\10-.-I&B8I2TO'N>K9?@J1/35/PPS=&0\V*?KO*40?K7SLO[%0]IBS M8F]5DKWY+D[A,KF*PS_078)`+1Y/D)<5)/,%7RSRX-Z[%\21J*KLV3&9HNUT M)F"UT$8`W38 M4/N,C!9+M',[3(-]I1FF2A)GS@U%A$06,\U!\7:89PCIS'#^.^W^M+4Z@C(TB_.SP\OSKT[%L3LX,\/P6IDYNRJ_]'IH=A&]4JO2 MQ;FLO2E#0GCFU4D\G;-M&+T'!>CV@^S:RNT(PW5;D`K-*-M;Z%>>\YYY.M?N M,`760QX(SY?+9!/GV1E<0G3+OHSP/8C)BQ4[I&L^YT=H!S(R"X4-`=68&8A@ MEH$@BI*/Q!;&S\!6R>8R7V\B$!0#DC7XRXOGY#'Q7UZ\``'YR8^;&()GNS-: M)AW_[BV2C&OP;(_^:`;0FF\A*=,>;3T+HHJLU([R/O+JIT-7Z0<54/4,(&Z, MCQ!&`X?.[)[J,T^%AKHH74\$::S(6;1!,+D\%T=(3Q\GM@%)!\0&\"/@&/UZ M:ZFH;`V^ZY?MU=32I^?LDWK!!C]/<=N,J+^_;:S&U)5PFL+;(%RQ9[SS>,4% MG"R>ZRK3.BXVJX"2]$4W&5D6$^(J@-0O`EY%2H/3O*2IDL58YQS`-41@5A?! M?1GGM"AY7=.YU4@=F,A>P;$1N%P`%2GOOB\%[O'2U+?F81Y1FQ<1@6IR''=3 M446LJ*U8Z_CTX779_4)=8GJ6I/)$.[Y?1!C]CM& M\@EXW@MVJ3.V?K=2I,,`9[C(#CI!2W)K]W(S^BA%THV2B0T\%0NXSA>L;H'@H/'LW)/?M&^B\G?>A M2?"]3OGV!6A0\?,W87`91F$>0M+YXYJT'XA62`/3&H]:"0W*P)Q7PU#%3"(- M;X[GKX[?'%\<'YZ#^'9^5^#VR3[#AS^\]WQQ6\^"G,LAU$@WWDO`D0*0GZXD; M,874IPY&-/-Q9&MUGP0EP:0K$XHG^V1VZF@\&)085>0]G`9;',)UD$W3F,EM MV$.,1%_^#/O:MPW7R2I1,HM@E4;IJ0A>NH$K_!`%QEG`GO:3*P(GDTHZ7!&4 M#7=D;\Z+&FYR8<&#`3^:B\5R`/RJ'3U>EBI(@S9.TB$UD1*FFYMP[-/CU^X` M]S6;A2O[;_<`D4SF.%E#BDAW5PGRI>`L\7::=+.N<:!TK-C87\A)HD6Y$QD,ICNY?#_6SBY<5R3+-E.,$W%8[)8\NH7C/@36 M?S6F]LQTI$)R;Y(MR#0L-C`0UAWZP^+'__.8@V5KK+MN9P>70W)Y<71T*? M`?+=#-P&*;C#7X._['[Y]6[5T6:&WWWN[I+_TY]D(-CDUTF*RU]]!Y[/7NQ^ M/?OJFSWB/WL^^_:KW=F+%U\5GX99AAUM)L](,>RO=K^9??/\!8/][*L]A,;S M`G;"M3T9^$[55S$HH20V*D"UF3DDZ+-:A=@C&$2G0;@ZCO>#VQ`=T=PT5OQW M_;,Z?4G?CX_TG3WY$(0Q.+Q?XO?42.I.T=XAS/$M4.K,K7GXU(@Q\/G^YF83 MX?I$7>6D;1:STT7!>7!2!SMY(*J`4KP#[*R`Y\__;"(-#:^T-KU,[_]G,`]P MU>2B8QHW-ZZGO+339%AA5J>EY=E>K,Y,5-*"&`:OBTSNGAX+"?3BI^C3)17.R0J;*;8D?5$X9XS?S106JHR0]8/6GVC68;&:3 M:"'@.L-$!SF=ZE]]A;^X?L;^.\<:R4CM@J!-1N-4%NZB?!JDBY0T9WRPRW:_+;1@BKH^&Y5A/CYO,M1LU>]HC!QH:[I292`H9UBU:2!N6S5 M_"@4N'6O&9O&J?-5@(#LC"-;Y>W5]'%4:X%20<-03PP($F+`5COM'E<;L%O91T2";LS?M9OCU-L=1 MX:OX[>SGPV3C=^\%U".TB`6ZN`8Y.O;F.`/%X!6\*C#W"D<1LX[V!4SF,+-! M"0%4(/QF$.KRL1(W'721G$*\E).T' MV'.[!)>I17AH:0EMH%9B>)WJ0A=%F9^[`@/R!)2``!K.DEWPS_&_Z@U2W#_E M-61T]:C7A&(.GV,;H"=\F*W'44E%C\^#O2:OMVFOYPR_YQUJC/1#<:]7>G&2 M]5Y'XW!.Y_3L#F5>59V\E6C@3C4HX2/LM=[%E$G8%I:8,Z0L0_$2LGROSQHH MO((Q7-O)5.R;TN7;AQY<^A["\N4:_':@5.2CZ!%LU]H'E0Z^3>$R)/5$T-\C MR`J+S&^2-`__J)76&5>\%.9U*V/]"$D%K1I*LH;X,=X=^SH(D%,GU.> MILE=F"$H1TG:3N)`,Y5MB=($"(AE`@B0A(I(E M-%"`\W?`FC.^/'$-J>?,$V.&G\A>&LQ>'_:M-PX/Z%9'@E.O@JQ>8\O&V2>9 MR6U6C1@)V0-P'+W;(5_7JZLQ8\1W-FPW[VIIU_)EFS7ZOD9T@MEQS/H;QROC M8KA*D"PD5'>'`%2PDOG_Z5A\VZ.CB:J:3,E<'KA*2M%#2^CV[^73 M=&KLVF7:KG$V';J>X4P'>`#IGV@N=F@551JY)K`V#A4]!,:T>-5?AVGAJ)X% MS]7X%'?:]7$D&0E$O7&0+K$&-.IM3E485Y;J&W5/.)X7U0@=FBJ\5 M2@B3R1K4Y:,XZ;V/,GY>*_1@I?):0L`>^%P65DVF%P> MRI&^#S%]">`/,4T*F=X$6M.\VF1A#-&-(WN=)ID5"ZMWSFF(9`,KB2`67P$R M*@N;^8F3D#P)4SOE3;1\4RF36&0"[>O0HA?-/AV+7H"=JD4O.K1]BZ2^!"A8 M]#(:#;?HC\(XB)\-/B(7Z_T4KFP5-^^;U%-5ZE[$I$7.[Y+H M#LL?_IJ4T2"?ST`,O9OLRBRNESQ7H82Y.Y2'3V,$7&M(VS+7GM!''DRVL]*858?!TH_6K*X;I9M2&EP(G15_4GO9XDZ>T5> MGQXZ#$GJH]V_+H)[]KH:&^GB%T,"T]V&2`Y#R.7[Z4&82@28-6/#C:P95)SV M3SMAY0F0O4KS6A=S%!'BQ7XX80>4!Y`XLQQ)O\;LTW&&JHMWZ0PM0(#+K=#G MX3D91U\(%/RA'<)JIKK7:[A$]@C:+B07[0QIB45,JBO%*_P'CD'=!1$^0:QH M:IWYG989UL%,IH@)"&Q'%$``A@**EX/(LJB78O.C>@U$H*9I=0DUQ-00@SV% M:9BLFNEK-N15:_[1Y;57N>J@UZ%>BT]QJ*DAH7ZJK!MPO59U79$CN=YD.;ZLME`KRLF%>3(GKT*8]QUDN2$D'F]7\NT M^-TOE2*"C'TCH1P[C#LOT,KH26-2B&%H#B&K/DU&F9:^/=_:*+HJS."@<&5'!J!=R+>\'VI;_PIRF;2_>A M$;W<5;)05Y_K\A0D%^3EGMH,*XAYK?HCC*W:AD3"G1PU!11`R6I-='! MF^D4VK'%J-V!K^[1IH%9CN>Q M?U;O]6RQO#Z%X^ZJC>D5GF@VLH\\/<\4L:7Q!+.UKG'O%"<)\7HCH>SYH5' M1U8F8P9-7G",.YB)TW98=/TB*5[4<"^%U.Y1!G#'EOW>-#L#).6=%(6Y7'R: M0O>K*_>6O3GG^6Y[1@1T8U$/05'25G$@D[W=+E.(H1! MACW7^7;<-J\J\%W[?\Q1U6_[R@/]:W";9-\!"AL\VK2[P/J2YZ&BT=LM5)6V M3IU-PW#5[!.K)`A"\^QS%HAA3BT*&&?R)3&:]B"Y"4(KC0?$$SG-$A5A($LZ MHG)7?@S>T\_]//M38E8MFTBZ5`O:0S%S@63,UL19IB)>!1%.'??K9FJC*R*T M;%'6R-R3;B#&9T^%R)[>M)^!,JX\*OR8OF3U-+#HTF9"T#X&R0UH:X1U+(=&@'(W(D2R? M$_B1_,9*,K3:Q`Y[V6@A9OJ9@9-DZ"C*%^N+X-Z&#"K-ZU)=JR`DD4!:R:8V%N!AWJ5.A[F\W"G3PC3\ MM4BO@ICUUJY]:L3%KDSOM MA&EK%;)'ADD.P1[8`:]A#-,@\O*)7%K.0@PD MLH*_W4%WP1M:^%&LL;RHK$Z&\7I'OEQ3:[CV=K#F@R#I9_M)EF=5):2R*+R1 MHAEK+F=YW",AW*6[GB'=-:D:6S:DHE1[8Q+4W#T]$`L;FG0H2JZN?R/A*]D1 MC=?;O$.M2`,FD&?4M[9#/*>@K/LY(8T^DHCQNG\,DAN^_SZ'5QC8&;Q-4IRK M/-0+H@//J6-#`[$NI?X55NH4%#B.UTEZX[WXK`$+JY``649"$))G?ET-Y;NI>8A#JG:T$)1;*87:6+EQ9(NUZB:SO>LD,UG29( M9Y:M'EY=NNYKI.NXIRE^6W6;<;!4=`94,;="U2:SH>\49W9M4ZJAU==VC1L] M3?^D'M]Y[:=!(%-#+[R*PW6XQ!T%E\MD0UZFG291N-1^Y:\$R>%;126$9&=J M-194@T$Q&CPJQOO)>M5G767:*5/%0[TW5=R$C^2[6?;)\LF\'T2A70Y@MDS# M6Q;-0)?),%NL^:"&D[-)`PN7E4#,T>P[MSA()`!'8-%FMEPD3N+B\'J0Z0N, MZ%#3I*3Q'?,H"%.2/\?%YHYCM(%(.8.,[*FM#;B]2!!D9.=C'@&8D_XQHWSXZGU6SQ!P9'PK=%%F9DJ?P0`$0\!#) MAN!A3GDW#):IVA$PB,S&/5B"%)>TQ_T(R*9T(/Q]4SI7]ST(R6H=L%&XOCP- M(*J9)EXJ(*AQN58+08$H0YZ+;"XS^&&#U/SA767A.)`^M8E]O'-504Q:[[$8 M"^C@Z8JB%N-K-H,R?8Q-Y.4U7&TB9(/_@C3Q-2X8;&XN8^Q!6DR9>(?E%19J8S8=3YW7C^X!9$U&,C.7__\ M[=.]O>^HS'BU2;56*CIK#4AEF$Y5-#LF`A/>05I.BIBWTD[9DM-3$90-ET)O MJ7\UW"0'WQE<1VAT1KIT!5F&IEH!)`:(.1E[>YR1RU)27)8^!FD:$)<95ET; MTLC__L_?_[2S M`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`<2AO^G'$0QO$VZSF7]5KW:<(S$-S/C7,I.%8,AR? MM]A09!!H;XZL[JSWW2M-CYU<-S0-`CELE*>.E;@5GC+?IM%/Q0G_AE0S%P9D MYOC"=46J%[W:MMZ8S_$]BZ'Q,[F+S>/5X?TM7)+^5?A'W+E/[0)WF:H6!@@;+GGC2JORBB^OXK_#L4U/YD6$M\L.'14>_[X&B5(MTN%3=?=Z3/ M1>3,GY#9Q[)QR3R\A^DRS.!I&E8[X&&=*9TKLM/P90('3=>J)<=/*\NL&`3( MJ"ID18IO'R11%*090"L&&?[I!!K2>-\9;C5*+X^]-0_SOG31>3>:?'^ZY^/# MD_%A32O%[2':^%]*\)@9QIT3T<]Q]&-\;-T&$"TL^M7:(.EZ&5]WB=JVJ MYV4)`'`0``9!-,H6(GWRV'/=/(\2WU(<'K@X8;_-_.HJA5=!#H\1WF&^+/&1Z34!0^!=ZMG='%05L]H'CW>4F47*ZV#OFLIZ=5N"1'<<4UF_+DSR]K,BQUI$U/I.\&;='2;J&8;Y)*V2G:+:*T'3^1'C\-4@V MZ#[NL1M%'/Q$GN27,I&]-6E%%XP'OBH:I`@-*#.U9UU^"CWH3C-:IO M7`6/]"1WM"7!'O6<-6':Q.*W#$'\>/?!9?^T<7>:FNMJ5=U6-'EV'9!JI#]N M8@B>[`53SB%(ZH36\#C#J^5P9HN;7MS:_=*\ M.?'\KWV@73*=$+:W#=$?UO;#U*F%NKGE//Q0M\)B/D$C1B_,K6&_?`Y6B_]P MMR(G33L=%XTF6`VM;(&,TH!6V%HF-_`@Q.4C+C=$XZ7):K/,L^)/A.I^$(67 M*=67,+U#2C!C?QKU@[.&A-O"6+:7T]HDD1+,L\+>9TF&3X(UV$N MUDSCG$VB:4;?;;W>"0$6$E5&O@3T4T^Z3(%#O%S(UN;:#I#@(=IV-2)/0+>- M0_'=T:_GBN16(?.$2-M#TN$/*\L;`/9`Q9FLM_4X"DX^F8_`CA0;B;JKKJC% M@)>^):67>[S<=*_7:3)/)RJB[2F@O4@7/FP>##%16H"=[%_'EFIK?N6=ZCUL M(>5/IW0XJT'7PH`ZA-Z@DZ9_2])OI[$)*[P["=Q*+F^O8N#B/P:KFB! M2KT:DAW#W<8NY(A(]A,25JY2`43./6@&HC(-FKQS':_##+28B$#"L.Q1F(8>[_ M8)1SK*:Y)0LV+@=\@4N?$Z@,W`G,Y_$*W:ON0MQNX2A)Z2%Q$=PWK2F)0M<$ M.;:2[^U.H8>?1)X($)PCTI8E(F(E-+!.4F8:``+0JS?6C-VERC(@G<-J_88H MBLX8`N7SXI31@4/F(ME_HEBE1$'PWSNK+,U-*FL\@[\0Q!N=LUY`SY*OS65, MYMFAM"(W_EK0\O0AI-,)8RH=JS=.8=V_QFP]CM_%*0PBG'/[&C$8W\L6\0]P M=057QSF\.8Z/@C`EB6_DAS9,.D-,W,=GS!"5/6$EP`"2R`H

!;B+AA4'G\;L'O2O.G:RW`L&@-V>L17+8(`""."@2"3;AUSK MBP4ORYJ$,W*&%??,,W2M/X#9,@U)BK.&==0-P5W:22<>/;?LQAA1$I=SJTJ) M,Z6=U;_Z`>Z9-V$,%^O]%*["_"A8AE&8;]\&]^'-YN95DJ;)1_Q&)KA%O\FW M-O2;UOSNCW8=]"2"B$%@O4:!@`+*##`XH`0$"DA3*F9H(B"\IM.FX)"S6C09 M4['M!G&VQ;@]L8<36@DQ7_`@1X M:7=XUM*CB);:EE"E]0`SVG#R,)[81F$(/92-0M&UME$H^(>Y4>JB-<)&X6AM M&ITQ?IR-\%DGZ0VN[G<1I%_3;:&RZVL0S)YN&V1+"\#N$= MLISR!.1D-(C0OR,23KZM(+/("A:F-,1/YT%&FIP&&(/L2R_6EG6QJYJ@VN*- MZ68[S/+PAMB":7(97-+;#&$EGGJQYN8E.)V5?"/U50ANV6N$/OK)<7ST&]Y5 M\WB%_GBFM.=LSN\\4AYEFUNBM8$MR$MV(#+C:D;KY;F=WZ06ER,K'J# M+.N'FQ2\V@+^.S8Q(#/S^17T"=TDVSL)$9Q,(K?A`NR=&>RDH-/ARQF=4'),/*QSHDM61SDG-9>0_M!G'G)XF39?FU!V?LSL60\7W7WDZ9 MT[P`JY'$/&^TR%L[@[=)FN.4M:(?GPVYZYC-^<53CHNL8E>9-ED-`<48[]+5 MS\A:%:[NQ1N_O`O2>+')F2+-SF`4D$;"1:_'^?+#)LQ"*L'H6])O&)M9Z0K] M->-UM#"&*WO`,_ZTXP=T^]_OC+X*V<4%#<8E;`JS(@-L+F0Z@+(A*C\=H/,! M-"$H9@3SK&Z_-$/)[A,@K$E?E?Y@AT?&E<,9/OMHNG`%J9OT77P;A*M.U'1V ME39L"_:\ZM[1Q;5O@]3@`0JP=[/X?*8V3!R:8FY$3J.*C0)H:'(6RQ(*_BLGOT%U[?G29RC*C-FM MQM$:A'/]\L+.,2%,:'1SEGO)9WRHQ_GX#265I,U$6W>*U,#3SZ/,^#P`=QTF MTAGJ0Q'71(^_]E6Z6HN--?=S[]H'I3@6T,^7,`[2,+$N3;6)7/:"%&(@ M"["P3YHRXU5B1"P22DIK@0/4SD4*@VR3;HGC^"W$+C\;XB&:QJF*$2`@*US# MOF1!@O?T8T]]AA38Q(N(;)6CJ)!#=`[F6VS0)K&3@TDXH9^#282*S#-$/@75 MMQ,[F+K8*%0WTK4/DBJFP][%V2UIC8DV>.M=NWI(KN;E)8LO'5WL2MYW$6_/+?'WD.^G)Y:?'E8Q! MM?95P@6:OM8C-7EM'4\5<*='43EM=U=$__9LB_BUIYFU50PY0.;+Y>9F0QPM MI'TF/I]2>`W1O?P.TI:9]O2!^N0N;T#*6$E$B!O/VN76(!3=<5FK/8%Z\:-@ MM"6!%T@]F@VX:,U7*^)#"B+L+CJ.]X/;,`\BBS+:.:%3W=6)BDP8RS'$D[@3 MQH`-$TJ>%\%386E-V'KI,*S"08ZL*;C"CNDPOLKLB99D)K],QW#32HS;?`74]`Q`GI6AT-C&:YU3&-^H2DCH>.D M">E'QS20$)HN8FI.F9;FF@0_E\87,`UETACB[KI4GUB6<(@^HG?C25R7Q/2M MLE?;2W)^76KC(,PJ[J3K`R"LI^M2&Q&1SNFD[O1I.^"Z5!1]H;:;AAH2#G24 M*"1%0)8@5-05HM].X'#I(GM5_4^V0K>O8F1H"`M`]E'Z@9':PAN4_OYV$EQ$ MBJM![P\EJZ0K?*2X:& M2'GU4OJ!D=J'\I+A(E)>!;TSW\IK$)5-E=9AOCV/2\(,$X2ZS M/`V6N9(R4P+DS.VD@HU$TQ5#B5>1#@;<:/"^&._Y[J/#N5)\E.GB,"N$.$1) M0A][='T",7Y(TN_"#.%UE*0TN>\BN(?2D+@>%+^LT\-5[$'6))A+L\+.,WP1 MT\>?R7^UEX=7(&'\AA7RZ[:EMIK"6XV%N3Q>C1YRU].6:\FNE,V7RW336$-, M<\[?A+1+6@BS_6N\JNPXGF<9S#/T!?=+F5"-`-JCBAH!^Y;,C$9L9TJ(/WIE M?.:_\<@P'HT6Y=OK<$9"RVTOA;:"O2D]%\GY=-J5NK53]:O&"*,V6E`\Q\M< ME]EQRU!F42S6$JRD+J"><3Y=;SVHM1U$2C1PI^C-*V]U7/ATP7GMX^N_AMF> MP_P,R\W"I!?4),WQQXH2VVM'=F5>_[7!L9717P'[C*T5T0D0)'^7Z0IEMD MZ)3-6T2;E!16Q@$=\A=N_`P$.2A`-'OK>"G!HK),$9LTZ..TH,`!O,R/8[2! M2>")?^]WN%[#91[>P[#FXVTQ2L&"BJH,U![$3D#)6A0P::I M=03Z###XOG?@(.*(I&`$:KO6H0=P#9%:65T$]]2Y=P+S$T2Z;GU:C`)H&*#C M9@"-Q.]"L*BS)EQ1E'S$YPAIVK=LJUU/7.]:L9BM_31R6](!(8!5#0DZKN#J MU?9=A@_C8]*@#ZF;.9:UTCLKXB!F%E''!0S<)NT1!@/"^#$H(8$*E._MJKYH M$1-U2::=T;&"81GAI_W-#N/5`=KD]0P.OK!(!I=?7B5W3]!06E,$_:592D0. MUI$)($6@+X6#M=I$7P/\N1>SNIWQ.4PPKXN(4U_7PL6 MK;&OI21S6Q;5-"1+_O,SU4Q4)/>D^=;#>V"2/P";CNU;WU(Q)NE$Y6C_(%U` MVT!VNLE'ZE1,<:$IL@P;D"?DQS/`882N700GW^+ABO:CJGDCOKM4%-9ZMO.M M<:5]C=CD9>4'F7R3JS]%@-Q.C@8"/-*WTNM< MEHC%"G1PVB5&&)(D/\WFF_PZ2;'XO,.=$CD9.D5<*OMIGZ9(5(F+D_T$]T9F MLO8+#*^NL:C>H7O:%3R#N,`]TJ8X<0*_@]@$$5[[4]U;SXQJH@Q4.+)VCKPF M`03/6=G0'!!4"_.NO1+7!Q@Z4DFI MZOE-LL$!]*,D18(8T]O.VZ]U>5!5'>)&#ZS2)PN7V`M[G MK]"I\7M7(UA23OT4FR)XX`S0H>`]^Q/#``2([UKK/6L47E!4R.*:5\53NXN$ M)&4BK-+D%J;Y%IL4Y!DN^NGM38>CK>P$G2>`P0`%D!FQ(M%N)HZ8`I)GUJDO M6<1%78(9!4GIV^=]B(VRZ!@9>_<_P>UP4TH,UF&05(B`K/<=?=K./@;D:X`^ M]Q8D[61*86O)5^CR9BH_-$@GOE7]]:+)>4SA<(>QWQN=^H+USE@QN9R:6];\ M6IX=E[X/<%MD=>J;].3T&C]:P+DJ&CZ*FEO#8H1?+7;$X2EP>-6=97Y;07OE MD\,XDY;DN#:OF\'RX_@TA?A-5)$PR9XW%R_*:118WN*FE6@`PA@PD(#!(I)+ M_?T4G'=GB!D51#(TA)X3R%(["N,@7HZ1I59"FGZ6FF#1&EEJ4I(Y-<)D_1R1 MV.$^:J]@C/Z2XRL@6@;2-TG*CGI\:&?[2###?)Z&&5K'P28MTZ+0QXOU17`O M$X+>SIDX!RG&-96X37^*IDQACJZFY'ACN!7Q'"Q7!,'2O",H`H8=H.BQU*8R M8QWAZ/4TLTQ_D3PZ8;G;G'CQ"4R/5Z0QT?J0P&"'(A85ZI[2#RZR\"&6QQ(@ M%3X5;]YT3*5.LJC;-PK4-2E+S?D:JG;7-$S()=Z,YC+JFL.53:6&3H\WB6MJ M7L;!N=&^CE`]=C:<37W4<)O/C?$XSK(-7/%JC[SN.X$?R6^D1@]-0*"CFR<1 M@8`/I(_T`U]%$[06*M03ZA1RRCG!6==GGW1:)I7I,`/S/$_#RTU.$D;09?HT MJ"7E>LF1EB]7Q+5>ZCR,5Q/*.9M]=^GI9/!^AEX813[YR?;MEQS_7ICY2U`VXQ^-8'4?X:OU#RNK*284MQX(\"") M9X$'.M7HA#%91*(TD,8#DEE_3B)TN0Q2>LD8X3(@!NL\F;6!0+=A47Y,KX9^ MKP&=?*G;&*)%NDRGD#LKBD2/,[B$X1WV6^AFSY3.G"J"S@'SG5.AM7(]/X^4 M=&[5/L'A)(F3HAP1=:YS?1_DF1'\L#+\P$8^]I^P(%V5--^@APY32!?@[(ZL MQU>,3ILU#/,-MJAC>C>UE=R9J9JB'$XD=XZY`E2#"#XM48>L,(H<6!&'*02O MZ:5P4/2ZN`,+P]>3"F`W%JOM=Q*$L/T4O$;G&T'T.HE6R&C![[)R:3X3-ZY\ MK)9OO?.H;SDB[JB1P.F^*AH_',!LF89%1A32$V&V6)^BV2!KEMM[IRL@`0X4 M81@!AO,->'#@O?C%J!]FZE-!Q%Y36KJU';H3V5MYZ?Y*LHE(W,@:'Q`!9?7< MSN!MDF*;#K\G&R,2U@G=73BL"XV>1#PZ!I2#`!TU@1MQ-\\:N7?RI0\3G#-X M%>)VQW%^$MR,4!]9"-7)&2";O5L^JF\!_MAC:94N?M2%0;"^3ZZ$X_SJ*H57 M00Z/XQQ9?EFX+/LV>'V75XLPE$B"$LMFZXRIWN-L,AG]V)U`_@QR> M0*K2XCR+;:@'M?"/3L>=7F)DZ$R?YAX8E0]6?.D&DN#6`62MY`E=+K%6R(_P M=]+.'\Z*<+-6$-1`+/'Z5&O<"'D@DG,?4N!6SM^$,;:6R7/OHV!)>X72LIWU M9YCBJ$-,;Q%D."C&SXHJIZ*7J7["$`J+%,JW+^5Q>I'+NL^9X.13L'?&IDQ;&AUM^BZFQ!!E>' MJF<3K'=YXGVF1!/7P05A)L%362(,^_*OP6V2?2'TOH-!!K6 M>Q4\@`&R(@X`77DH5(#!X@\Q8.K*HK_QW(WEA5X[T';OH7);:N=:B@TNVX#OJ8OTZ258DZ8I>=[-SI"_DM5,R4A^%C"$^ MY6(4P,-\=Y"4KD>X>7I6;YH+478NX9*=AM_JA%"=Y4*(9N]M+\-]Z^]!:ANX#SM&X6`R@7X=;+1CM( M+M8TT0I;C^?PBEC(TOJI9`16L-484`SRZDR3KT6D6OM6[CJ&)?+HO0WN<;>9 M5TF:)A_Q:]+@%OVF*]E:XO9D@$`)"12@)N?^E*U9U0O:3;.'5-&]%8HB#GSW MT7EA*)+&<#J"\).,/XY`<1OA=G5.NST=+O`-8)-NR1V]4]Z*+XL*H-/(R6CC M+^*>;)6./1#E!7BQ9K6YL0@4S5-ZR@9SW@/O:N@,D,'>-U7?ZD2<4J/(PTBH*PQ'UCOV M+@@C;#T>)>EKG*)N\42N3.^BT7`Q.N@J,?"A/##@ZRH5 MUH-%$62"Q][BEO:@[VS?,:DWJJS)V>-4V7%/5Q4>ZGKF)H>)^-+76(NI$Y2] M,:O*,![&JX,@'\$=)H7L,K-%AH3$558\'.1+:J(1``_QF,_2QZ3"C]:YVA&J MK19Y<1;JK?*@G7G+I2@HEEQE>9FMHJM^:ZX*N"2NNMIIPNO@^R2K)L-I/L81GE6_*2YH24S.*ZOPL\MV<+E1^`]^_/_`5!+`P04````"``N8@I!O#-)7JDA``#A0P(`%0`< M`'1R;G,M,C`Q,C`V,S!?<')E+GAM;%54"0`#%S0E4!`L``00E#@`` M!#D!``#M75MSVSBR?C]5YS]XLR]G:\MC.9YS65HHB M(8DS%*@`I&+-KS\`+S(ID10``@3HX3Q,$EM"-[YN-+H;C<8O?SD\/+@$$"`K M`,[!9'W@#OXO6/SMX/!@X"^6][9[<`4#\EL[<%>`_`RN`"+_)K^?!\'RW='1 MCQ\_?K+)1['M(H#]$-D`TQ\<'![^XX#^][__\PLE,D"`DGAW<('<@WXX.SCN M'1R_?M<[?G=R?/`P'AR\[!V_C+]$ON&Y\/>)A<'!X\*#^/V+#+''"?)^\M'L MZ&6O=W*4?O!%_,EWC_0'N<__.(D^?7QZ>GH4_7;S4>P6?9`,>WSTY>/UO3T' M"^O0A3BPH$T)8/<=CGYX[=M6X/J0@:^#TD_0?QVF'SND/SH\?GEX M_"-&[N#@%^1[X`Y,#R+6WP7K)7C_`KN+I4G_3H M&'^E/_E&)(9]SW4H]E>0R`7[J\TT`F1!3*9&Y7=$?WE4 M]?6C5+YRN:1ZA\`<0$PT+J;)RVG1$!&WLGD]LSRJ&_=S`+CAS'WW2(G`LR2^ MW5J(2&T.`M>V/%R'V^VAU#`_L/#\PO-_<`L__1YA2P9/]W,RV[GO.0#A\^^A M&ZS'9(B7/CIAX:SBV](T\L8/F)9(]#EYPJ+#]5CI]F2)(QJ,G6Q/+LP]'M(] MF28R&9*'?$Q?!O&^;?LA#%PXNR7+S'8!/EM'?UNSL%/Q;:G"&5L3#S!9MLRG M):IE/"*SA-*/*\"`74TVGY>HJGWB(UHS$)D^/`H#ZD`Y1/H/&#B!3S?G,`!G M%B:[!W2&KD?^Y9Q;")*/X%N`HN]%?#$IES1BLA;+?;A86&CM3\D.2>E;<(WO M`]_^?;2D3B-FGAK;0!(%=Q9B%P*,[\&,>GAXM*1Q`4$J]J&&+@Z0.PDI\5OD M.Z$=X/1/`N[`\MP)BASC>X!6+@D$DC^99ZR6`5D"INMF"`++]5A76?)IB;8F M'I%YF:)N0B;YQ-$RBFX/ M[;GK;=1XBOQ%+?T*_'(1^XA$A^]?'/^4L<_BTKBW`;20Z_R_K+>,+1*.W8$5@"&X]'T'WX!`B285T3%&B79VE!SV MA1!EE.>`L#X%"`'G.@:WE+6(KT@"-;;!##MIV-&`T+*DM&V(XH++(94QP\*R MD['@&A";$^OQQ"2!6D\8II]8"N55AE8CQ52UW4&QM1950'N&J[RQ<2(\; M+%KXI%",^TBV0)9[44L$^KHY@8Z".4"%4BM)\>:^D*6G`75&+:0BR,]3]]:T M=5QW34RSBB531*8-7F`A/(G,WM25F9C`J/K<^-#/.K4>`/[K01]&9 M7P`(\/00,#]*7+[V$01SG_QF13X2'7^HT)(FV==L[-DTKE%Y)NI[6B\=5T-O M"?_)6CHC6Z&B0*>,5$N2J:5(I)R,)@&,L.<%LJ$#0CQBLCM<%/T*&^'S4SRV$?$]8:#D#`%[?68NJVT M00A!&#K1O[P8;^>W,$XJ$P4<3MK/C/9+JQHO"=T:^(^.GEAA/R7*?$>W8\&B@9O3 MH>Q-## M3KP;3NVMKD^R,2;XDBY@):MYE`JR&)"AB_($G2D M]+VIXURJ\RKU2J12&W>=2'G>(Y:65@:_ M]N%L#-!B"":*X^422IHV-Q$G91]F4@[EZF8_,A-K+/]13+.%DMV/HY3K).+Y MD,:D6T&M-4$%"W(R3N/J[IB*MTH#$B>5:ENR06I*H=1,FE2G2=JQ;AAR)"(- M[Z4$XR2&6?@P>I/VD^6%2BYX[-!HC>3*49+1X5XLM',;>62]SD@;5T MR>+,<*@DQMM/56\!=YD>YP(]!N@T5NN1R"=%C37$3$) MG1=5;4F;._J6,'QZVSS#.;UP;ZMIHLQ`U?R5S0*=QHOK8P0L'**UVFVV@(KV M;`Z+\(K0$0@CRAM#B%YD).SD/`050BN@HEUHY>J:OWJVBX_$$K_:42!U\AH1 MX5Z:FG=)-G'N1Z[&<:YY5_>_W4:XS4'@VI:'NYO\W4W^[B9_=Y._>JUT-_F[ MF_SMN\GO>?X/:E`N?#3TPTDP#;W="S@JZP.X&#!&[7;VGEQ6@0]4;4_;9^(O MXO",4#0[)W("T^<5%&=\2\FV0]!,`&I+&66XBU]+Z(?!W$>TQ9IBL>Z0:TMK MLG*\-":(=OBZPCAL2(8)*>U9!T$)IDC)N08J27R*'X.II-=6018]]%+SYI.$ M;&W,F_)T;4+&$">U4G"%\$@X#M7T)H^%YQ?$EWO!NP67/HF2#"@A$\0X;/?F MSK-/"?$I6/?2CA&!?)<8ZA)#)B:&-@:$/B&]>=&^;P?N2N"R'.M@QFA-H7/# MCHGNVW-_EO>1>+54^6M)?%?F-D^QX+%_!VP?VF[4Y2BYU^+3SCEDAEQKC7O0 M5@F/'S)9]XOY'@[!]')27;.Y?Q1MLA-5W>@%D?W@Z+:?Z964S06SI%M<\IB- M"HNZCZ06AY99CXON\Y2"I^-ANB?F"$7;C<`C?_=`!GH MMDG&+##*:9C))^A;Y*]<3,A?^&CWL(VPN.GI>4<@1BO&.^D"P^IR9KD$*@*7 MKJYN41[QS,+Y2_5*XMIB2IJ.KX16:!E833>"&\PM.`/X"B;ME:`CW'*%:21= M?3L$G%E&:&J\AB3GD5"RD=-T/AB"^$_"<&(ITH863Q9#2;3)QX"VAA(\FI[O M\\>%KX#[)+OL?9?C=)M0=+.VFJ"F5Q'DR3N'GK[W+LL93)IFIZY]8?/L9N3. MQ$GK%8(-;X&=0;FF;+6D:G8[2(GJRVG)WP,V0(I[;C4R66Q=K"JGS9:VE$!' ME^O'*W,IF$KK"2!OW6^U9&K:`I20?R:VH`Q<60V#1<^9:.`3)1$MHRIFF'4]H)`+@*D_BV4=&%<-UJ(#XTI,='7!3>=!E"\Y MS.G;WT,7@=)W'50L9`[J)J1W&+0[]T0&![8&Q/8[[)Z%F"@WVP%D7!<.N78BMO%U;?-.^<*$%;4F;=M5@ M+=JT*S&1F)@7[`6T3-1R-$W;H](IT?I?PHFJ5D#[B)I14,2@S?GF0'NQE+E=@II2K))$7`"@Q-V8KV`A9HKHF0_IMD#^3JOZR9:!"LZW MR\H3]@UB@@/%**_]@$C,>]=RD2]\1)0J1/:0UJJS.KH2$W\95P3E1E<-:0D'-0U M!U=2UA=#Y%6E'9I>@CB?3H%-MCH"071:<$?,U0A&E=,PNG9*!\X8)W4,-%R@]2(M,WS=:[1&XD M+<0+$5&P\1S$6PJ]+,&;&M\SC)Y=5E19TT3Y/FPD7N03+50B`P$<4$;55")E MQM>89&-3TJW7Y3/(:&L^F*N`426C/`EM%P0$Y;0%D(Y;=65VXL:/8JNG,TWH MU#U&E$3*[$-&67@FNO"V\=>SBU/S=R!Z3F/LI\?CT6DY=IG/,43&U9+/E+L@ MHNU4!%)Y72N:Z:JV^Z+6F`SSTDQ*@$KLMRFWR>`RX"BK68EX5)GM4%L2QT9<3[:+3.]`G&`']P"M7#LY MI:--;F1+PM#9# M*+7S"$0J_<]5]*"->S[9U M=2&FUH6HUE:.I_IJJU?W6E\5Z-UK?=UK?28?%\FV1$K"5=D\&J.\U=&M=-'( MNK+1G!O8XWY`.=NB1\R;JQZAJ]-]AOX8D](T58G;.52=0]4Y5&UUJ`I-B0I5 M*B84K8)?_G)X>/"?SQ\_G?SW/U_L9?CX%;XZ=?YXLYI]7<.'8?CC\@TZ??/A MY6\/XS7VWJSL/WK>OX*W#X/K6^?KO[V35_#+9#087JTOQ]^_G/CW@_#T\\WJ M\N7J^[^_!Q_FR'+?W'PZG;WY[?O9R^G?/_SZZM/EP] M1_.W'VX?1Z>]G^'PR[E]_?H.W?QV]D\6_/EZ'WZ_^%7[L__QQ M??[Y`O1[X][5A_5;^\OIY]EP^-E__'GZ]F[P\^!AXOV*?GW__K\'@_N[PT-3 M5E6EIU>B,U*N:C7LK_7X;V7E;I'G3F>C8N2!CP/\U-QITU=7R+>31:OV)M\Y M@<8Y@9+UD"<'USF,GZ[M`GRVCOZV MYC_&NW=GD*Q`F[Y0NS,L7VZ(:20)NUOG$!GG$'%I$5HKC4_@NX"C5TBM(3&?@KL"M1[QC M=8(78<.,[;\Z2RR"KKS63F*+WT>`N)F#D)"%]GI,PR+B51*.,6$Y^J<732-A M6.FF(,Y,.XR$.-82&T*)->1,.JW>`A1I>0/*L(]D"PS"7M1J/*4H8_'?AQ,, MOH=D&N>KIVVJ`=FR$6[%HF;$4%9OI4938O2,,`I0,/?5PZX'19=I:T^FK>M! MT67GNNQQ<[Q,<+RZ.XF=>]6Y5YU[I=J]VC(S M5W#JHT4$P]DZ^653/A47*\:H(JLOQ0=TN^XS)@F\Y$&;,,"!!1TRR0?B.@8^ M=1[#@#J2M)S:&;H>^9>S?3X?KP*!O:F*^#A'O%]*G,L]DTJP2YH]/]]-A49V MF3,SMN+.M>M<.Y-=N\HSM8PMBLR/"A7C8\`8M:MTXSA!E>6\,0O_?#H%=C": M1GN)NP)DBUDDB3KZ7-;*\NBI#)-SPSB4X6?-K("(WPD0E-0>C4J<@1W%:G"A MEK+0BHI0;EQK7`'P`\NK7=S=AX'K)%IZ#^P0N8$+\/FC[84D_KH@$,3^8E(" MM^,F+NC55!7J(8%R^\/3 M,,9GV:_F30M8//.S^RZ]H0:]/YLA,",2N"*3=R%V[:A/2CMM>=ED.C->)6GQ MK-2NEANEYLE.1:.'UKG;N[S_B=WM`D&*M^;P3+3(F1D^$Q>;=49_7MO,+'-Y MS4DD^M;Q05D_#.8^G6/T;ST3C2I71<0S4&")PDQ55\H1FK'*6[5\VZK2?P)# MK5SNJ?;+.5H[:/*^]EGR3DIR[QR/"$-6?"N=?`8,71P@=Q)&"3[D.Z$=X/1/ M@LW`\MP)BM.#`*T('#CY4_@.=PV&^E4,"3V#JXR)[J[W\ZM1;TISF[O_O3TC MY47NA00-.1#?7YU<#%>]5_\2#4F&_`AVRQM*3%CA%XUQ7*LTBV);/&UI#W3Q M2B%9B?Q2*/QB:Z10/&V)KV?Q26%,KUER@)_]O!FG4/L`S\U0UI-48GM`S*'" MRS4Y`N;D+O>)J`2@3'&=*4%3<]=I;D!P!U8`AGQ>=L'7S-&#PI"S:*)Z7XV\ MMSR`$YX(=TI6ZA8)7=M7N9;EE'L;$#FO!0@)YQ+YF/KX4SW5-+(%2>67(M&'O*H1'4M\79ED] M0,N+?@.'BE3NV'A-.S@A?BAR_,E+:PET^L94B):-IGE`6,%*DA!L2 MY47O@_HK%Q/D+GRTX7?;QZA*%+(/J=4X[M':31:1`Z$:&8SMQG=B*Y'PI];+ MR!,P/,E4@DJ-VV&%4FKN/9TA""S7Z]ZN[E[I4<7MM?[3?]7:VL"3/M%]/55G M_$^#&Q+>E1Z/9&"H=W9_#3`>SRW(<62Y]16]4.WH`T5I>U(2S^2YP(V8*SJ> M+$$V^WFM#EPAJKG9E!3Q&+E8&F[-IV07*:9D"O25/F(92KI696BZ*;L-$/54A7D!-#-JE*X8N"K/6( MC00$!$?+B],.Q!OR$7!GN+' M^#E6/@?,AS/:2F(()H%8&%@]0OWPJ`ODC`ODF)2&/1KC0OT*DJ4&<'!G4:W' M-G*C*RJ[,5F)NE9]WQ1[MN-*5DY:6K$IWR44XE%1=C@BMZVOZ/$?&/2'(KX] M/5W>XO75V>B.)SK.?%Y+#,>(;VY>6KRM$D8YXN7J$8Q6[SV3SX>G)EI$Y<$U M'6\T'1!%=(,+RW8]-UA_M![=1;@X\Q'R?]!V7-:2_"98J]CON>BW(13C`U26 MO94F^R1\4/O*&!MA4]P4;G$78"CQIHR0J*D+>P6)YQK2&67-8C1-YQ8@F^*K M)O/"0;T50N=!4W*L+5'R\7N([@H\L4M_'"6@$XO5K#*P,&3&/BVH'4R(BY<. M2ND#*,B]"PW3EX2AYZLO*>+R*AVUY/)Z`@\*/AV2DZTW<]IQ!SQJ?@<^#O!. MHP\LEO>31:OK\_#\$H22]5!Y.X>NK*,KZ^C*.K2@VI5U2&O2EK[?G;2A7Q$O M@C)_X:-+\ETU%Y]5\=J2`F1ULM+7R$5T2L07G_IH84':V@S-0%"6.REK!*." ML"%;;J$2J4%:7D:M6>L5KX2X$[R1?:4+&31EFU)CI8IEHBMS=XX#=Q&E$9$_ ML29Q2IF``U:4X=$TLRRBF=P!VDZ.MJN,WA&(9H0C\TIG<_&5*D@?.N2/$R8# MI9*^P>D8I;#+2^KI5Z9C75IT;/0VIP9IN=D]_HQ!GDF%%YE+*+5BXRE#2=XS M;F+2.U\L/7\-0-J]KW!_O/'A*NY['&E@=&4T^WN:Q;KQ@Z^TYY+MSR"M+E:A M`.J8-=EJ-"`J66^G->LG1_^CW;C1AZ:WBP3?AI\<_^A M3WS]1?JHT=*-NRW36E_V$%X1?8-U2"GLXH^=26K8HLP"9U]W:]7&F6/<8+UL M6(+2GC4S3$]CJW[AH^1']'-*]MR&9]".9GU-B[7&.VEZ$ZAE;Q%&8)C_?"X3 MW^U0V69$*/$M-"%%O46^#8"#+PA"C;V#NY]H2TX.&="K\6+8;H#:?/U:3^1M MHZ1G_!U8^HA&5'6;%/&,U_4=>I[5:`(ZU4`KH'-R,F`#Q`O@>U.7>`H?,*CE)@QGDR1^N4D48Y7ID;%D%1R\]5: M:2%/;%TH^?19%!7Z5$'-C`5=Z?-4826OWDF3MT/=';X;],DS.B1&F+@P8JBN MM\,Y9%=Z__R<'3&MZBKLNPI[_;7@785]5V&OTF<[MQ`3>84%/V457_+)FB*[0G=/!R#W!IN4[EG'B4@GML8^+&*M'S(Z:K#T0!-X1YFB4B4\Q-XY9,@LL) M9QS2X+B-%QR)A>$-1G%#WXXNF!,C=$XF%ZRO8%2/2L<626%7C<=WPYIE(%Z; MY@#W6SS:'9C1]]8M&-Q8BXHH#@/[IYF_.B+?C%UR\I=M3[QT5#U>)H\(J**7 M@U(SV4L'3ID9D\_51SDWFA;;(0)N'H,M)XX;T;AW:W!!XEK+^PHL=`Z=(3%D M]=$M'5G?57H!M,OQV7Z#6=1V$!]MXH M)9G;<.*Y]H7G6Q47?OD$D1VR-1:G`(W,K0,AL],G/#B4CPO/DJ#E^>$T170B MT&[AD"FCYP_)<^-E.E%*A#<[:GOE"#0N"NLR(5SHEX\>HM,2C5*F<)B,0L3 M#__)]T("`5I?N!Z)-V6AOSUL^W1^!YAL#:S05AF/&PTW(([GS$?23$Q^T!;Z M@5NH9,LXZ]GTS\#S/D#_![P'%O8A<**+^T@6\&7#MU`$I4AE2R[KQOMQZ:ZT MT+1XV#89FQ)@4LQ/1(U-.NY3O'M!?B+!OI<-W**-M12;%/4:`6=^[/0ZA0+D MLT.WQX.O@"<%_]634UF2Z_[EB(Y)+PY&__Q_4$L#!!0````(`"YB"D$Q"+#( M/0P``'-K```1`!P`=')N2;3!@"T/"G'>7?`G(>GFZ'ZG5:K=X^Z]"`5T2 M1@16Q$7=":)G+]3P)2J@,SX'A ME0-5I4,%D=P7#I&Z`!4*)TC__?,?;_4@9X+H(6KH0E!4]_NH7$+EPUJI7*N4 MT5WG#.V7ROM!(VCQ*&O2&9`A1H]#C\F:$DP>[X5#*H&9=+#2PQ1UL])AI;07 MUGSL"H].JVITNN05%WVH6JH4*9,*,X=$]9D_3*[M*E%4DQ$I0@TBJ+.'%!9] MHJ[QD,@1=DA&/'*N^X=*!*5<_/3^ZM8(.<7"608XG!6FD()VOBSH1[.1>EAV M3:OHB8%5*)4+E?(4F$?9UR1LY6JU6C1/HZI+->=5JA]WL025$H\,"5,77`P; MI(=]3QWOW?O8HSU*W#A#KIKV%^_KH!@\W(NF#D)Z*F#&N,**>9MZ4#03I'>_IF56(2/O#P]U7@#*J M@H4CN$?L6BJ.!!_!JJ"@YIDJ@@Z66L]K3C\NPIC$NYI!WBN>/)L\(T&^NSPP MIH1)8/A:$.OYB'))[[L+!F-21A/$>BZA'.Q]=Z%@3,?W$LF:%TO7[H`@2'^X M:S>3S9_I$[8)R3WJ:H/?9%!,;F$Z&-.PAZ@;B/V'K59\JD0`9NH_`>L).]"T MNMFM9IW-'DC$>Z@UTKL;-)/HQ1W#ODNASLNWQ<5.EP;T)7%;[,1\7IS48?.P MRC+8>-OY>;/8,D'2>.,%?A9:3RDJSG&TO-(V9$\[`8(,").P_0X;EX,+C#VG6-'I\ MDB3&'',':UA1Z!7I;G?+,1-AMP.8W`/NN43(\WN?JHENN,]%)4:;I=**_>\P M.W/Q07Y`P3#HA;_C<"6'UUS%71;S=94Q/`(R&E0Z'I>^(/!%MT+:Y0Q")5ZB ME=MI?*;QTH+*2QD,V9M$K6LGL4&Z:C?#K?I>4GAIE?6I)JH[<.FX\[5P"B=! MUSC>X'4;>784V"E8YJ"T\B!;+B728-PQTC<;0Y/UN!CN&,C"0`(%I;UDO',L ME!-9T*Y5W8'-5IIZ'*;;M<6>4LH1=!7[NS M828>%DU85+IB?;Q>>SNW\[)C9IF9%&HR[/('Z^SR.V(R$],@"E-O@9:P<+7I M.EQMNH*^_AZFR[RG_^WC^P^5WW_[Y(S\Q\_LH.I^.QKW/T_87<-_N#P2U:-W M^U_N.A/I'8V=;R7O9_7F[NSJQOW\JU3%NYVJ&J\.RQ6?FH.'YJ'HP_E04N=^NUO M/YVU&U5Y6:G\\O@C^]@X4*SZH^J]*56&/[^_\N^;/_OOZZ_?3\X_7I!ZJ5-J MOIN\MHX;O=#\_'!__CLYNVV'JPN:NT!@F3Y^8H(UL M^4IG'+C@J-P!"XIK&^PK`@:9.E#>H!Y\<\^Q8%!%WA!AVAD3$/>_=T%E)HR.`0K!]]V;&3+6;O#X=83'A/#8A6'V83:53: M&IDS_*)=S59_%9_[R6&<3'SJ.@$('>D'&"C$\8,,&J,0RLXP9EF2:6LR2QQH M/SD.E.JG[U9D!G).?4D9D3+4H`SS<5@_2.,`=2M!N[Y&=".XZSM*1O_!4SC# M'NT&^3NW1(RI0V3X?W$E;W><#)-G*425:?+`XPAY5$]"V11]F.U20W$!4(0< MO?CWO<_5?Z/OP;>7QL>*B80BF:+ZX?>P>M($WLW>9=.2:EM*J]XI[B>'R18C MS'^O`^>&E#2XX^ME4F?N.5-436++*B#(6F/U2BXM[>91APAZ1$&7*][+_$7I M>EN#$;7;"(8]83\%B`$1;]G'>&0:%HFGY+2OPJRO M*:(U-;-\&2*+#(@2KRRD'6Z1`WTX`?+ M:@BO4)A1C_?B*4&SC*!6;Y;3/,WCJG?!/<`.``G2S\A M'-;2FYBO$\5-+>B-8R MS\'<@-"$].D_$;.9T!?G-H8$EN=ZN>)2!CWE1_Q,*%-G\AT3!#SR;\35K5K, M]%:7DBAY352KU\&/VYS@CB#N4V9X%O@+!C1]ZL=3E?-NPE9@M2UV7^CDZ$!) M.1(N$9;=`K>)0^@X.'$_>8X&'IO:B@V.`;4P/QOG(CH`5;ZI2L.PZ,X<;#J:`M?9ZN MZ1J%=R'ROD]DQ&Q=IU&S"\&'TPA@75^^S]NJS8K4)F[=_>)+9536X6"X.7.H M1\";"%RJ#H>/>J#\B+TV8NL*UJ_'FRS7/*^&:)7P1O`QE3#&!1=APJ:<[=!@ M\IIL#+6YF+2))&+\+$9[6V>\#82Q+O8!9GT"QX?0$6-N/O?G3#`MOE:VOL!*[3?!;?S0*"K`W>]$R\YM"/>;)HUT7L3T6`JUN,'4;OI:D M,R`W!JS>6'(C<0:,\7<;V0B^YDSW.[,/S,WU,G\F.:PV+WG]M(FG3Q4='F4' MQ-X3Y]DN;").^CQ*.V`M'S#_1*?#+.#35=(2?N&, MQ-YL\-D<[I!'=>IQYVM^]+4UR:RV^(J#=2/Z%\NZ*H=*L<-+GR9SFU3,.PT7 MXAF72IJ):%(3P]U;]AGMZ6L2:ODV:G[$S0;3=NRV7!CIS%T8J:=>&,F/.IY5FM2Y M<=[K$0>.-*8#.M8)X>!IQ.W MP`$?FKAN?F2Q8$OEI,/AN!I/20*%&!]Z%L`.7UC@QUQ'5]<4)%4A;1U^;?`A MIM.S<_!CRS77%'YG\QV'8]G"S4]O$ZG:6*>:2T=08_/R(X<=H#4`.'78YR+G M0FC-Z'JGDR6?OOZ`A0N;N4F[9OIBAOX];BAP],&P/\U,T>H8!:7?61];D2K] MB'<.H(;:,,!ZZ`:O$R9U9T#).(C,QGHU([:)-F".B49H7UF/+"\!G/D%WHO/ M.D\85A?\JSQ5E]/$B8T]G"W*9MT+MC!P^:^HS;+%N]1SO+MZ&707E\$%IN(# M]F#;EM(?!@X>&'X:K$L=!9G?JZ(5^_]8YEN2SV8T]8$&SCY1B,,64I6Z+G@, MS-59"L*%CS(.-O\9U5L0UK+5AJ/-A:SOV`A3USIPCE/,-I4HRSDJUB`EW*]? M'.7Y+<6:DJ3OP2DN4/V1+L8)MG]V<%7-I4.=F1Z8Q-6>FH%IRY,%%74&F+TG MPRX1>7`Y%Q#99JLY/.0'>1R.3>7-TU8[/ZCC<"RHM=>@YU9^@"\@LAY&@EA' M&#O)CPB)N%*]KC">DSLI$G&E2F&[NIN?H$PFE$9& M`Q0````(`"YB"D&FD5K1EU(``&.Q!0`1`!@```````$```"D@0````!T`Q0` M```(`"YB"D&#&&!7E0L``,:!```5`!@```````$```"D@>)2``!T`L``00E#@``!#D!``!02P$"'@,4 M````"``N8@I!Y%F6K7@?``"4*`(`%0`8```````!````I('&7@``=')N&UL550%``,7-"50=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`+F(*0=O1*OPK/@``YT,#`!4`&````````0```*2!C7X``'1R;G,M M,C`Q,C`V,S!?;&%B+GAM;%54!0`#%S0E4'5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`"YB"D&\,TE>J2$``.%#`@`5`!@```````$```"D@0>]``!T`L``00E#@``!#D!``!02P$" M'@,4````"``N8@I!,0BPR#T,``!S:P``$0`8```````!````I('_W@``=')N M`L``00E#@``!#D!``!02P4&```` /``8`!@`:`@``A^L````` ` end XML 27 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (Unaudited) (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2012
Mar. 31, 2012
Current Assets:    
Cash $ 44 $ 32
Accounts Receivable, less allowance for doubtful accounts of $97 and $99 as of June 30, 2012 and March 31, 2012, respectively 11,905 13,800
Other Receivables 1,041 845
Inventory, net 7,224 6,396
Prepaid Expenses and Other Current Assets 1,067 1,064
Deferred Tax Asset 857 1,041
Total Current Assets 22,138 23,178
Property and Equipment, net 5,426 5,306
Goodwill 13,384 13,390
Intangible Assets, net 2,265 2,449
Deferred Tax Asset 315  
Other Assets 849 654
Total Assets 44,377 44,977
Current Liabilities:    
Accounts Payable 6,248 7,516
Accrued Compensation and Other Liabilities 2,873 5,171
Income Taxes Payable 219 366
Total Current Liabilities 9,340 13,053
Long-Term Debt 5,852 3,365
Deferred Tax Liability   139
Other Liabilities 1,382 1,042
Total Liabilities 16,574 17,599
Common Stock, par value $0.50 per share, 30,000,000 shares authorized; 7,905,461 and 7,840,994 shares issued as of June 30, 2012 and March 31, 2012, respectively; 7,406,679 and 7,341,007 shares outstanding as of June 30, 2012 and March 31, 2012, respectively 3,953 3,920
Capital in Excess of Par Value 10,932 10,810
Accumulated Other Comprehensive Income 357 448
Retained Earnings 14,755 14,394
Less: Treasury Stock, at cost, 498,782 shares (2,194) (2,194)
Total Shareholders' Equity 27,803 27,378
Total Liabilities and Shareholders' Equity $ 44,377 $ 44,977

XML 28 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 5 - Acquisitions
3 Months Ended
Jun. 30, 2012
Business Combination Disclosure [Text Block]
NOTE 5 – ACQUISITIONS

In connection with certain of its business acquisitions, the Company entered into earn out agreements with the former owners of the acquired businesses.  These agreements entitle the former owners to receive earn out payments subject to continued employment and certain post-closing financial targets, as defined in the agreements.  During the first quarter of fiscal year 2012, payments totaling $0.1 million were earned and recorded as compensation expense in the Consolidated Statements of Operations.  There were no amounts earned in the first quarter of fiscal year 2013.  Earn out consideration unpaid as of June 30, 2012 totaled less than $0.1 million and was included in other current liabilities in the Consolidated Balance Sheet.

In addition, certain of these business acquisitions contain holdback provisions, as defined in the respective purchase agreements.  The Company accrues contingent consideration relating to the holdback provisions based on their estimated fair value as of the date of acquisition.  During the first quarter of fiscal years 2013 and 2012, the Company paid less than $0.1 million in contingent consideration.  There was no unpaid contingent consideration as of June 30, 2012.

XML 29 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 4 - Segment Information
3 Months Ended
Jun. 30, 2012
Segment Reporting Disclosure [Text Block]
NOTE 4 – SEGMENT INFORMATION

Transcat has two reportable segments:  Distribution Products (“Product”) and Calibration Services (“Service”).  The Company has no inter-segment sales.  The following table presents segment information for the first quarters ended June 30, 2012 and June 25, 2011:

   
First Quarter Ended
 
   
June 30,
2012
   
June 25,
2011
 
Net Revenue:
           
Product Sales
  $ 16,365     $ 17,182  
Service Revenue
    8,732       8,423  
Total
    25,097       25,605  
                 
Gross Profit:
               
Product
    4,210       4,268  
Service
    1,997       2,030  
Total
    6,207       6,298  
                 
Operating Expenses:
               
Product (1)
    3,358       3,447  
Service (1)
    2,255       2,281  
Total
    5,613       5,728  
                 
Operating Income
    594       570  
                 
Unallocated Amounts:
               
Interest and Other Expense, net
    47       45  
Provision for Income Taxes
    186       200  
Total
    233       245  
                 
Net Income
  $ 361     $ 325  

(1) Operating expense allocations between segments were based on actual amounts, a percentage of revenues, headcount, and management’s estimates.
 

XML 30 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 4 - Segment Information (Detail) - Business Segments - Operating Income: Distribution Products ("Products") and Calibration Services ("Service") (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Jun. 30, 2012
Jun. 25, 2011
Net Revenue:    
Net Revenue $ 25,097 $ 25,605
Gross Profit:    
Gross Profit 6,207 6,298
Operating Expenses:    
Operating Income 594 570
Unallocated Amounts:    
Interest and Other Expense, net 47 45
Provision for Income Taxes 186 200
Total 233 245
Net Income 361 325
Product Segment [Member]
   
Net Revenue:    
Net Revenue 16,365 17,182
Gross Profit:    
Gross Profit 4,210 4,268
Operating Expenses:    
Operating Expenses 3,358 [1] 3,447 [1]
Service Segment [Member]
   
Net Revenue:    
Net Revenue 8,732 8,423
Gross Profit:    
Gross Profit 1,997 2,030
Operating Expenses:    
Operating Expenses 2,255 [1] 2,281 [1]
Total [Member]
   
Net Revenue:    
Net Revenue 25,097 25,605
Gross Profit:    
Gross Profit 6,207 6,298
Operating Expenses:    
Operating Expenses $ 5,613 $ 5,728
[1] Operating expense allocations between segments were based on actual amounts, a percentage of revenues, headcount, and management's estimates.
XML 31 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 2 - Debt (Detail) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Jun. 30, 2012
Line of Credit Facility, Maximum Borrowing Capacity (in Dollars) $ 15.0
Line of Credit Facility, Amount Outstanding (in Dollars) $ 5.9
Debt Instrument, Interest Rate, Effective Percentage Rate Range, Maximum 1.10%
Debt Instrument, Interest Rate, Effective Percentage Rate Range, Minimum 2.80%
Base Rate [Member]
 
Debt Instrument, Interest Rate, Stated Percentage 3.30%
LIBOR [Member]
 
Debt Instrument, Interest Rate, Stated Percentage 0.20%
XML 32 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3 - Stock-Based Compensation (Tables)
3 Months Ended
Jun. 30, 2012
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
   
Number
Of
Shares
   
Weighted
Average
Exercise
Price Per
Share
   
Weighted Average
Remaining
Contractual
Term (in years)
   
Aggregate
Intrinsic
Value
 
Outstanding as of March 31, 2012
    597     $ 5.94                  
Granted
    -       -                  
Exercised
    (10 )     4.03                  
Cancelled/Forfeited
    (20 )     6.65                  
Outstanding as of June 30, 2012
    567       5.95       4     $ 516  
Exercisable as of June 30, 2012
    560       5.94       4       516  
XML 33 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Accounting Policies, by Policy (Policies)
3 Months Ended
Jun. 30, 2012
Business Description and Basis of Presentation [Text Block] Basis of Presentation: Transcat's unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission ("SEC").Accordingly, the Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements.In the opinion of the Company's management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included.The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year.The accompanying Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended March 31, 2012 ("fiscal year 2012") contained in the Company's 2012 Annual Report on Form 10-K filed with the SEC.
Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments: Transcat has determined the fair value of debt and other financial instruments using a valuation hierarchy.The hierarchy, which prioritizes the inputs used in measuring fair value, consists of three levels.Level 1 uses observable inputs such as quoted prices in active markets; Level 2 uses inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, which is defined as unobservable inputs in which little or no market data exists, requires the Company to develop its own assumptions.The carrying amount of debt on the Consolidated Balance Sheets approximates fair value due to variable interest rate pricing, and the carrying amounts for cash, accounts receivable and accounts payable approximate fair value due to their short-term nature.Investment assets, which fund the Company's non-qualified deferred compensation plan are included as a component of other assets (non-current) on the Consolidated Balance Sheets, consist of mutual funds and are valued based on quoted market prices in active markets.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock-Based Compensation: The Company measures the cost of services received in exchange for all equity awards granted, including stock options and restricted stock, based on the fair market value of the award as of the grant date.The Company records compensation cost related to unvested stock awards by recognizing, on a straight-line basis, the unamortized grant date fair value over the remaining service period of each award.Excess tax benefits from the exercise of stock awards are presented in the Consolidated Statements of Cash Flows as a financing activity.Excess tax benefits are realized benefits from tax deductions for exercised awards in excess of the deferred tax asset attributable to stock-based compensation costs for such awards.The Company did not capitalize any stock-based compensation costs as part of an asset.The Company estimates forfeiture rates based on its historical experience.During the first quarter of the fiscal year ending March 30, 2013 ("fiscal year 2013") and fiscal year 2012, the Company recorded non-cash stock-based compensation cost of less than $0.1 million and $0.3 million, respectively, in the Consolidated Statements of Operations
Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Translation and Transactions: The accounts of Transmation (Canada) Inc., a wholly-owned subsidiary, are maintained in the local currency and have been translated to U.S. dollars.Accordingly, the amounts representing assets and liabilities, except for equity, have been translated at the period-end rates of exchange and related revenue and expense accounts have been translated at an average rate of exchange during the period.Gains and losses arising from translation of Transmation (Canada) Inc.'s balance sheets into U.S. dollars are recorded directly to the accumulated other comprehensive income component of shareholders' equity
Earnings Per Share, Policy [Policy Text Block] Earnings Per Share: Basic earnings per share of common stock are computed based on the weighted average number of shares of common stock outstanding during the period.Diluted earnings per share of common stock reflect the assumed conversion of stock options and unvested restricted stock awards using the treasury stock method in periods in which they have a dilutive effect.In computing the per share effect of assumed conversion, funds which would have been received from the exercise of options and unvested restricted stock and the related tax benefits are considered to have been used to purchase shares of common stock at the average market prices during the period.The resulting net additional shares of common stock are included in the calculation of average shares of common stock outstanding
Subsequent Events, Policy [Policy Text Block] Subsequent Event: On July 16, 2012, the Company acquired Anacor Compliance Services, Inc., a nationally-recognized provider of specialized analytical, calibration, compliance and validation services to the life sciences sector including biotechnology, medical device and pharmaceutical industries.The acquisition is not considered material
XML 34 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 1 - General (Tables)
3 Months Ended
Jun. 30, 2012
Schedule of Weighted Average Number of Shares [Table Text Block]
   
First Quarter Ended
 
   
June 30,
2012
   
June 25,
2011
 
Average Shares Outstanding – Basic
    7,375       7,277  
Effect of Dilutive Common Stock Equivalents
    306       331  
Average Shares Outstanding – Diluted
    7,681       7,608  
Anti-dilutive Common Stock Equivalents
    428       475  
XML 35 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 4 - Segment Information (Tables)
3 Months Ended
Jun. 30, 2012
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   
First Quarter Ended
 
   
June 30,
2012
   
June 25,
2011
 
Net Revenue:
           
Product Sales
  $ 16,365     $ 17,182  
Service Revenue
    8,732       8,423  
Total
    25,097       25,605  
                 
Gross Profit:
               
Product
    4,210       4,268  
Service
    1,997       2,030  
Total
    6,207       6,298  
                 
Operating Expenses:
               
Product (1)
    3,358       3,447  
Service (1)
    2,255       2,281  
Total
    5,613       5,728  
                 
Operating Income
    594       570  
                 
Unallocated Amounts:
               
Interest and Other Expense, net
    47       45  
Provision for Income Taxes
    186       200  
Total
    233       245  
                 
Net Income
  $ 361     $ 325  
XML 36 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3 - Stock-Based Compensation (Detail) - Summary of the Company's Stock Options (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Jun. 30, 2012
Number Of Shares 597
Weighted Average Exercise Price Per Share (in Dollars per share) $ 5.94
Weighted Average Remaining Contractual Term (in years) 4 years
Aggregate Intrinsic Value (in Dollars) $ 516
Exercisable as of June 30, 2012 560
Exercisable as of June 30, 2012 (in Dollars per share) $ 5.94
Exercisable as of June 30, 2012 4 years
Exercisable as of June 30, 2012 (in Dollars) $ 516
Exercised (10)
Exercised (in Dollars per share) $ 4.03
Cancelled/Forfeited (20)
Cancelled/Forfeited (in Dollars per share) $ 6.65
Number Of Shares 567
Weighted Average Exercise Price Per Share (in Dollars per share) $ 5.95
XML 37 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)
In Thousands, except Share data, unless otherwise specified
Jun. 30, 2012
Mar. 31, 2012
Accounts Receivable, allowance for doubtful accounts (in Dollars) $ 97 $ 99
Common Stock, par value per share (in Dollars per share) $ 0.50 $ 0.50
Common Stock, shares authorized 30,000,000 30,000,000
Common Stock, shares issued 7,905,461 7,840,994
Common Stock, shares outstanding 7,406,679 7,341,007
Treasury Stock, shares 498,782 498,782
XML 38 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3 - Stock-Based Compensation
3 Months Ended
Jun. 30, 2012
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE 3 – STOCK-BASED COMPENSATION

The Transcat, Inc. 2003 Incentive Plan, as Amended and Restated (the “2003 Plan”), provides for, among other awards, grants of restricted stock and stock options to directors, officers and key employees at the fair market value at the date of grant.  At June 30, 2012, the number of shares available for future grant under the 2003 Plan totaled 0.1 million.

Restricted Stock:  The Company grants performance-based restricted stock awards as a primary component of executive compensation.  The awards generally vest following the third fiscal year from the date of grant subject to certain cumulative diluted earnings per share growth targets over the eligible period.

Compensation cost ultimately recognized for these performance-based restricted stock awards will equal the grant date fair market value of the award that coincides with the actual outcome of the performance conditions.  On an interim basis, the Company records compensation cost based on an assessment of the probability of achieving the performance conditions.  The Company achieved 75% of the target level for the performance-based restricted stock awards granted in the fiscal year ended March 27, 2010 (“fiscal year 2010”) and as a result, issued 52 thousand shares of common stock to executive officers during the first quarter of fiscal year 2013.  At June 30, 2012, the Company estimated the probability of achievement for the awards granted in fiscal years 2013 and 2012 to be 100% of the target levels and 75% of the target levels for the awards granted in the fiscal year ended March 26, 2011 (“fiscal year 2011”).  Total expense relating to performance-based restricted stock awards, based on grant date fair value and the estimated probability of achievement, was less than $0.1 million in the first quarter of fiscal years 2013 and 2012.  Unearned compensation totaled $0.8 million as of June 30, 2012.

On April 4, 2011, the Company granted restricted stock awards, which vested immediately, to its officers and certain key employees.  Total expense related to these restricted stock awards, based on grant date fair value, was $0.1 million in the first quarter of fiscal year 2012.

Stock Options:  Options generally vest over a period of up to four years, using either a graded schedule or on a straight-line basis, and expire ten years from the date of grant.  The expense relating to options is recognized on a straight-line basis over the requisite service period for the entire award.

The following table summarizes the Company’s options as of and for the first quarter ended June 30, 2012:

   
Number
Of
Shares
   
Weighted
Average
Exercise
Price Per
Share
   
Weighted Average
Remaining
Contractual
Term (in years)
   
Aggregate
Intrinsic
Value
 
Outstanding as of March 31, 2012
    597     $ 5.94                  
Granted
    -       -                  
Exercised
    (10 )     4.03                  
Cancelled/Forfeited
    (20 )     6.65                  
Outstanding as of June 30, 2012
    567       5.95       4     $ 516  
Exercisable as of June 30, 2012
    560       5.94       4       516  

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the first quarter of fiscal year 2013 and the exercise price, multiplied by the number of in-the-money stock options) that would have been received by the option holders had all holders exercised their options on June 30, 2012.  The amount of aggregate intrinsic value will change based on the fair market value of the Company’s stock.

Total unrecognized compensation cost related to non-vested stock options as of June 30, 2012 was less than $0.1 million, which is expected to be recognized over a weighted average period of less than one year.  The aggregate intrinsic value of stock options exercised in the first quarter of fiscal year 2013 was less than $0.1 million.  Cash received from the exercise of options in the first quarter of fiscal year 2013 was less than $0.1 million.

XML 39 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 34 157 1 true 11 0 false 4 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://transcat.com/role/DocumentAndEntityInformation Document And Entity Information false false R2.htm 001 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://transcat.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations (Unaudited) false false R3.htm 002 - Statement - Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://transcat.com/role/ConsolidatedComprehensiveIncome Consolidated Statements of Comprehensive Income (Unaudited) true false R4.htm 003 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://transcat.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets (Unaudited) false false R5.htm 004 - Statement - Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://transcat.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Unaudited) (Parentheticals) false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://transcat.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 006 - Statement - Consolidated Statements of Shareholders' Equity (unaudited) Sheet http://transcat.com/role/ShareholdersEquityType2or3 Consolidated Statements of Shareholders' Equity (unaudited) false false R8.htm 007 - Disclosure - Note 1 - General Sheet http://transcat.com/role/Note Note 1 - General false false R9.htm 008 - Disclosure - Note 2 - Debt Sheet http://transcat.com/role/Note0 Note 2 - Debt false false R10.htm 009 - Disclosure - Note 3 - Stock-Based Compensation Sheet http://transcat.com/role/Note00 Note 3 - Stock-Based Compensation false false R11.htm 010 - Disclosure - Note 4 - Segment Information Sheet http://transcat.com/role/Note000 Note 4 - Segment Information false false R12.htm 011 - Disclosure - Note 5 - Acquisitions Sheet http://transcat.com/role/Note0000 Note 5 - Acquisitions false false R13.htm 012 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://transcat.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) false false R14.htm 013 - Disclosure - Note 1 - General (Tables) Sheet http://transcat.com/role/NoteTables Note 1 - General (Tables) false false R15.htm 014 - Disclosure - Note 3 - Stock-Based Compensation (Tables) Sheet http://transcat.com/role/NoteTables0 Note 3 - Stock-Based Compensation (Tables) false false R16.htm 015 - Disclosure - Note 4 - Segment Information (Tables) Sheet http://transcat.com/role/NoteTables00 Note 4 - Segment Information (Tables) false false R17.htm 016 - Disclosure - Note 1 - General (Detail) Sheet http://transcat.com/role/NoteDetail Note 1 - General (Detail) false false R18.htm 017 - Disclosure - Note 1 - General (Detail) - Average Shares Outstanding Used to Compute Basic and Diluted Earnings Per Share: Sheet http://transcat.com/role/AverageSharesOutstandingUsedtoComputeBasicandDilutedEarningsPerShareTable Note 1 - General (Detail) - Average Shares Outstanding Used to Compute Basic and Diluted Earnings Per Share: false false R19.htm 018 - Disclosure - Note 2 - Debt (Detail) Sheet http://transcat.com/role/NoteDetail0 Note 2 - Debt (Detail) false false R20.htm 019 - Disclosure - Note 3 - Stock-Based Compensation (Detail) Sheet http://transcat.com/role/NoteDetail00 Note 3 - Stock-Based Compensation (Detail) false false R21.htm 020 - Disclosure - Note 3 - Stock-Based Compensation (Detail) - Summary of the Company's Stock Options Sheet http://transcat.com/role/SummaryoftheCompanysStockOptionsTable Note 3 - Stock-Based Compensation (Detail) - Summary of the Company's Stock Options false false R22.htm 021 - Disclosure - Note 4 - Segment Information (Detail) Sheet http://transcat.com/role/NoteDetail000 Note 4 - Segment Information (Detail) false false R23.htm 022 - Disclosure - Note 4 - Segment Information (Detail) - Business Segments - Operating Income: Distribution Products ("Products") and Calibration Services ("Service") Sheet http://transcat.com/role/BusinessSegmentsOperatingIncomeDistributionProductsProductsandCalibrationServicesServiceTable Note 4 - Segment Information (Detail) - Business Segments - Operating Income: Distribution Products ("Products") and Calibration Services ("Service") false false R24.htm 023 - Disclosure - Note 5 - Acquisitions (Detail) Sheet http://transcat.com/role/NoteDetail0000 Note 5 - Acquisitions (Detail) false false All Reports Book All Reports Element us-gaap_ShareBasedCompensation had a mix of decimals attribute values: -5 -3. 'Monetary' elements on report '016 - Disclosure - Note 1 - General (Detail)' had a mix of different decimal attribute values. 'Shares' elements on report '019 - Disclosure - Note 3 - Stock-Based Compensation (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 001 - Statement - Consolidated Statements of Operations (Unaudited) Process Flow-Through: 002 - Statement - Consolidated Statements of Comprehensive Income (Unaudited) Process Flow-Through: 003 - Statement - Consolidated Balance Sheets (Unaudited) Process Flow-Through: 004 - Statement - Consolidated Balance Sheets (Unaudited) (Parentheticals) Process Flow-Through: 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) trns-20120630.xml trns-20120630.xsd trns-20120630_cal.xml trns-20120630_def.xml trns-20120630_lab.xml trns-20120630_pre.xml true true XML 40 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 3 - Stock-Based Compensation (Detail) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended
Jun. 30, 2012
Jun. 25, 2011
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in Shares) 100,000  
Share-based Compensation Arrangement by Share-based Payment Award, Performance Target Percentage 75.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in Shares) 52,000  
Estimated Probability Achievment of Performance Based Restricted Stock Awards Granted in FY 2012 and 2013 100.00%  
Estimated Probability Achievment of Performance Based Restricted Stock Awards Granted in FY 2011 75.00%  
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized $ 0.8  
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period 4 years  
Share-based Compensation Arrangement By Share-based Payment Award Fair Value Assumptions Expiration Term 10 years  
Less Than [Member]
   
Restricted Stock or Unit Expense 0.1 0.1
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Stock Options 0.1  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value 0.1  
Proceeds from Stock Options Exercised $ 0.1